From d77ad6bd6e151ee33ea78b5073944eae16528032 Mon Sep 17 00:00:00 2001 From: Matthijs Berends Date: Thu, 27 Mar 2025 15:36:27 +0100 Subject: [PATCH] (v2.1.1.9227) unit test fixes --- DESCRIPTION | 2 +- NEWS.md | 2 +- R/aa_helper_functions.R | 8 +++++++- R/custom_eucast_rules.R | 4 ++-- R/eucast_rules.R | 4 +++- R/sir.R | 6 +----- R/sysdata.rda | Bin 98252 -> 98196 bytes data-raw/eucast_rules.tsv | 2 +- ....txt => gpt_training_text_v2.1.1.9227.txt} | 6 +++--- man/eucast_rules.Rd | 2 +- man/mdro.Rd | 2 +- 11 files changed, 21 insertions(+), 17 deletions(-) rename data-raw/{gpt_training_text_v2.1.1.9226.txt => gpt_training_text_v2.1.1.9227.txt} (90%) diff --git a/DESCRIPTION b/DESCRIPTION index 4f3cbca44..aa3557203 100644 --- a/DESCRIPTION +++ b/DESCRIPTION @@ -1,5 +1,5 @@ Package: AMR -Version: 2.1.1.9226 +Version: 2.1.1.9227 Date: 2025-03-27 Title: Antimicrobial Resistance Data Analysis Description: Functions to simplify and standardise antimicrobial resistance (AMR) diff --git a/NEWS.md b/NEWS.md index 1f0c92396..de3aab738 100644 --- a/NEWS.md +++ b/NEWS.md @@ -1,4 +1,4 @@ -# AMR 2.1.1.9226 +# AMR 2.1.1.9227 *(this beta version will eventually become v3.0. We're happy to reach a new major milestone soon, which will be all about the new One Health support! Install this beta using [the instructions here](https://msberends.github.io/AMR/#latest-development-version).)* diff --git a/R/aa_helper_functions.R b/R/aa_helper_functions.R index c0c205b62..98fa8842d 100644 --- a/R/aa_helper_functions.R +++ b/R/aa_helper_functions.R @@ -1299,7 +1299,13 @@ font_purple_bg <- function(..., collapse = " ") { try_colour(font_black(..., collapse = collapse, adapt = FALSE), before = "\033[48;5;89m", after = "\033[49m", collapse = collapse) } font_rose_bg <- function(..., collapse = " ") { - try_colour(font_black(..., collapse = collapse, adapt = FALSE), before = "\033[48;5;217m", after = "\033[49m", collapse = collapse) + if (is_dark()) { + # this is #ed553b (picked to be colourblind-safe with other SIR colours) + try_colour(font_black(..., collapse = collapse, adapt = FALSE), before = "\033[48;5;203m", after = "\033[49m", collapse = collapse) + } else { + # also colourblind-safe but softer + try_colour(font_black(..., collapse = collapse, adapt = FALSE), before = "\033[48;5;217m", after = "\033[49m", collapse = collapse) + } } font_na <- function(..., collapse = " ") { font_red(..., collapse = collapse) diff --git a/R/custom_eucast_rules.R b/R/custom_eucast_rules.R index 86cd82738..ff6e558ed 100755 --- a/R/custom_eucast_rules.R +++ b/R/custom_eucast_rules.R @@ -253,7 +253,7 @@ print.custom_eucast_rules <- function(x, ...) { if (is.na(rule$result_value)) { val <- font_red("") } else if (rule$result_value == "R") { - val <- font_red_bg(" R ") + val <- font_rose_bg(" R ") } else if (rule$result_value == "S") { val <- font_green_bg(" S ") } else { @@ -297,7 +297,7 @@ format_custom_query_rule <- function(query, colours = has_colour()) { query <- gsub(" %in% ", sub("{text}", " is one of ", txt, fixed = TRUE), query, fixed = TRUE) query <- gsub(" %like% ", sub("{text}", " resembles ", txt, fixed = TRUE), query, fixed = TRUE) if (colours == TRUE) { - query <- gsub('"R"', font_red_bg(" R "), query, fixed = TRUE) + query <- gsub('"R"', font_rose_bg(" R "), query, fixed = TRUE) query <- gsub('"S"', font_green_bg(" S "), query, fixed = TRUE) query <- gsub('"I"', font_orange_bg(" I "), query, fixed = TRUE) } diff --git a/R/eucast_rules.R b/R/eucast_rules.R index 3424d8c37..6d85c90ea 100755 --- a/R/eucast_rules.R +++ b/R/eucast_rules.R @@ -656,7 +656,9 @@ eucast_rules <- function(x, if (isTRUE(ampc_cephalosporin_resistance)) { ampc_cephalosporin_resistance <- "R" } - eucast_rules_df[which(eucast_rules_df$reference.rule %like% "ampc"), "to_value"] <- as.character(ampc_cephalosporin_resistance) + if (!is.null(eucast_rules_df$reference.rule)) { + eucast_rules_df[which(eucast_rules_df$reference.rule %like% "ampc"), "to_value"] <- as.character(ampc_cephalosporin_resistance) + } } # sometimes, the screenings are missing but the names are actually available diff --git a/R/sir.R b/R/sir.R index 5b3b0963c..461ac0a1c 100755 --- a/R/sir.R +++ b/R/sir.R @@ -1715,11 +1715,7 @@ pillar_shaft.sir <- function(x, ...) { out[x == "S"] <- font_green_bg(" S ") out[x == "I"] <- font_orange_bg(" I ") out[x == "SDD"] <- font_orange_bg(" SDD ") - if (is_dark()) { - out[x == "R"] <- font_red_bg(" R ") - } else { - out[x == "R"] <- font_rose_bg(" R ") - } + out[x == "R"] <- font_rose_bg(" R ") } create_pillar_column(out, align = "left", width = 5) } diff --git a/R/sysdata.rda b/R/sysdata.rda index cb96a51eac87492a25a9735a3aa2dc42c0bebfd9..db2fbafd931da54c1c95370a027b8951ed848605 100755 GIT binary patch delta 93789 zcmV(nK=QxL{{@u)1&|p62s*JF2o!&Sh0o2Fa^;a6FBx$>H^~@8xaNQzeflcBc)ow*VB5c4?Soo#HBK5F(!q|UthTw=x zVglGmhZ8pLl_Ow;;Cd6LgK?#Im31KCgAXZymLA+f4|*_J&ktyEc&aZlrJCdhHlD>u*EbWeDf3dfxo4BY3Iw|`E=3-bcb!CiXxGg9>Xq$6gDi~I%Ci!8f*E!5ezoY% zl$%J{23AzhAUgjv=O^54gJ^%^Js#XvjBPyR+`oU<_M@J|*G}>VtV!}H;y#R+mD7wS z{km^T-u4~bu@RATsy$n+5QySI6c4vvw8z`*{V!Jjs?~kz$V~sG`NXh>;ZheRYu<}_ z03PW^AHftMq{~1^JzeV(0(^EngFOjv+3(PZx@7{8X1BJQ$2K&ac`AQ{(_u)rpr4%b zmb$?j?f`$0UJ;%}1VvYi?rNuh5$kZus1565$Av&IdON|R(=$Am3gMfTF1k#03rT|t znlz+pTOxZ)uD=Veu7_e1T=LOedvRH5S&??F2|veYRiYGcz3O~>2Jep@v#{jD7&V6C zT|G55OYSMSsl^c>BNBhe2`VyK=%0~ahElw27KeZCkzFm_!ADJ8H|3LB(BznIG8kn- zSDn~Em`jdlv}&b+&4Y{>@+;GyE6bNCwrs0uLB>&2Ce@mvte)(5+XR?j$8L}A@Ugh> zx40{k^(f!i3q;s;ShVMJkFQ-R)HY_i2p0%lN}0P`H)~KRW+Q($S1)>g*+x31T5@{r z9NTt)t6?F=db7*%)#x;F4Dx<(=&KEFvw^JM$y)+1d`tt?f(O#3Y8er;5fango*+fv z7ej@nfR2kz;xOa%SWXJH#8Y-?b}k$Cw7wS9llP zIoP&NC}jksp8Ryx#9H#iRk_>EV+nx!d8%S@m4OwsC*_@TAK8?k>Q`RM6|Vlmy+oFIhN9#MLxIQOT}=E0mMBPUgp11~Rj3_u=8GNxHo zQg!!Ckw|_XB8eb2JE=h9x23bQ^8;U01$mQZv%Ue_I5Tlu+=1r2nG;`IJC?s=ZB&P@ zy)Fd!eh+&GEdb?osuJf`i`MMsI%106FWWCiG0%U%1<^h3^UA;M6`{aMeb_JR;WMl$ zvBxzKAvf7Wy;ODQPN)xS_EJjDR#_Nm1Pi+rn%U$SQ9w>S?+~i<3uW+IW}@glpP%DY_5?ed(_@{3=-Atb?uF9e>SwlkO10&ZmA}hbcO zVgya>3r}Wk%Po11Gy=gA5(s<_QB;ki6$rTrmjWr+uu)$c_<-ggP#F(PykW2qjR}cm zbClvJMslVZYKTpqF6uQTS-tm>=Blr!`v_bFy>kNe0_MyHLTN}*VI60r_*z$3x{rSj zkeB)Uo#|e+l5SPKTT}O;^3D9aeO9tzs%PCWG znTzDhx^oR!Lm9*7N0(fb)X~X}TskFmXOgP()3^o#w^V#<@e{f8`tK>bKAC8CPj_(3|j#^VAh$P6;ar;J>%PpH# z7{__B@r02&R1i}94YCme{Ys(-6Zkz0J<++wHIYqu$QtdQ z{orQuE0%nr4QymdW!k0b%SGfo0)JG{yO9IgBJ@xX!jNts3U>)jpi3AHw%%K11EL-3 z#7AZ^3u@q%FWr@j1kpQ_!dF@! z8mErFZk@1u!>800;cPgGFAnQ%0x~Jp&H0F%mCl??)M0+RV{w16b??jrX)r+5JWujX z>8csiFYrrm4|zD!OwkSype_`Qv{CL^XrePBy+fvbZ1sNnuf*GFH_Ax-{T%qUgf5n; z*Z#jk+*3{4GO$jXHqu>y2cC>s)deACGIQ0?Gx~a_o#eOhlh?Nqzwhv+ZVQTr+hqDA z%n87I8xoU(dl`QR<1;=?mpgkXiJ<|3+G+HhP>`!g-6ChL!pw3hm?SM~^BbPQp3M$5 zT-<-uuiRO}pedyr_J38{Nl%8k)N3W8Sk-}MAJtpZT2T~^YC_w{O}zQj1IlTwW+n1y zXxTg6d_bihpjUXi-UlgfiybgILS|{bXA_ZJsK=(Qx9)#g!>Xb)03DyKl$2C@?pIjB zEv=OJi8+?*9?ROSmCob~7-$$7*98JSw;d$;oQsl~;I)`QdIt^^RV^(JE0%HGy6*?Y zi0AH$Vlt09)N-Uqp6ro9$0r@&mwa{WK^it70b9V@RW(dfOxQ*RG!jC#dul@;R}AR! z)vc}~<=cO&?14WM&54leO~f%1Q&;nRaTeO$H`l`C;#m5rCgQxUVzm)^zKC=hI0)4L z-6IOcc$mn_o1pnj=S@H&pD zJi1tvM61g+hgoaI3bOV1avRhIk_M;=n1o`($4mx|hwxY9; zDp}(-ziI5L2PZDN|CzGst(9VLE}=fT6KonFe+TVaW2exS(=u0qzsSD@et@}+JNoey0iu|e%M0U$-YL7 zvtNJtl{+wUJN6?W1(HU?MXT}hWL>X&mhEDsp)XQTQ_E;{g(SMw5l!EZHg1zlg-4F8 zUq9RAX_;zJAu6n9jbR*bk!i0M3#oz$SrVP4glt=A0F=MZRcUB7;`zgcWaq$m2@I6H zq)$9!uykCfSg8Q2v-l?SH|CFrHXHxDH)DTncZlDZQ9W4VM;6v@Fa;2&HHvaFJe@waQ;by9IsDV5I<^M=mz+!dE<&zFcIlO`u!p` zJWqHrY9tgvi*!PyE^oWP8Xkn#%Eek<>jOboG?Ulqc~K_)Y(>-pNutf$#F$y^o}w2njcY%@7e77zSuFbaHIGs1z{+z+GXs`K1WN zY!;3uGLq)A34WztJ&rsG(aV6y&S|&UZ1@wiAgL{i?v|@NTC7X~r~>$|;a?X--Q!ub zvt=yv!B>h69&==Ydn8lktp9(gS?qmbc3qh6N^OsEoqZmB4*`|o)iu(Y$*I09XEm7g zd8K)bC=f-i8^)}U9EB`*E-Fjjilc{1oqS`CN7?925;%@a)#pg-9^4Z5&N&FIbH2gg z5QINQxzc1npX-F%-}oxYU$NpZ{&H&h1yHmL3vS-|i-0_ptUzz)>&k!KbD34(x-R&` zvFiokrq9m_6lIX;)TFSt#a%k3rBH0KS4k$>e&~|_XgS<-QrQiLio$B_OD=)%kno{R z`=kbg{h7!vkjW5}Kv5`u*L8A@G{dwJ5OGx*@#|Bsw)Zo*f5kBVd-exxv)y8iy4>7XbK}!z<(H25HZ02t)OGR52F&pH&I>r*Dm@y z9DCaz)x$N2Vp1q;3wI?4x_EBH3)xCQgN&`5xv2P#*!OwWWC4H3K-(**(#y)bgI;S* zN7M@vHE~7r6qWzZ+1+F%c|}h*_ApGKC11Bc5fW(cR{e90mt#g0!Lto98BSY9X0RO> zq!MT%JNR#Y2t9{;!RS^t11BioZB0*O#?uS~^U4`wuJ88LDOAn~h4gGdjelDw36Ee_ zMl8LquFs*7o6>*2wG0v>cK|Disa2x;N$Ur^bgJ4q(8|e-28V&b3H!Bl41$8oN8zGN ze!;5i!P=t|J`2c@acLL13yf53vSJNLeD)~l-;=pv*Q5Y~1t3(97eMI=X63Jb)II+u zcd)7O^RK`57aFp>q+lS0Ls??%5 zKuV{3@uCUb@lG;qWg>WnAp^=vZDoZSNDZ4iY!r@hd1e0hSGQ^p~vEW?0;teO$ zQnv7@LQ|xXiFqewPQ8qubT*9Q%#s16d3oxrF!?ml+bTa3Wndv9=mEi-siwx>Zfq{S zw7r-h*u#G|DP(F#grm?_-}$2@F83h$_Y5J#qkNYfw;yxi^WyE8T%6y{lm zA2>7k(cm_w=~qoruhCMIyiqpQ*c&Gh9yjSU|F36=EP77g`oX!sZO$oj04RLqr_XBg z@Up$^4vDh!r0IsmmX^Edsf{c&r^SAE<ICz4<;2N>>V(}jC zaWEyH*)inBUqHQ3c^mO_2&B~)D?PJL6$c3^B+s|7Gu9FHTeL}lf0#j$t}&yFgI{ZO z0-1mQ0#@%@4QJ_AMl43>ui=?2Y88+(n8^tG&Ree)!uP{bnXEUG;H2OX9@d#RhO)qo zDOoH3+C#JRWKOO2|BNG|ZthyX<^30ust}Nf)RMDxno$pT6x368z5o6TZ7@|2gt@p z{?6yVWj*}tl=bU6F|=OWfmN|;lrkmPCanXE_`cJ!fg z92udi0E@NUSxxhd6(AJHIDxiW-FgjKWmXhY_6OZKE4)TkY3hB)&OHu^v|l%QEyjO< zkhp}27zRypI+tqHFIQ(|$PP-D;8G($0@A}nb>?kF$D3MIgaM>XHJR0|ll(yidearD zPD1xP>_W2|uRnN6wd;v+3sl2;Xe>cW#NVl_>rVTRWj+nh0yTwDYgxb#FWJpK$9GEn_BRIjaUWg6%0B zj=+hl4b5%-;aV=taHz{RkzAB@`ol5G&|o=OxKkPqgQ@6Eo3DW!#kK*mV~p?&L=+xx zV?baV;bPwMt4rV5L*_|o{irkO8UcEknDH%; zG8g>`bwgQVVFZ1>dNj0@?9}|wEOtc(?{DE>y$ikpvckSTB3{M+L}0WI1Z1lZXJ z{9}5v5N2q&hMylryT!3bVU~Y8NSajsG`oKVchg53TFyBpGt!rVgw?R;`+XA$l7>+w z2X=}fvAU`=S_S>!t%U|MnXM=xKRatlM_PH={28so)a|9}-*Uh;bm^LGGNN-Bz6vZl z#{li&B8}lqjrjfO9=K^d2yN39&iL`;$VG8%HyxK(&S(P7bKta}tr>r~1owhJ`ii;7 z(+}>1HCz2>6J`33t#$7q%};O>1*sD_Z`>xo@S3vqT=Rn9;K#eM&`Ea*#BreWx9s0X zRU?90p31qtjv+wG$)v|~#H z!;Tx_Q_@#bUhOB5^?|VnXoBb3l4kS=S$QxGn`ZnWF;E&5;AS-`1B(b)sUR<7q7ztA zj;xpTR-eHI+YW!pbf%2f0FoiPT+WX~6mDh%0nHYb%rha(W7Jty1)Qx|R_aZhaiaxRJEc z8OxY7Xjr)$;N%Dn!B8}6fHeD z%qW_u#o~Wg*71c$RH|hp{rlH=i>G8KS0bWgit!ydZ0+$9M6ePbkR@Z6tgRl${Hl$w zE$>*AyGpC1h^D%Q6Cj1WYrYInEr1vez=%4(<}fE4t<4K5(}N)~RAGTfjs zdU6vRxW+${cWqIORONse>%Y)%=o$Qj8RQ^g&1syC(ThZ+7ZLhUxLZQkr+xE@%kv2) zHf13EsGq&Q9hZ5t5Lb4gC!J6h`=IQI8`8MSwNgRYl4kk{^4}i{nLkb~;a*>10W@zb zOd7hTpzenuS}WN0ii}niic?Ext{@;}36KCY!K=#c#m6;(%_%BQ-nd7($%ZooXcIF;H5n=i% zkx3UdSe#f`w3i4=TBjb_JO=*(qfcqJD9CBBEP!gVbFfniNO(Obqsj;zHDX1OkYBp9 zs&snyluT39MPMvhcuag{V7*v(UVDEW2weKrbHa>$RxY;|Q0^{q=moW%&W(oX}Rg2%`QDhhFQt=p1I)7JEWHn~Ek$XF`*<|QA zN<-VTs7^guW0HB22$phAd3qH%#j{k!1opa=HP|325!4pkitZrZ#Upuy>6w4hfq0ZN zgPw*sJ;VP@qAX~aq&N*yz6aN$kwv%EwF@$-y|z2){Y*)agCaqoYOktUsXH@P>c>fL>+&j*;f*I>qdzZ$OQ^WiX3@fOIh7mu*f^brN_}D zEwFUK^<1j^8B4Ij{CAAX?O3~bf;`+_#D8(zeO769(End5`%kru&h1;$!*l)}HB@5A zQyu12;zyg=w>VFuor1;Yzb@Uj*Ql|mJW zIG4|EHvEBl&J>y~RT1nB(UYv7mAVyUNm46l3l^jYR7m#qcsgx?r=OC9$zZo^vX@;V zyP!Cx7{4VWDCM~krk9lJ7f$F`j<*Our2^0hK}t;hP!8}v(S?dCNXsw;xo$cOvT^ka5?u!`igbn?$(J6@>a$CVL}u1^{B(TCWRtR+!#LJ zGcFO403%s9%-6wSSz>hRKzu#Hk0YL-TQJhaCS`#c3f;WG$>IxoDOuyJp_K)rfYSMH zMFW4lfW}}iF7F<@`rTsbEYyLIJB66MY?5x0qUDfkzKd zjX_8{=G;V6eKkhvfVUi#*G*rH+AJ}!|5(v_s3vAUeGJdpB(aN^mq=c*;D#O;uj3J5 zLO6U0doX`Gft@9R2{KO2YL03ms63f`(3(uyT;S-4{f`^EOCPefcRz_&tCx7y^euWZ zdGW(k%(5`VY#UD+>iDO?5P=2sr}Pt|hY5rVuUa}WK9Ye57g-1=g$-V|ekTGGZfmt( zBAoFF{f6l#sUthL<5w|=gj5bk~BQbx@c@YjN!;v>@vm3FtTW?;~MT~nC zxjr)pM?&BwoB_)_#aSu5GU|F^x9HA{w(}W^)mZb)$;!+@HqpUU?GR`8)Vb$H=)N7` zyRCH9)Y>XDf`GY7K{Z)jYw@b2pw}h+KYe#D!YsS)dA&8>dwN9{82grRB=qsu9T2rk zHwAw)qQrh7QXnZq0d(nY(mJ_|-08(V*9WNc@ECBBOXebMl>B5k-Ai6%%x5kG8b%f@ zcg1jsgFz8bGMw!#dqXFTnwtc)ZL^9g-L&SjpzNE23kP5*14IAQ}SlW z$P5>;!z&e~9b%aa0<9KlebL4TA#L36@YtHC>B~wLrSf_>Vf$lziLk!XFD+B3%GiI( z9O|il2!Z&Hy|o%k$NYYWtq&}cRvEzbP=N5fXn|L`fQNh6UPrGA?3XY6E;RWXw+h*= z*9Y03iaG$;;D2a-_2-J$JDFJRQ2}E+R5zh=nZiAt-+VfWVsb zN84i>N~?b{519fhY)4uVUS0YPW?Tb(cKLikVV~c&zkhiv2mE%BdGVJv{abS_Uei3! zznhxLcgjX|l4yP616tTlMfMyyp`B*6PO!tBWRgXVODSkFrUh25w z;mG`1^IUa6E$R)NW&<|*iO#TWTc~4HHaa~Vav2_=6H*JBvIqnD?j z=D<-XAjdqVZf?bx0qw{d(RyXyvhPBN={2xGL;OGGz7DDSXv?|yA2lo={c)KmZ~l@s zQO*E5rQe@bv50{n*0++z|BY_D2i*pPw!GQh;Fs($h}$b8Q@E4%9UIc+C5td+(oW-= zCgU7pY24Jhp|qY}>y-RR^bp%GYQ1&+;+TWiXf=Muv2?aYI4Ucj!D`FGOy)V^DdA8Kh#^mDlk5GS@$$3Q5TM%xya_Vf> zoAcB=Uof*uinpS;$QU5uzawo=y44^{E}c_NaTc=$UoEEbo{rSkS;V~ofCB}^%zt#3 z;bDYhXA4_4Vcc%ujH8i7W6zpxf=2!VrnF=6QC_OWLea9i_;LP~nZPeuj^itvCip@a z3o2$KOdjiy*o=SeVQtU$+F|o1R%^|`rY<&3#VLl`lc^*1NM!SQ1#~E6_g^gNeS^#l z`VL3yiZ#6BIRb>90963=+VH6k)4+_5yYy4ylpYwIrPiKTcf!JpwwVDt)13*_6fH>L0~(W*lzFN!B+8 z6*)LZF%JKG?R6sJyd{b@(_|N*FF6+pMP?2Q`e^75f-#Ht^|U4b|}W}R&_{;iu#z?87urX!|8YOYU^>$x?V zKw8t|<=l33`M3$k()-wooTJJ2eKvrnFkR#xC@+7nt(N5NGsF$X%%r@BQ|4^d8k^X0 z@n<{RJWS*O*$CCT+iQejM-~b3jNbRfoU3vtGEo<}YCdwvhaf~!Nw!Di5J}_3YNl#x z!cxpuEZK;6A>IE!Stf6+eQlT>IPTiz*Qk~4L2avDF>vOD>P(T+8$hl zVhaF=gq)F?jf=xXPx9c zHloa>W`!Dih|aN%S(?hlSj=0bR0T0X{^ox}9}I1kBGtO`N1Ot(LLY9)bZ6CqcX5~f zCm2y$NrPrKoxa-nupNxxIsdK?=N<6rW(a&(ug3QVHK)*a)Crd1mT5J~zM%Ag3V7R& z1=tllbjTtE0aCrHFFL^;PYkRf)I3XYj0H=hyvC{DvTt{N-E^Cek~$|C2952fGJAht zdN&2I=vG420v^1oGNvF+!aM8zF2z0Qbs6ABR@Fedw|Ly_ZV3a6gmR_=82vRdOUD7# zBhZ6f0%uTFP-Y#(xI&<`nyli6tF|qXlf}zR-Dv_SzbT+FUM#1Cahvcs6LPD*ItjOG z-3~lGXZD^Sf-5RkI`$9i{K4Ck4Pk$aheX2;Ormn2`3$vb$c8q<(+7m47?6Lro?uB4 zjoz6Mp62s@8a#VSBT$Suhw$w@2biCx+BN?QCZcgP;DMUH$T*S4^!yhm0 zFYdsax-ORy55NFD2>794<LD%9&Hc);|YOGft+V!h(OP(Y%=aACOKa)PR#ZPHoZ0;$L4(tlVWN_4)K^d*_`~ z1~&eD`hd0}VG6%nF@_AuMr{7c-$j0(_Z$cUhE#2{=pdoz-=Nwnw!Ch!j~DBD)* z^LVks5f`l41agE_leEN|7m42_x~nM!71LRAxa}>_<4)afYP;?5WtV?yi^%v6_RM+q zhOW}e$EGfuJhow-g+))x@k0lf!z(I(YuCKc>(Zz?^6XWq<({96$vlY+H{Z1F7CYW- zM(}a~-W{vUX$W#_&xXyIJrVOZHQ5^~>^^_RnoS%pq4Nf$2J(unu^ z`YlJ_n^kjK47?ORe5%Ni4fRN&K*#LRqr@bjht(ykcf7h2h7zmqNGgH>e%CEn*L!os z2QfU^aNh+l_x=hnVo!cDMsul;#)*c&NFlXlH|+3B2C{O_hMm0WK1-LlMX#0ud04rz zv`HKq%BY&dbdP`RUgq6-WrMg_@1X(GqIrA!-1xI{UZQArq>vhzwXxTpqP52TRUu9` ze@_IzTY#P)tPw%M@OVpE2}}W^jtD05gn1M0=PJd(8If9J>#NM zhT~R9C$)U!mr44#`hH&*g8j7r@GZsmUh%vJt8rs> z&MTuw-TC}a7!}+P=F7ebpb%j)Q~ZuLW2Fl6>T2rHofa}!XW-e_y@%v-TL_GifqjZL zETMk`vVi#;UP2pWsej?TxwSv7pT?)We>K=G-rHRstElpJ^+nh~Z}1&5-Uk0pXwrj^ zE1A10`q6wkM;jFjfrYyXutyW(Z0h_*^3^4Evk5)Rmy;_>dqu=<@gm<6A zlZSk@^&}u`Apy49f!OLL$H$Lp#;J4XLHmCg*i-ls-tuEIn&Ur*j|bb-_taOe5%m#N zxVDlwHHoDdMZ&pCBh{mlsCIPgVzTN|^1~cP(Dr9n9wkEc{$HG90{_-Yd;P34KIBlz zn$eYBs{}^xHl(oQhY`*%^e5{DW7n*-p zJlZa9XLuk)*YwLhDPpp(9j*cqK}oMtoIvsAXJv*U+LX16oz~NAao(s`3GF}aRs$&2 zNsM{#379%1i$Y(tHXO*f_<2F}BJjxqv)rE+?lk@9d_>0Utp`F3x~Fz);fb4(J+P7` z{+7Vc8>TR3t7-c3OCRMzJLi3-`sROcbV>3O4yaj;)nS-@Wllo^QQQI}Yc*11g_bqB z#Qs`$DR}L*D%v#p4=>wVgF^;EN~Hbr4O4oM)XisQ&nZE_%`=^`oe$Tg!-v<`FyJ`o z6Xp3AKVCoU`meIxJ7DPr2j#xWf&?egm#^PVcR2m)F3Z>*>a|eg*)@DVARB+e#lcNA zy=NtYeL~-Ls~`)b60(H~a(i>QicG_RpEz8^;&=5Tcm7~JY}ttC#M9~P0A zU|Pj{sI?u>;px1SpadxL+3SB*2Gy`*>Q?^l^Ef#CAX69H1(n2^G*Vd$R9hkoy|@54 zose?~{kRmigc`+$(Y;ZNo-LmYo*w#$DbFizx2Z%sfA&yhH(5!>cQY4Kp@=^t!Pw)O zS=M2sh3>U#fQLW%whN86`Zs~|>5XqC&qsB({)W;yj@_!gXcX)QkV=#_EI$b&)a|eloVGvh(^6^fGk~1g|ou3L%pFq zqVd)m|C9z&$^fFr9UFhd<~8s<4Ry>#?v@ad=Bejc)!hxh2VL1pT1EU2S@0Un|DD{f zkTk#(RD7`}+dT=IsnSaDfQ%yZx32|ruvd=TO8-ji`h2#(0J6SoE-k#e(mQ^6#V7qU z{iWWd0T6jg8tP5snJ@^{y0Zbag(m02l>SLp@cZ(src&8u$f18@>-(Ta&gDx-a+JPp zDCLnw(x9zusEG}ibEQqIaZjcpf3e4C@E0_DA#q-z_)RLc#|$L7rfa_Z#EjqABL-@p zQ&*irvM0m+JMe&i$7aM>2u)@=39J@$e`O84(x){^J&D9MGS$CMR5(BMacp{!IiSHQ zIotPc8PXS=s@{Luvv)h2ScC4>%mEl}{!C52TZw>VC@Skp#CJFk7e@<5Ut&z9OCyUM z>=AU(0&d8yF_dosjuT<~b`yNf4~+@I^@Y|WUlUu@OJJ(B*e4&B>Z}8pVR#KFG9hWU!%6gL8S{+s+a0W8j-4b-{a$S($%Ojlt|ove7iAgZwqCfZe8u zDpEP>uX!#I5ZGqbM~;53j%BC}+LTUdnS6+pUa~Q$TGfX1Lc2Mad96GtF?C-~T#dS# z58otPU4@t*svsWEu<#}!SlD5FwU!FM`h)~lLA6(IdrWTi9vZ8{Hy+FoUD6J!Ovs<_76OnBpUWAN^r7@p@x&QD&0g+EMXBe z5>okb>j;$T=#J#j8ea&({m*;)(sQ{g+F+yOcP%~>cb|9S3N%#l z5qiP@nM!q-E+AP+Tq?){W&o>1sfRyj-!ls4 zZ4H0^KE&0QxV*8;L>xOQ$F{W#|4HpVS)c;YJ@z}rd1(`Yc3UL;3AJTwKvh8{+GUtz z8$(U{YZcG;XucwnRTo_nk8a{cb1s7(VVLbl1)k}oOAu0n4@rN-sEC!Q3pA4O2|~Se zaY&*F1;Uc{@R&!Re-iA`G5%HIxx_i*!dI%k3!TcUXY*v7TN*x+D7tQ%a3iP zRp9yAjgrS(foAq6M+u?@dHsG*v}+%IdTqau%j^tS`xmJxOL7X2*nxDrbAWWj(bw~< zuTPDBjDiA+04+x9!;E}Hor7>DLDhfngvR0|iQasN@)#_TN^T1L2s8a;Mzm~H?>RHA9*l4V#p( ze5!}jpgYBnYHh61763BeU#@?(m{%|TK(ST)&2uc%;3zrdy#+~=kz+)4lBmWN_l^`*TU=wo0U2VX3`tzbCO1RK_j3a(HYlj&(Vmfjo@5uK7sYswi zG{bJOVT-nEu>C^RdTi8PxcU0fOW-r+ACd_IZHq3B@6*7Ls}k7(tU`bIw;u;2pREc@ zTe%c~8=D_GE@GAzhXT>DcOhn4u%7@|%3RK@MSRQJLc_Kpx7fWsA%S-UCru^^yh?}B z$p* zpQ2Jztl&UDnET48Uk-n^6scGpnPc~(964MYrG;$1e&25UG~BR|W!m%k(5Oh$k|3rr z$x_&#y%Aj)+3{n&f8j*@KnQ4;o{cRL7{4!<9zn)cdZE1qk$831LxCI>@p(~`^1fi1 zzpQ$W{?;d%pHFDrmd3=Xx~wtv%{g;o;!a4h#?IR&f~8i?^?iR}zT-h~)6Vp0Mi7t> z@8aWuE;JZ4ag{#F(#2;s1Y!*E-yI~CexDd?FI1H3TefX?{>R|N?EtL`?e#(BE!#rb z#GwHK#E0M-{7ULA3H05f8XXf*Gp3V(p~?rH0JuvR*uPMsSK2PA>EVDe^1H`O87iI1 zE4WG_EuQC&mS}$}L&aYai^*Mpb^%6(QpFL~y|9OrhV*hR&f!4_AMyyI@AdN(b*W- zUP-WZ(=UIk=yzj6kFd;B*4GAZTC(duS}jwDL)klgX3fi+8+Oc|tD}8We?(=w^vCZd z;WOl0s)jlMVo-eNjyJ+q-Ii-u8o>_{9si0kMehuPNHWyd@N52i>(4gPJz-YjpT59C zMOW(L7hiw>x4Xt+l!pqX#vtFOg}ug)YNEXTFQ9skKraQQ@SWxMT6phS6+Z5q0Njr% zFxvX2f;4~U(lU}HY zw|(?rWR7^15$|!hz&jeW)<>AQ9gm7~fhp?HPi242q!hx`ZvzOkDWon7>7U?$TDHO! zcOPw6KZQB2Q{e7vjE405g+X}P$p`^nO{(n7N$5n7?#I{$=cntQaDSGd>ejReh^mt% zj!Lxg8KH+DLdHCKBo+tCr6>KAnIh8A>#BE$AE$LMDavwb&^o^atnGB*9SPi*9lG0st?qv$M~?lT?E_AIB<7Zo=a`uWLO8yCbK?GF?K8r5z$Y2GWj<8Zsyi^hTu@%( zZ#!?mj#H;w2xXp9|Nn-RdjC0TnWvvBOk#{Cgq+LX;8*q z{k)JqP%h+b2@RQL?c{&jE7uO>Q`d&hU9ZOv!j@#MjCf>x@tB-ZVki6es2FpeFu4CvTtG-4* zTc}|w@sSGZeTCm>J|eX%Q~i`Q^4RIm4dLIv;HS&Al;Fu)qi-ggN0z4V0<+?4X;`?q zv^Rd?=hhxU$U@ zcJr_yr^Rx}eX5qffdmvxTiwf9dkp6`K7Wr7^7Y#g@bgknosuYnq^C>#q3dxuLucN6 zT(Me^SDJST*!-%nD`LZP)LOsGlO%v|CONp@USbgb-&}evk1tXOaPoh{*M+Lzw81>s zEjoxCWh$S>g!ob#6bSPpMFZ(P0PT2@mB%YJkmsF3dvJ^E(mbbJcAf(XH*=}6tS#)& z4xifkyfE!>cIP`QcShmhJZ}3tzzM4&^gLv8gES(2B>jq^gX9!e$u9}aUj7>PHOKHV zB8wX+hu)g$alo(}$Gd;vuu?QSC=AxW_JP~+k;lEW?;yN`j&SxAa~V;Qy%-6`oq-wF zj6!QY@_Cxs)ck2jb{>v{4cBM2VUS_a%z5uC!Gn#qax*e!(0UT60e32|L7DX^qmv0I zCR!6~7At|?f05u%0GfYOv<%7XSj7M59P$NH z0Fl@m5(9+wCUwUy*v#xD!B9{ULo?#|-=BM( ze!Nk2R0`5Y&pzqh1~h1aK77B)>c78v(Xo(oWHhtt^`8C!;;olgoqH!@tg?GtYjfLFHJhxXaHG z2?0Ov#-q+d!Q823$FGbW706$(8+(cEoY`_TW)^8)deVL=sC@d4Cy~_?-z}o)<5YjWi;ESGS4|{(qIxcO9;eCKZ)|I}06sYDy zzf!P0tOGyJP&!fJ31dd~}PX2y%gT!&j-PmlBZT`bcUuk1#S{&vgHFzdWKg;eieph5q%lUs zL&j#^{X5MJd$RVVGp%ja43i%(-Sv3b1p*d_XGe2M~S7^_O>1p3~n>Z zFWiLdIrXNS4ol5XtTMI_^xM$Z1C}R?06Rd$zd?O}4jR5oG~-i0(;wfb(uivYV9z3=aeGZS>$#VLZfiUWSXtG%2(bO_oydTeMO>`+`;e1 zPn-oRj^L_TMvn#ww&Bocz5YPFP8#ZH%)@7LG3zGl+tbKd_B@Vx61)1~5GWC{mbc}9 z9nE={*zGbTuIQstm=Gs%m$A&1Q#rB|ckj<-ZL5tc-&1~u#$DU`2WEPTfsX`r&u&Ze zWD)|paiSg<#ubXj##g6DF0N*-GA;+5cxnciX6BDI$0l|z^E(}%Db0|-k-{R!n*Gft ziF%HrWQ2A`1k7-;YL1X%`5=5OzRkmWTTj9WH?e)AH3f%;x|l09CTsUxZt2&BccYY`odr5kTc=LZ>Uf^H;dBQw$>!ltvnL|M}W~9#?P@ zG>aodl7~&y)kDmDWFj#8-E~U_*wYd+AxPbC0<(76tQlGw+k%uP9pDzq$VBXg; z!0YD>ykLtUf9ImrodQiq@`i$TXLaW{w8b_HpA}(~bob_)n|OZmt!tv=IqX;|24O}= zR6gLHbm5dQvU=tR9rg!fLt7?))w8}Co~IA*utw~@F%_fpvv;wKrtrY#z#OCMJfWc& zmoHX%eKOIf_dc{B-ZlPX_nl388FdGGbmW!b=JM>0@uy(e$x|?o*GnrxEz#LaKQeJR z-4dlDpZnAGx>Ca+X z&pJTibmbQ=YKt_WH&|DHW;0n#s|PtbPY$;btAsM0=2Se6C++42`WR0u0b~)gvu0vS z(`>O_`-LxhD%qL5ce`AAe;DNpb$#3;PH9;O2 zG~Xn>!iBVvc_I(pkj6Zegd%k7&>ndYpJa@r%G$I)iexx{_-xmfyY!Fdf+tTXy!jNn zN*>@IYN=VvRsl%HQ#)Jt(L#jhgQ}8dh2o3)D$d<;88(g5=5QPdKXj!R4EMQ!@K@)x z+iuhbrVFXA)pR6nDPLrfKP_K9AI^RDm^&)Rit6>zj_KaRX(2U3fybd|gk! zV*M0XexQ|n*fM5GH?hV}Y-V2d>7k7?K(iddf(uGFWych7k3VLE*;~!x^Alg+=}uH| zHBv@@{deS-;R_g3ofzRM{G(wLCA*4ZGCKre#Zqp3PF}9BA%?m2Fip+4SSz)n>!|Va zKei$xmuSb!THp*mZ83f-sR8i4Yjfsrl%1le41#}{M+1fOboIBz#u2cK}IAK=IYdZTzOaWU`)rS9#*EfHf!Rj?Q3wS8_t~ z&Xar4w90ZB{x^Z4@vy*%3dad&d+n#Il#ZDZbXXARk}{$UhJXiE_#gz)1x$48#??`O zxYobqyHq!S{2Gw}MYP5NrOTatdVioiPxGyWm~8$@e?123?iQ)`#&3Kw$ye`OCTf6ir{?Vd8k zeK!toQybkRxnG0prSm#yo2(ZE7ifup#?~hbr73#tiB5ZVM>|7qW3DD2WQw8%;f{cR zz;yqhDwI?=jtcu^Nc_XHG-&xM72A+k^MWA(RNzh+i4!}tb*8BLINUFu{~dm zb}_Ih1Lgrz@IgUD7rqG>np#xYLD$IadxnO92%>w7a-i4bb+30qyi01YZS3rS*jPgu zk=&!;z2ShosG_-|JXkvik}FhZt$V!4H0whLXeL@M9i1yc442Ju!X(PEQF|Bna5K<`& zv-3GXJG{mnF&G++Yz5H*S;18Cs>1}@!GCTR14G!bg;8KrTT;@MUk4l~Rk+2(RHFEe z2IFxw`HPCQam!E+!WfKvdAOoRXgD`ERX`!z_oS3;EtFe)VX@9CE=jn5kisD&^aH#6Jx zjeq^IO5f}a#mi(pPnE@gc1$zu%K~$Ehj?Y{3|B09=iCr9`BCt9p8p?G^qX++{CN;D z%dg{>zr8G;h4jdkB(MPrsm-1`eZlEmgI05uWp$nyf#~jz1N#Gy`zSl!Rpi;7 z!ilx>J$8IRi*H`!aiX2c9cqpC=M&$6idPlfg#Q1Znd z;hLf$$iQ1-s9S4Vb_KC8?p<81*Xq+UPPFen5V`;uW9~9aBC%M{riVRH*OD_gwpw!D zKK5(j^>r{tqJ9rV+nYbifpID%W$gV}cd9VGFGeWkcLldKpiucTV=+`p9ug8ow{59r zU~#*lY`t`7eU9pX0ke>#pBPYR57Jp-8reFHwl(uG#A4b8PTA-wc<&~?lj)cx2;AA) zfk|I#rvaom1k|0z1shkrzpSJcTyza*sIz}Vw>5>o)Yg>9`1#tXyziBC6L3JnGTtX+uZv(Z!J#X%cu^RH zuZR3S1?X{;PvHi?{n0!8%YT4bO{({BYxQHsJbMQ@;!(;M0HR7m@ZA%ixQops3Z+EN z%VujcJQ@vuoZk^H(Ao@o*Brk?uE@be<*$>JXv|_m1{RJ3=b+g$pF4^*?fIPS1&(Qw zrP8kmLks#NYq!BNkEkcGoC+z(6i5C&&!!i6J6SyAX(qsBuv~~LCn&+*Xw49ftoJRV zIb+s!=L0aJwInhQl}Q<K1wH;k<(^)Cp2sK597CK@>dYGDXyzY;tT4?J+6ee z`AwC7NDMyY`;|jO!Q_ieVF|bv{GMh4jnIBf51{{uEQ{iQs$lt^#t)8A?rSuw{2x{M z^;RmMURbqR?zB? z7k%LrOIr(Rj;DGl>uKDi#xOYWdga{&#iNIRG@;uMVpGV7U`y)R+G`P#^&;KvlT3=x zN2Rl*BIc22w+9!WdXm-;hjYt{Pr@upfp5=xQu)Ie;jCBO;CEaLE5+u}pvrDTsK0GS*}HSto-94*$_% zXJR|OX7?2A5Xm9*?OT85|7vtZH{NS&*zDMBa8^!-@KrL^!)ySdzP5_FMojsx>i0*M z!L20@;iN3op4NLJTG5zi0&1y4b>HU!*DRM0po7>niUlaSDux||d8rP5d_ zh3SsPu$+v5VWlLE`${J$y=(GdNA>>1F`b~}(X>(e-m_1djzfR>cA2`p&HmDcU$bB> zLd@~U<2z?-GPe}l>5=a)eh{To_ytQfey`lkN5jQl0*dW0N1)m0W7152M3l$E`Bl7< z#RWP82hFj_Z{p%L&)n0)7WnR|ka4fTvOnL+-`gW4Up$-^fbCH`HhD6R6cjc{g&gZ} z*vGv8Z!m{zmtOUq(slq_*P@7sNJ;cI$`HW*YQt?}Z9^+Xvek!5rwQoECqDMvf&ajx z1P@>Wz!(rKegYFby(M0M9e!xk_C4u5JLjZnJ*@Ag90o&m-jLEaL5|!{RA4E>W0kK?ZkS{J(c(0UyUw#7B6UJRsqdR~P zXxjyz4LQ&c96rYr**HV=S0|fhQCxLPIBYO`1ucHk2nG%lx-rf415=qk6P+;PB;MfnS5~6b(-pSZI@q%X7Ab*Z4AB=lEVS9exWacinBDE+ zC|ygn=6~_tFc11j*#0;`(6UuYg*+2wQll%FO(6}$th|WI#8kwrp+TC z7i%rb{;h*w3UJW_G|l?CpKuT;U(KxUs5O&MX1CE&kpH9f!i|iP`=QX0MVRx5x}Fq< z!F45XChnb${!M|nr#t&kf}@HU7U$aBH8YRwlctdRv6 zrbfLy3nWheaOJxOd*Qu_dKd8UvcGW}H|3YGL3izEvv-C1^pV?uDut-UwUTaB?U>?!~pw zG_7xcki403!ZaPD2mD+GVh+IPNervT(AX!TLy3e`dHuGcs2KyHsZZLGG;Lxd=3a&^ zfgoWqsJbWT0O!VGUMM~EobBIC2eiBnNk@EJYTD1IJz2msagNF@NvG=%jG;Jtr1r}p zlO_(j@vG zFHv9g{j7HS-x-9#IrZG|lM-j<+lSpQ>hJwp(sosVylKnRp}9&xfD9^=*CIR+@o;?U zqW)OZK=6}$Pq^?zpc!^NifZN%AHh+;k=JjCp+EcPxVQ}`=8I^w3wWzy2z2*llK|3x z&#f%km!&^4ga^YRW=J0(aN}ct1&E3iF-EZN4oIGx3E8cIdUZ`4t+0h}Dod{ieTduK78~eUP zOYy2?XkqF_3%wFj4k6&-E2~Ub%9;u`n2FVSWu@JJ)$=K} zq`NJTDii7@Hd*x&G`U&8jH~l<<`~Rq#%_xkwxI*eU~%yhev1r4 zLUW>SL?~~m-rFkK#CB0KAz$5p^)24<2d?njFxu&h>{rt9Z;An4Sdyj??RU}q(SG4~ zuJ=3b63wlcNB_u36Ut;w4U$Iyw4i=DC;E?GV7g;+Wwo`()Y{~nWn8c+7Rj$cuVIR_ zo=u!J_*lIPgVRV2!Wbnw8B*Mon6U`A$v%}Lg%t4L7|M9USr|o!5HPoY|9s3YYlCap zxRg+@i&T1)!(yHkNoJmp5nvH)9PYXcNcs&nh8JD79=(-NYyMT8_4-YSZ8#}cO9Q-k z|N6d9>&)LXy1`x+sQyKVyi1?*AM7Wv@Kn5g^|n4Y$vD5gJI#<WbuIp9`SPXZ*^zGZO)I*fGFqnh$9R{N|lCmaL#j?eJlM;YbjhfL`&&mIR z{g{#rb>(;rS^})ijp%ot5W>%H?bafi90RIy|3C#h?`Gb4Q6p32&TEeXSZijwssq@m ze>b>pFY6b3eS+7egI$@(>snr<*^aNDH?Y>BP{L~ZGr>Zc3x##IV= zq_7%;@3cDo9PQ@e`%A#;vrNp=;3Y7sZpFLP`DZ6Hhb~@56T5bDeEGz9p_0wi{Y(jF zMY*tmc?Su}%Z;*_-GclMBJKS~v$PuBvBW4W3!2MyE58$e?4%z`a*`Z;z|(SwSC!&g z*CVYrSe%$Z{Hk!JuyA&`sKwSj59_3x;%>upX==_Oz#}l^AHB?;#3PtYMRmIpn+vy< z*$@`Q9%8d06~%c;5SVzI{(ub6=yyxK(4NcyBEv#<=6~tc=<9f6e*f2=)F$Zj>2@%d&cOXGT0#K_EmtYv~2vlF4Z(dMS@yW-34Bnco*v`=uy{TD)sqe4$($i@p zIn5^FisLJYtpZ=NSg7X5>BGBDdLobT?CYg5Pvc1g1`)ozc7|qzD2H75m)X(d(Zc67 zK<={?et*2gZ?wc0kusZuTGy>r_0`H$Xv$XpjaLxC-aD&uMpXi&kRxz3&apJ59tDw} zY$M5k2>^Df^laCb7C;JU@j|OfbOq?E;Z)6cV1!AJH(jK!i{;JOB4S_hsbkYCzvsLT zjyLaCO!LevQN>8@APnj#$~--u!^>PtofL+1+5bgs!pZU_IA~IstF(ytah76P?!qIQ zRi%@p;JE*7%ERTK{7cXGkz9rogUDxk99|WFGsxl@6Q`}_ZfRDEGVI&T4^JO-CfSJ)*+in-Xi~6m zRl@z;p70pn^5g%0b;Ut(QeX`Sy%C<1VJq~X*3?sT`aR)0(||fPeC?2$XxM7xA?po) za7$$yS*2-Z>oyR86`O4!EYjo{UFfwhmsq1 zi$nDoPmPVJ>ja5{`LO5}EWP)0teR57R_El~0nUWbg#J~r88(|E4@-}@$I#Y3YaR7# zst-11F>OBzu9lD_h=~BudHW$^B!mEeTFFpaOZELoHQ*BrOmna{P=9q-VpU8_>RR~L z8!CnT{9f86Q5-{#}4lld0LEO*WpV)g!9eW%M~z8Mfvuqp;>F@ru~0ur*caboNCi2-$;-rn+F8Y}o_AS*hKk zaoZip=;+1FPQmn>N)ya~uE`I6YEi1&-o>CBZ0(CRLZ*30o>#l`tELHzHm-oCAUyV+ zW__?>^Ji@vvW^HTB*_d{rFI^GUK!BMjPG8hfwYMJvfYKL@OgMPpT^j{*&9_g(_{Y9 zbG7^nvCza#4MdJ3-U^b4mu^d$4x0YeTB}yKL`TzHIDD2@I*xr^OXpfGxRo>uKrspQ z=IOa-%6st~0Y7zII5Ny(1XEuOV$_nB2B%SZE|8N(e?ci$SH!_h!Bt_>56z8gTS1#a zk4Wy^)r=Ag_ZB&Sc8%_v&D`B>G%Q(Ytj-tlQm(H|MT=~NgtcpLcHLbCWWZWq(Vf^$ z@wMS7?G_8xI^_ygROA{VZoXy#nb6 zWZ}hlbT+h1)pN*%v#iwzyukFG*TgR`E;R|dG)DHC!YaYVy)cl+EGM47>XUVw&Ao>- zB#ReZEfBW~W{KMPdTe0>iuaDCNj2-WyK^iLl)-3!ibdp@02=v!&QN#Ne$~21JualU zx@j8gM#WyE5{3N)(Ckf@R43!}Ci2F-Z+JMzm9qYt1fHOGp&{dcfX5Lx=*iGItaQhO z`}ZbpjhoOP92DhXpo=ka#_}eWInFRcLWSb@kH~^neB$I~P}mAhE#xP}{S0AyNr01x zkxH(Alfh}WeCmIUG7E!zE-V1Se`ZpHV}4#`=TCNk}%f{3yR)#U{NZ?3gSr;sxaQr(L9<#=-)Yp+E=< z)kqH@DS(A8m=S_7Is>mIeG?R`S%v=S(pCw7*jl+qU5O8(KURSgD_YlOrMM|gqm3f5 zmRNCZ1O|+){WR2XOM|F}lc$3{)a!B`e9_U8DVaY(5r4POF-7L~cerN1Gtc-i?}ufR~=GqbUA`su_SU!!6RlX|Y~`sX;ad08)-zg9_x-SXfpr z<8giHnQ0QhsE-PT6YHIysp=7yyWB%(i@RUh@JRV8^z>1o-%~iBJpg3-tZG#R`i(gH zkol5mn!r=5SAiDFdsevb#Qwfxwc(6QpqQz#D%>)BX#k* zV5M!BQz-0frgfFd3yh#!tj)M@)M+6EyuP?To?yC(MAATyqj=iqIz!ILM*eS}A=k2w zbbGrh4gam@z8P{RL@yj{d}u;{e^%7_S{QUhTX**37ZzT3&ul8qA0~1^*^sq#h&^YZ z)J>OeQ=Xz+qZ$?7lobEWJ(iK*hOT6ChQm%mDNib$@_WV=DjWp(+Lpp9Qd7GQSI#XP zZSCkoB0Qq#K6PAVcK3S~u1aEvA^av0Os{9{zuNChs}bu+uzW+d_3X%hX@m!9Tl(1H z6urHbQq1$^R>_+lycd1aZPH0e+EfG zlVR_BrkyxEH{u&uA6RNcf5`DODak73t4%ZzGF}(cMrQ%+OK03A2#P@PxDh%0C3dxA zfMsY)6$Zs^6hpGwNoV|jiE8Q6tX`sCi#Sv9VBUkeytS(v^zPJ<0LkBqB;ipterhF0 zHd+zZkLVigIb&eLXF6YKj-PMMNt*PEJD%{fSxoFeWj7z*`R)&a!w52AQ;MSM&kO1v z3EPG6>>(a&jm6Yii}GL&&;Osy(xXrvsEj3!+w-fayBR%Y8-DPABWTFwJLIbtIcAAh zERV3>_R|M*V8|mG-sr#L#QQKG`)MC`;l7%_`s1n~AtMEQ2t#xOSJ2MzhQz7F1=UXK=s{@hi-8GL^rGtFM0)r^=6MH-z?C%-rzvbwwj?e z!Q%-1mA9%QEAf`LnCye!_DD}YQt?_)c;+NWyg94EXgjw7P7$ zX96=X!LW1i3s;zoETz$_WzNl7H%{RcVs-gLKL}Wvm1OdN`}_d}VlEgAF$5V$FYV1w z8Oi9L!7(?y?H~<#@jwNsNnPJsVrP`H3ymX$A2MqJ4y}P(AlXe=#z9;+yv{T#1GipatW zHy^G`bVe|Lr>V?6xMbP_JIgmtZHZeXa}_VzvnM1i0PJm_7Vl|sYB4GJ>Ax&la1r5w zly7|Dogq4Q>d6I1>-BU33f7zC&Q6;=k0ETNoN|Jm@_1d(BX|-DPV_%1=#Ba;^T?DT zHB57raA$g7pfn$=nu5}yj~nH?G?nqwNF*nLeph^d_;6satr@9qz7d3w!IZ}9>zxOw zxS2M}DqQ3=M&>^wg42_c%yc&zFat)(0;tR9qC+U=|^z}8lvBjGNs%vC;) z(~Tl??K7POfD*(kh|sgwbgg4yz+uJfXb>2GvIn@p9D6!wmz9z{>Y`38iy9EpE};$n zG@}c^ApY|NWZ z24r#bgrGnLp8{f7C}}3&SR{sUx#xb~(FzYgA3HT3m_0HLsafH_P>=vw)_gJOio5uK zXkCvA$$XcVhg7fw57q-!)RkdmeM!&9cIq7B3o<10zLj-C)BsXc#M40Cg3dp8&493qeAW3&XZGMCi%2UX*d9`~*9qPf zUj6=`wPgu3#)#tWd?b`!`+5p zG-xUB&b$K;DN=Q5w0>2<^K1u`#NDVi^9^*LacQxl$NwRGuUl@#!&L?`aPWx{kVtQ>b0de;&G+js;iQz5s- zL_%c=N%*xpYO{Klgw}x-y(uP!hyX|c-Uawk`Dft*w!yYo5$J=*Y&89GE2ks{>%**c-5TM9&I)9870o0blNMIJZwuRO z$a{FmoPOplw;bfT(j{;)L7C@98$Px~wrKnfN9c0cM91dw9sKMpxLeYH@{Wd-vtlCq zl)Y4^$=;m9M#|*qSk8UdB-rlR;Q)M*Fku-xC=@d7@AKuQPS1l}T}Yf6MLvaz?+%)i zhQGM*8fD_W(DjmiCy!S?&wexwf@M3p5Px!EcYh@NPJ>M&G>_>sVjUlvz~KvCM@qW_ zN&z8D$xTUj&WofM;?e?thZtMCl!&APMMkb#3r2@p|Hc02SWOSi_)7u#({uMnU7yCz z-E6id#HX-zg%$@SIP`wEq4cBi<15N2>iY;Kcg<%w+`O4Agu?c{PYw^dJR`GyAGf=Z z{I8(?L#9>HfmIz0f)xd=Nf!fi)^qqtv>hK+!OGoW&tW2m=sC@QL_K2!hL2>zkI6m5 z)h{6czX{hFgA`TR{IepaC^|u5G&otvd!g6d2t>AtAvHxGMEv^ zL4@G@))_4Q6GE?|ICHX9W$4oh7x+^v=)ZLe#Yd>HD}bt_HO6$W=+F>(i}{k^Y< zyE#nujEkA930fR)+%wx#735t>AmtvBIr9r>JQoySy5$yspDtFxadr-u9yl#ccgx+R zS@!P6aUN!Ne4g%qm$c;dBsH?FXd66S5+ftRW{*y&1WgCAmnlqd2s?xYU075rj?g;t zUeKW^oCcC~@}oX{ty7cw));DyS#5?{IDAjpH7IK+T^J%_mPl&@t>UQcWWvR=69BFd zjVQ4mY%t`1;zH0%HQQmjfVcS>BxwxhnYK3r zgiDfElOIY~nL4IGyj%2^PV32GNe4c7^ZnMM_v$-;JnhLRif0%U6Q|T|tyOKG*~NnO z;RcT^;5w$e$CyWY9<(}=j@@*|#&H4_@NV}*BB3co;~$Vf4~EiQwU1spc-9JX|HX&U zmBOmdib5(V82gOBJTd5mcpBANQ$*sb!+4#g zl7Jt76fl)Ndi+hl39GLKx}0iK$z$gws`a;za}M*U)-<5Vd&5){ll)}DSp zx5~WOG6Ho>W0Db;A!*1b>34@7ueMWHz=SP-ulMbVB)IF@6bhh0NMYHwhY3N;N9PyJ&`Cd;!KfP-YVMKMMHS&{x zfV$f<+sw~i2xY3t%ZA0q38^mLjpRYbMq|yu76ksbY52e4K8D;X9~O)p#_69yKK37akQ?kxM$6QTPWwfv~*?^V9lf>xT=wuR#{w2SW; zuuGK$+#$4lx+vS2P$9om0KH3T2+ibP9Fn5QG73_pEcqs|> zOJsDCR!x5cLj-nq=nDW)Ol=c3fDy(lt8yxTM^^RRzhw{SaJG&*oITWiVZ3#W(N2!P z@jxXV#VMU(5?Tll77RVb7IcujXq02T8CUCh_L9Th_Tb*u#5V1p>A3vrxyD<6>sA_X z`lwaxl)NaPKJHXM&!Zomx^#Q_qs8=e4k@qIvr{M@+_P!3hhb=g?{(YGBKqIw)zUer zUrp?Ms3SfDix|lPI|$fyM8YSzH>__4z|!5LOWYf3HZXuHcSgvekIHHuKpwBX;Q}7D zE}zz+RVs0p0)-Dc2LQgei(O}b-{%xhrew>2%(#FW+UVfQ5N5Nbg&--)L0pgV1m)hG zzh|iajgh3|p=VyWF6{J&FP_k~cj@*Oe5jlBHbS(Ihf#S(MWqe zT8mcnXtpo5@4_H{?=^D#A6)M?G=BtT(}7)0u3KrNJvJWtPaSn*M~ z!e4MI69@pT{#1Ig)fpfGb`>o}!jNm4L72G|?THz@si;C?_~SAgA++S6#jw@8suDL! z?fC*(WSRG&H9+ju5z3sRvG!yuI!O6Z?l88CB0I7WBjqYnhv37&7o5dajNb-c!4DDI zEQBly?YF;-iH>ew#)*u7iSbVo4#0t;DI{|cc=Pi;J~8fnKVozeq~m{u_7umM1S0y4 z3P)Z5K}_*2VfR<>P(q&I_Y4HwJ$$kXk6rXDRbc`3Y_@GyZ4smXoQZB+9quCey;wL= z9{Tmb7KGlPWIMg$S`OS;PvAYHu8}o_f(o0vp{2=Rnc4OeRU`s`xlOW5d6Y=@O_fs# z{C^t7zwF3-l4W|w|)-1X{?uz=#<>vitU_ql+%8Y z(9%*;Xmwg>KQpC&N#1Z{K!0}e6`E(mn&d>MJB;%8*b{1#DLRB?{8o6~=DbfYc$3NQ zcOU4c=PN^1b?XTee6owfp&SdDaCSd-aDdUgI_n_C+|jm?tpHtTAQ=@+-5>-1$L>rP z6?5~8WDe**75W8%a-+5vL*bt^>oW4XEUj>%g&FMavYA|ed(JGtDA{?v(}Q1}2%~9C zHC=cHY{zRCS~BErUPo71@p&6Bnpzem{^h>hZKL0M@~i}oK0;1l42{~5%K0N79;=bj zIUd`?bH-=>08yke>N3Hj@)M8KJ8x5E3Z+Q4ePYQ*cLhI%Aznu{MZld=HCyA@Zs;AN z;FzY3yr3C>)GXzA{cxBFqn?dHG`Qy^veUQ$iz zT2bpEyRnj4m}GHFs>aJVrD=flSe-(>GetNZ<03BE`BGEJuiabux5^w22;2blA_-w_ zFd<%|n?FCt;>SC~+9K@yEfKC;xX~zo4$CwC3r5F({3x(til^+nMCsJHV}V4cSv+Cr zlwBnVd8@XglQK)3(IVUuGK)6AqN(zNM_2lZvi-zQX{dgqV{ciooSHXgt&C4Gcg%TD za_fT%@&EcervX$xf1}~Nw~7V)2^S`Mi_ic?y|h(sSS{fFX19mk?uK|s%5P#1T#Z$% z@|-e%H-0I&*Q0mIWab&ee4gGLEp#%&y$rA>v+U&}MB`{K#r`}KMlHcBgw?)xl_V6<**=e+Pk^cv ze+d7vUgf;Hn>%SN#nYaJC+uK%U~Up|2t}iR!b;^sxEqGn|-5*>3uWW4C-x(Hz#g+zCiWaQy~h0UbnjgnE=BG5>Unr@ggV+}P@ z|DOE{h>L%QX?HcfJW9)qU<3$6yDnt4jQaeP>>P%7`zsB|o#OKaHhas&&}D^%&j#gx zAK#X#UJT~~0QOb{(u8j+E~xiy^K}Sd3DwwSJs{Dov6kRL-B&3*ZHQgLbTM1;D|ffZ z6*T{W!K8f;4j%^rs10u@eY(p$p~WcG-kfYU-i^48Fg6w$--1)?Dr9V@iv*MW2@BYw3w-cbx7}IG?%fY^vsJ)Z8q_~xs>L$E+#ly|71uZbUmR5s}-a!ksFtfE> zPhqBcUrN7$)p9iv&Jr24C5!wpY4ZjBIX+k8)w{Y3L)tYnk+hFd_UxD>Q;=`tg^7os z!r5|{#~>#ME_oST-s z{sC?|8+g$Kd~#uLQJuvau&f7(K9q3TO9BO8Y+UB zH0F+m**5@`!I@CCeD1pABAA6s_sq{k4O7anVd+!X$ibCcMksJRvU@OpjYm#k2MG? z5y9-9%WqxJVE_OqpYdCtpm20AGqUp=2!pwf)LV3%293 zb{6L%<2ZP2MR(@4DokV3O%FCmFs*@(ZKJ>ZCX^x+Vs-JvedgI_exFRtQVNeIn*N2+ z{YDAPQeK)}OF_!vFaF6G^K|arC7y&rYZz7X5I?U#LZ`Jr+c=zm#Gs}vnoVDc{5uN$ zxqrW*d~RLuiPY87BA2lCqPJ_3Nt*MI7wq%*h3e@eA6PUtO=K0%H%^*)s`XPu7gS=1 zXY?;?`)$}n!2L2s?DucGizo#>WTQ@&(!H?%V)rFW)4%nPaub5Hh{WMw=K#Wwad|dG zc>Q2WOM6NYf}6tUWca$hCN}#i)vdRwPVhn{Uu)75n*rb;#is3%kp$1@5gbnC!dw ze0-Eh;=3kwuO3H0O_4#4mW|?dcBUzuUHTan1ZRMf_{}!(Z93Jn!JB&OIhZBzs9fX) zxAQ29Nn7S5xq%G(v%sv{{9K81#GtqA7Vy_HAdo#HPkhr28ZIr2y1)gNy#D`2Q9?>d zS}A35ZFvcQwZ84!%5LE{8hX%(!O%KMV8ljPLDw88yTFK{9It&*;n^}r+CV~E!K%J9T3DU6wmE~a{Gz! z9y?e!*UwU`iABJ3(A!Ub0XgrCL#{vbs5-TUzmR?9awU7ov!rACKKQrF$8(YCgE4|7 z410G9>~1V!xGY)}pk!+rp{`+sihfcGjVz|^^656gQzQW4pC8$RDFK8=cdUS-j*7JI z^S$?fWC6JajytCGn1{Dmw%g>-bvMgQAEXnS`ThbrnB? z#3xPo5|kjB!=Y|UhnmLL9>PeV7`a9ztc#_8o{dC{8yH`rv}VxRO^QnscWWc{!n5&Bca}Sv1>V z98>qG&zY_jS%99MZytbnw(HDe8~{%oE(R|0U$>^+R&i>0f;RnM4pZyubwjbgwzZM< zJ~cj?6qlAA3)64Rz-{uDn?&Q5tYKS!;N1R{d~b1j_>0a{S_|@s%BPo9wb_H5(s%-2 z3e?u*UiEcLX@cXea8SATf;F6mh!#v#ivHQ>Smmz9kUYQP=Ss7{ekwOopMAvA@w=fMqd6GY}lK-`;1pZT2m@f^1$?l7DcE(_NQP>%!U>|E-0Q)yj9_ID&k>ADN<6 zLZu8Z0D)siYX+i~ET&MW2ZUIK)S_7vV$Yq*sHzPL>swM6+6d;mv^0JI6Kk zc+dolI1OkGoy0_^jdXFZEG23TmD~~u=wGHleCxb?wkd>04s=UNTrbd7w(k~_9|ja( zq1nvIv$f13{4qvm@w#B$>8`nK0$L&iO)iPz!PxhkU<+4ir z^8{^~$VV7+U>0xf$1CGB~+W8Zlrw-0Vo|$fn8x+kioi|X{(fS)g z1VQZsF`#x@?&zk2E+HQY>`iDEE+=O_42b69$`hA#JJ*s&QvQB_sU+SEt@w2hvz2BR z;|MSbhr7Ucc@`_~N^27SlbnZl$8KyEc|z+D zoAXHaO=`C#3Smf`@8VKOcF>4Z<{vR-J(;-t+pGVfG=G&&&ro-EORdUW6c)6l1x0#Y zu=GKF)4;mPB;~h%SYSFMyP-Y9w^2^Q!+&e9K2CoUD@iI5Kw_haeSxew@Tce8Gm1%* z;^(x8>sXq*Na1efHT~fso~yAa(@?G$db|S!ZcgVcr=#>1XQPvnIsrQPZOg^1q%0S8 zR{i4itBx}3_aL#z$PjSG0(fT&4~C=M!#D*Cj^%y8j&&u7YZTf_=%u08K!$zxB*%9m?}y zYxlWSxu%G)tJllaq?|bQt3_?wqp3YH9g%l$J0MJk-EKVabM(-2V zrvMv?(Pu#3ucQlE+)Q)Alf46dL?!|8D6|f!%LYZu= z1W4``5QH7|3Ky^5%0GWP^5<+2JHUeY*J$#W{?G59NKF;BF|5Kws&>LWyUNyZGD0C9 z>a7b36sBPBP|AodtRgv~IUrlR2yu0f7P!TayspBjbf2xX@xPv^c{{+3uLtM&C1`Ak zm7>Esn2#BDe>6kC+~@Btu?NF55;RY6GM;l^#A`)-m}NKUasPEGmZq4I%1s$Yus)P< z++KjW!Tl>(suvq(3fe<8JvaFRst7s$UPNO3)~-aJ>=aNaz=bVQgPzX$hXnb=nmj;H-y;347ebn3P{*Qyr_~AsQJ-wp7A6(iIlbH$W zDzCBW8mq>W*;Zy3HnEjnbz z_C$06e{D2Y%0R1&eY!L%;_hCD#!~Yve`)L)L@SREi-i=yJumbB;rb)eNb92)4AalWpPX@&I3m8eLb%pHTD9ofULTMc5sc8DU(wXbds+7cSj=h ze;p)h(|EMB%L0IC0e&^?)}aeH^tYkuz^NWfjZPR3`B)DT0Mhu3pA3<6Jnf4ndzkow zmxqZ4N>`<*hm4@7oIQ(&D&NlxBwX(|35B5E4Dv~U5cU2%pijZi=LhgYPKHc+>@7d) z@Es|=OQP)F^5Jz)Bp)?3BXKn8-U_^2f5&@yD#z9_Da@VpMUg-DVc*qF6j|6LOP4zE zb5+cFoN|}6GLiBJ5;t!TUaT2G2l))_gMU_|CurDP%lN*)!RSWj6LgWC-N5De|xB` z@UAiiv3O&_>WFLfuK9J}dg18K9MTCY=fgoPc59|lU4gO&&s`*^x@gc?OE)Q#Xi7L% ze4r2)BK)HQ=YyZL`zjhwANA*50dq)(I{aJ^1bQ%kF;{H^ z{k#gx+9l))ihpB_OD^mSj70)Je_%+>+c3j2ph9|w15G>W<$=@qZo&9f4QyrOKFsA5 z_)N7P1hjJ_R!t*Lae~dD56@LwSX_H}`zjddPF(jh4j5k-ehRWKjO}rS&iKsSziTbZ z)WXq~XGZIZiKH7WFPFT631;|WWwtrZS$MJ%`R1fSc%|cIYJl{9fBZByf2x5%ca1{G zyOGmtQS1JCnN!rwV|tCvTDu-h>x{=zUcM(kap-yNmy~@8)=u#ZWqq()n@WfEC&yy@ zi7yxZ4v2lkBaq* zxDmpQH5iD7{Y=45m#5^~e`=LUOh~4ze`VPOiqn%y_ir_yxY*m&aM; zHwNDAgV2iANm{R`zGJxW{waAj;$Guh_&VGrqFmx0SNk5Ye=RK7=_Os0MASp@E;XmK zQ_KI8P4IAw7ePu86 znGvI+FP+sC=w^4>P zO1+zS^G6-6e@IFkZfH`R6tl)cFjm*2e7OX+50!`QhD4{I%Bmp!uC&2&M)-es8B_0E zK72o5aP2c-Uf>7CaNW4ScxGT%kVr921{?&<@kG0XmB6-nn#5gSkWJRF)H13?-4sR+y7EE5Xt zf{*YPwJ+J7W{;is#s?S0v zkLHnaf3ga}S}{${-UTy;1`cW#YkY6Szn2gJImWgCi~8Xxntq9zRqJ+Q$2I=$6d%6E$NTj#Q60n^uJDX#*em4K+dYm zAx()NYjkpij5MTCLcnX(ju=J@^}O5pz>3L;YshvB@yp&rQ~KyfX+mCv1L&HYw1kAu zf5Axvl(C-dGPuzvr6QHYAj2N4^bExF5ur4d(YI4r^(HF*dCW82DU;s3Cnl^r^a)V~Xf_44TDVZJLE@`?%Z3x8fXFZj`j zd;?F({SO-WEtFO>q6`0=t$p06#_Wvj2g!a_!QIeRE_AwF+`{(FFE3X(4u+U!e+xi_ zGA84NMkOAQEYk7Pv8-tD?0rbeFKk?colv~v?=T$CbEnScg*v;C^khr=pR{2tH7k+E zThNT60OE;hs@=4aaFJ)S;;-T4h2cIOwloNTya`R#vLVmHuU9M8QXQ;)Uyle_zLW!{ zD%mMd!&W4c0986R(HVJLMi>Ecf90-dN-0!#*uE_ir29S@nm+NF$4aoVXSd=nTzkgO zC!^H-nbUmoKnzzh4fwE?-CeZT`HsZ2l-ty%@>9A0WfQ3f4bbRWnxq_xp&}$0ds9hgwYNF$r;oB1JDkFwkWde@e>*_ zrVq+PgcB;udc9bs+lPPx>|0Fr2qbg1>vv&GBGql?g4gqrY$i zb@K~S@U@T7?&VR#9L+s67}9-3)tbeDjZBX6^ z-a?jokt2HP^7AlAQ*qNlSJ;eIUJ5a#JX^t*WWOeBtRK^Pf2=wH>etcdD2;^Ol9w6;-)*)Pme;e___pB2B=*YqlKMgQ6JX ze_#Ibb+*o@Ur__9aZ=ACU&>g*NvW=%$^r+jnBNa1wL@6+F{)rSwC6)hKH~7^w@iuW zE;9PYz~?B6QCvpv%|DkF(1WM7DC~f?kG3tWN{_zwfM{YnzB1;@pu$;pRSHg~@$8*Ds!-1Ys3?AJE(ZNY7KL;niOjyV*4=OqAbz8qn+HSv8~0sn(9? zFCwG0f7+9{ctOB1Wo2=~fxGRcjG*2O#xkV5Ua_9J9-VU$5>yNhmHVO5=XS$}GK4rG z@&#D8wUzwx|Is7C@8sMSSrK4}&1Lz(=MfJ{hSRUT0t7 z?56;TNCxy5_y5G^bJb9?{LW4u;Cif0S^1S#_VsW6GwkxeDmf#>e$X?Ta5b7VJIdaY zh?FZ;YrN!okY*R ze@)XWhZ*CxjrFqUK354_fqAKPSG<8r?%`GY_b;(-?LtzHoPd~LABbG~_2B~nY8fX; zQ|+jK5$$`kV{z3T&$tl6V))5Eu&C@A25{Bz-7mEqNRoFX7%bd*O?rPr7GDwumQQb|ysL}Yv5@D^ot7nmk2IPlz;fjsVwjC+<-Ob5l%8s@dXr;Qy#5VJU@ zg}T|B(h2ZJM8+hL-yTL6i=+wL83e^7XL zvX}O-Nl5zKLEM})d`Cl=-lABEUt0@<1FsN09Y#d(p+3eUWWIM?wRFqHonljCI{yyNP-b%QoHyB|SeP6V?IBjlx5s#%y$SatFsZ|}x8<;P z18Akc7a(;TvoS8#5Gi(|jnDuRfAHll%x4%DpFp9Dg+3LZw}l3uH5M!(8k;_c?K3+n zuHq5gH&9L6Ct+La`B2}b`_Qn`-se{EkBvo?QDv+_2SGF%0VPilmkO!iHK(n;x-1p~ z_p7W+hLo6a0{h(1`ovVDW(_#l`9J17j-uY-85^S5{{5h##|(HFox#eV#)lSCYzwb9SZIf`j) zW1N(ze7$gj!&Sn3CqT;WA}mOzXdG$Tnyik-m+bJ^N|{MLZj;qIe}?iL3)SQ=48U*ScTOzGD?@l0xKO$;mB0Da z`ZrjSEJj2bBWov(n{mvCh)t*k-cDOAT()}!0ll_0MWaz~WYhLYwyUU+i9DP>#gSBC z?B9l+O#g^;6z9`?S~?)9V4&luzdcS~&0Od9g4(vV+Q5@5aA|Q71RC8tr2>p+J-GDZk zW+m3)A~s7nYgD{3f306ot9ZWIa(cZCn`yUp+UZRY<>P~^U5rlOcMoAV*HSgZY7=KL zM${$V-p&vWs1OL&AYQdMVHvS=)VMAzy@YYF=JNMN|vvR)cEyc6xS#al@=_daD0e=xmDcG0Q#Ln6J5`b=o+ zir8@M;Xy*gzi6A9t>9v>>`c}qY7r?!C0;XE-xjXHqQP}?GYrlZZm__A6S9IY%07I% zfwcft%TU774kUa5mw?%w?ab6ekavwNeh%mi1`ksKe(`HeQd(H)RH#LQI8s7~OU?-;Gv%x?pTr2B z8xPVTv2EmBFO$9+g9%z{&Sfm0>_6pDizx2OBx7sve zCC0G8wIhkPB#!_cr#75*15-1oJjyxkXzU%I?pxU^f9zBfPfDKFBq0P-nOKmujVR^{ zsD+XkJ6Nrqz^6_vnHn_&t(6{5-@S>c9J3sSZbo;!H|hZI4JpLVxqI8y7SHw+`?ORaJolg6%@A3Vy$!GGle(P=FrD(yL3vjIgEgHaZjXu9;kQbQ=Dn*#LWe*JebY!1T3EJ@4 zXpIS~*>s>lZu6wI&tPV3m$t7y1y$+^Ye9BHe*&o`1McA5ry7j&xPFr ze}AR~hox1VPVp`Maa@uGumX@v0R5`69GOq3O1b^v1!rOO{+A|=?mvv}< z37<_)nhk)$mlQfeAwEcdW8s->pU1v{ZxxQR1 zPR~i+3hbmBS|FiHa$1Rmnn$7vjk)vvQ9RrRcs3_#H>*z5+ExT1xe?c<| zNIFo?B$r|XHoR)C?K#Z43d3-wQ;C7|aNZ!cRfDg|UMTALm`J$xjoJ&P)*`j&<6&&7g;Oig@Bjnu?4HU+e&l$}F|4{%& z(S3QN*Dfb1b~P>Ddp{y}NH_*Ae*yGB6yOVLlZ9f?W41L$&^>BkUfbtq0<%Dqmhb?? zc(;UpZi84K&=Njm^2th=FtAa&@TT2(>tm}4BoW4_Me8uNdp+Z_gWCG3FZ9Ugw*=O$ zG;9sqAye_6ol0~2*=6XMW5&o9Gdj{xf;gtx$9Znk=^Y|(D!2n{P{FUDf0UOaxExy< z-(MnUN;oG6>0q&Lz_ibRR*&`XK)`&^oyxxY96_R;n17j7;>PdxV`8CcPtwC8e(d$m zzlCgOYTWe~@&_BL70owD-5mgz+5Mr; z1ua%t>bG(O1em2~aKpp3e*k?O#JV8*L$*D=OyswArbBaYmQz~x7chZ1I*1(LSx({6 zW4T{)tefyliaiM8wjfp;s7aLCn`x8Vei%?}`_$7J!*k#*RYZm7Dpv)I1oe4Ka*}VdePQLCE49e?XsA<*y32OQ@po zIlX-l1vUbRHuyOhdIc$@YiO{SF@{nc7VUNQH}5!+{>e>H5q&P9`hWDRp()q4=0K7HO^mYGtu|&e;$kj6IzH`&fayNh7yU^UZCQ?B@FQV{#=};7KfO0c`+aKmfixK**g? zko11upZZFee*s;UN2@U>k>6_5Ph<~j)`M=aNwz+uZM_B+%G3#ebvwS)Hl7UXJhiCB zT#4Dx8T+WOyKMlDHh{eZPj@#K(hn&Te+;5K9gIr+-1!uD^-@c|I*x&eRb!2`g8>f2 zx(#(BRNYKp^X6Li1uO0(?e{R1Pn@`SG%57DI7p>#2oQypo z8Q#j99T;oafX#?q@5eS@6jaMD$vuJ=NxlAu;%evmST$pdTwrS%JfC}|t^{w!zEVPR zUyCDnG044>2ggqy=P#=YH$g86q%G5UTL>j_22Mv>cCguq-jtJBB2clg>_Qo(b3XB) z4ZJg(fAJ9Xa2cZyJ@B16PDG#X_SjZ}0XKDw+ugg(5f7kZ4y*$hh^=;xXRm1Nl^-Zn zb1S9Y<{7A<3J|;#_bshYJ-seTW z%^3;8xu>0Fn7Od@wB+oF!_72g|Jr4X|L3AwWm(Mu@`TL8GR^Pqd|jc)y%K48a`^!d zCBo{w-0aCf(j1-rXbbQZW ze=sO~o@JrazPqnVi$fl__;IPNv0A(mcx3~U6^8y*YQ)JK3B;u_f>e*suhnkBc=!8E~w!b8-Xr`L2R(AUf`6fD=p z9j;ngG_@V3VihZAJQZA5O2KZXcPbYWInw5Kzc2ws2BzvEaU_gF0a*iz8R*a9QBx6B z=Mo(J7|B9#_myS<_l%>-n+e3(ZL(v{kn{6BP0`ANKF5IzJ@;owXoVyh8*Pare{8$x z?SwZx>Yv)ur_&Y|ej8`j1+E&mnLVJzeDS$p7ACRze70DvE3wE7KyLl%1=9e!UP@I} zOzO8Lu<2snk+H;`)4jU!Nw%Gyejm>e|1O1zTqvtAC-EU+ybGet)?ko_xqxYAq^&^% z`|%utHv&A@uDa||Mvb9zvXSoUe@b%ktrUu8kUaO?JoqBP84WB<&HDYnm5*kO6hncG z;eoVp6)S-1Mk!F+@e4T3gAFGrQ=1*KyOUj=bA4U9rAs9@S_Nr3tO-{t zmMth+Q5Re-7F+?nypjJor^>{qL;mD;?6Dl5^Dkuy*tfcx>3l~jI&ElQfA>XPQ)?A& zSaK~Q84b#`4=^8N8JuDN=r-YExS(hPi6yer70$`>7$F1ur7@84ilPVXl3XHP{_8VG zManysnWJ>_)PhL(z@Uo(l~K7EazQAJZxUJYWWvN1ylFEYW@5A8nRkM@?q=E=!!dd! zS~9>{Dz#I5?C#119Xyc~X<0_tlSF`1nU=6z;r#Sm zeisB|WvNDuG|p2~CiUe_Kxj5&sn%D_Xx}N7%ov--1DMN2vUV$BYN+^{+AhjbMFldX z1uue|P#J>CvCUn_)%SUoyL_@Mcf$q#9JK=wzsTr!TZXhG`y+ZIMkmFYq#xdrRa(UG4)7(2CU zr#4FtsX$=D-AXdHp&(+gr07y;aB$AxBi~cA%4QuBs%RDy?7ml>ykP>TWw`nbE6fv= z40AzwI^68Ykv|lL3fomnXfTViZm!ibGzN~@LJD}Dr8s)967B27dDZGG$83ZcL+b&GQVC`VQ)aIE>L$^D8`xiC(9D)+jSka2ZP#65ljVQ+!ek$<3z|)NowtbbtYj`V&t<;YgA)Z{kv2%Win{mnP4u9co{7z zWAnt8PakLvlkMq=l3F3**X76(z5BYBi6hvXC_0sQe_(RMKk|P!ugi^Uv*W6)l9`-E zmqnhU{K}f#BW&c{_E9nB#a=ITT^CFd5e>8w>fax)Iq`p4-I?cK*NPfPI)ZKs_#png zNwp?gU{#SCWS4}nv~WwU0~`;q9zGMqCWx8~LR339$u4>>S z;k~16e@*(naP@dA8;8WFGX|pV6I`ylvlLk1x*dA+-w$GmZA~ee)ZCX?hGb^hO|vm- zvP=@C7Y3>6WH(Y+vOgLtef)K@>3HJ9cI+*T7V+C1)HVl6v1tap|JW#kq}4RF ze`Fz?9lXN>tNV;(rNH2GR9bAH-qyN}!RcunQLD7;(m9jLh+bwCe9!s| zb)4H$(iM+rDD-Zv`7JUTn3yp0bhwW~+&LKpELQckC~d>lep;pD;>uzy@9`jq$)*hP zv+=RF#C56BOhIH#&u4Y95FkmZ1bFURe>uZ0Jf-$Tl7S*!G<%5%)`Ri+xi+FsuaL1@ zeZjD4r&R1w~pq%di0YW@(LY znSngoQnP6rj;LrA;*oy2_Hm#bB|8eZtTaBnKq*`Ek5<22jAS??HLk`pz@V%J@WJx?TZ-aKAmnE0hWVUqY)&ni56nYYE~5Af1er4cF19c*|T@_JlD|p<1bmMTNV=SX0>+apt~@m z()HY9m2TMX+X9L2x$STEx8fEJffVtT88E) zgS%$MNPXR$w|mHBO-pjiZw)?RR`)8YrLoISXn3k0K3i3sV;=>A(x z)#*3!f;glEJgF!=wwfM@$P!IMC<8YHi` zkNdmc#+Z4v`a9}?|Y{1P) zYQkcalYsM(qX;)hO=9z|kKSu*$g`XtiwXFpk?dR7(W*uSV1bEDe}e0UL(b!#>({q8 zY@t)_eG;gp{lB;yX6W(UrrSgwjoIsW^#cGimcs<%bMD2i)v<{hz800 z=?M5XQ%6!vIQk#QQP&C>ImdND8TEeBo!H+hU0Hf4WR%JT+mh*|kfxsbaXz~9v2Ct_ za|6*JITcEA>#b-3e*t;qn*8gwSfP7+m{Uoq*R9I(7kCB46<+T;Fg$u~G?pZ&5z@8_ z7$qC`5B3Hu5(0KNahOSCgDb>#dJSe^-5eG|v3e8E_B&|Pw?tP4B5OTGF3BDR4|cZD z*8Nu2&iJV>2%A5#q`o&eCjGG#x|1r9WtUMKukL$arR-t!e}`b^@?%&mOW4|e@j4(B zfXEFGBnWAO2%3TbjsDg0_YT&Ut5;*5ihj27kV%7^cfw0<>u;ZrkD`DuJP^bW>wJOk z(mZS?lidX#_y`bk82Ihm$GHTChSAqn?C+FFpw3-Jj*FEo3zz>lUvj(~Gq(GlGn&7N zwT$#IrET{Po?T}q?(O=HCR;~jjXt6G||T;56b;|s3~XJJfT>nWdc z2rK^KsXpb+inp|d!QDvN1a)%7ty?PAM_e~PSdyX6aFW78oqhrPMp}@ls4AtlNNLew z{_Dw0f15nKC<%#}!g8~42Al?fT35ikqD5TW5obpOoYX1Mt)Sxt-wk8BMp_7#H3&Hc zs?M>GO=j}5SAAe#4*fx&4T*GdCs1KkM>iYN`kOLV5(Y=AK$enteurQngKM-F zybFnAeN=1c080(Vwk1V}NvM6tuOt|sO2Ar%rFS2AnGS3Xb$bw88P|ux_Mfwp(xv=! z$>CnO5?|+qv=)*0Y$I`!RHFi-Nlo;CYeBpxIh;iK(uPbq!!*Qck?G;jj-mB=LZcgr ze+=I<^N29R=JjVU>|Oz~BsWV-=Ndyd7Efu*snfy^!e@xX| z)mDfTO>d=;L<+DK5=XE1_1I+#rI!y0$@q6tXq&lrS64L;KA`~w`iJ-FQl~pt$4OPr z5vLE~c*sV;7$44NQ9<^|H|90FVKcNdRlrcSdWF5gTGYgS`8*Ma9P@X{k|XKL9)W?q z|9f9+sU0g7TZ?#m8w|3yE9Ohzf6oU*85Mc}u`BMxI4_%``*^z9w7T;3thIE7OFPL; z{+ozg*9ues<(4#jY7FphwHiAqB$qW0Znd(e|BfIjb!)*ZG${&2~7|;dnb=M?5 z#An?A=aL=p9_*NeBU){=Uwk>iZ5v!}?0N?6z05u|yo%pYyVO^Yf4Al8`t~)?O|jCb zHCVrc9Ee~rg<~OvIqM30R=&ACWO@h)-lXS+=b|@15t3bS3x6w*77Tv9rD=c zDLEtim9-*2TIQ~qf7|&0PrzQ5W5nR_Z>oCn0p>$HWKx3g3v~j7e6spF{RjSV>xVpDr)k0 zRX2>rd=rhJ@b9x-WYO@E)-8Z2>tk;8wij_$)bz1uzSVpRo| zH8SxCd8OWGe;XSC7GD8@hfRuC)ko9P_2yLK6ShER^Efa_0kfHw*IP4_(KobQszEU@ zhCO2iV1jaXt9G*KLFG!nh~ue46Im6V^m&}=SBgAV*P-xX5|x1MF)7nzwTS2=s_Lc_i99QJF4+exm^F^R+WpHIEtaWkLIa8b zAZ8^N!ac+zjqY(l#Y~VHknqp?H1Rbo0Nu8WfAJ_+7Adm=nc|<0Hw)-y?8XYchApW5 zHIq@$MaGxMFYx+Q<~$QWv*Vf?0HzA^%3tlYr#^TQlKOVvF`L((KioziCJ*Iy0LkA8 z^DR!JmGzONvFqvml5=l#1|X;i{A0snRXFfXEK!HHnc@VpiL%i(R#EvAoa*{bWTR~C#rKKQ-s~yQxEhDQ>PSdg=fJSS zS$di}=e&vRj9y*NQ-C9Zs5nT!hY@`V`@=@#btpk^hpH5P_12ilDW1=Jj}<(K<}cZJ zNd}E;?PBu^H7m>}0#VK2q!fSp+s*^ZfA)G=N}g<>mr#yj2kwLSX;&s-QyqFmbi!x6 z9aUnN3+>QgiV4Vu<}JwvH)4g?>}`j<2vs4@w?QLW531}TqvUL3)a*Ffd34r`rjTcz zuc%S=dl{-bBjmfG$moLK8Bef9@=1zqldnL{Q3~RtgV#>u5tUmlDY4d@L00+*Yo zd7?_v`;3$Q0ZpD)nx~%%Jkc`eZLB6Pq>v^MCeR+v9PtUj96u>s8XGo4M~JFbBeg&p zV^AS62Oo*u%3}u<@fe&1X++Y+_VQLh-04)Gv$YUt2tS;pgfTf$3sp*l6I4z|fiUn$ z(G&+u-SeyAX09QT$;_^8fAMni>x=!19KkZ}p0X`z*hY_22Lm#vSk2)mHVh%H)}tQ4 zP|C)~0)rdws`)42vYvHTZ+~&o7tCR${cCRYQ6S5Pm1$=#O?_I0C2{cFux(1^T&1UY z^FW-l z*K@O~>1T`o)aptlp6iJfUl#RjrMLM-&?j*OM5}=2IjsT}1cW@v#h|h)WyX&`2dfbKZdwlFd)(WOI8Y%( ztTugitiLlA_|V(qg(hD$B7()WK9 zV077#t5PS}4T!{jyG7o**rNO=R%-k&L7tdxH}}BR9C(}3e`M=uGJTItFtXO1jzs!N z^I9>>S3_EjkD55=kB@}&Lu^dSWwDK#d9nEaF1D%aAuSZ_kpX=*^OaCRZrT~=b=>^m z)O}ivo`(kS3dLE?lw0JE_dkrlnX;NOag@e%dL0f(585H3Q4c*RNZowy&0tESY4K z8zY3$D7?0e^YEIJT=At7fHCw#w3AG_Y?zGxs?A5B7ywEpxicp7dNX~0bDM8NNS)27 z^C~sOaXeW)$e6ZOhCke|2s&lBA0;uIIt?^IA%HV#e<;}-6L69xBow(ybajkeaY&EN zn(F!nTow)Z6{nMFVkg)(uqM9EYEZVGdFH*cCl%mr|APs&%n~z!m6?`+iyMi(2quHq znC)LLs=~DL57XCR|IKrcP6k#?ql7$H%-#L(fM5_?xd^uzGucL-1=O=%0$8`XDhU#S zfUj{xf3H_l!t6TBa-=e|!?(@Qn4KRqmCa@bxv)6O?Z~PGy_i|}%vUK7^D*H|%4E5p zIZ(VCl7UT*%C1}4p9#`%;m%FqUtekYeeXPcO#3zw5kV&S8H6iWqq-?SyCGfVnCepuw0zz zH>vlg)X7igkR8>*)h+$L!-hHS-2oz|=N>+-JHWTn@p3hS}Z8Xey;8iweeGt@=-U&hGt@%N&O4Z5F+bG_OlSD;m ze}R_aP4MvH`kaTQQJ!?iW8(EXrU(ZaM|vjpi6~3_E&Iy4AwQaibH;r$uqj>ulf7YX z;7XXBo3y-V+56=S?`f0R%(1%>qa1S05wXIh@7kYNRm7)AGlhZm+N3<)4NMDTPd4r) zsdq|lZm-ukbq?)`xkD>bPrD@-5tN@ve_j-QKzW2C)AX%%{&yurTT>AfAhIy za#RVxtmh&$a~l>65k@zF4cQi3I9;<`q|#7KmF_ksTAiItk;7q0-{dnm^5jt&C_MQZ znS-4X<|z`o9QnKY9v*+Yw_%N>O8AfH;0aKCqFMa5kVE_BNh!Q$BkGBXX(OB(ZN#P_ z+%xVoh6u}1wl?p_Iq}5^ZILbTfBEq5(TYG&pP7qYLR}fgP>X06Oy)#V+dt(*aDpno zvB=*$;cfvy(Kj%~ZT`PvsT>}-b5}^Aj<$$&)A2?wEwMa@+N(kL(E^UN9^Nt3w-@Z* zCvl<8%1v_tkcH zUl9&kLc(XrXu>%!@K?|#WrsmDj(}N1kBbzOJ7AZ1X;o&dCOnMeNQem+fTyt<^=*Mq z?ndE{2Oyn+zsf-;D0usg`$)dx^}2sk0ohUOg-PNK`@exrw@-GMze@DEM^UN|-QSVpBYQli#kn5pOpYjp<8PbK)9HnB>ZhP%Z zF5G03G|s46ln=Y)g_!E#Ccf`a=jWPS&~?~TQcPuxD?AV7j=i!3WLIal2EPS zx(Hbo&DRgzyMaXux0!r%b3zn@kX{*MMEy#}uzflR zo#EC14)Heum1ni+0)syukn7!|2h(f66vD#ESSIN@B48O7H;N zy*b*A6hQMFLSeu&z2TQ+-*Lqy`~_aSST!PrxFGF?o2-~wxy3chBYp#Od?ITux^qh2 zs;enjq!eH^c*v~MJ|)F6WWd`>PxqI|S7FW1U!-|LO)dqdg{oIhSo3-4&+KNL0uevd zxboU>Hi7^4e{=CCkSqTdEZ@c;a5Exk$ngskp&Hvc_;=(-jIb_~*1~!f`q-as3H+;e{GBo$hFi^_0J%FS1bN-X)%R z<5@9dJ(eMICQajer0(%s0Cn6#rHV{l4uMGjOjX^de|NmY;NueP;Dxw+VhIx%X5!7S ztMPsjZy)pjt2-Bleiv5zfjUNG$Sh`3)7U!$2t@q!LU#7>kg16hBVq@lYIN`?1AA^E z@xa|3-(K(Jj2l|Y9WBv#9W@4b8`0Y__TTljp!GhvZ-~J; z%nB}efAf?1$|3+{OiSRr2{sp()88@9UL=Oa|8|B(v z(?KmHvYsUlOccn0hTK9>7%>x?5nS$OeO5{Nf42xZml_{6m^9+7*PpcWqHqWWR3le% zTAw@Znch z4T$O*MkuaNs0~^$b`@uQ7n*8(8Vm4}f4TA!X$ggoZ6+GZlQ<&I*^4{icyVx9esxWa z(J~d@6~!f9qqzdoNM$1>+gH1|yum2oSuBTbV(>)mDLAby z?81Fkd)^(Hb6Ajb@kSn+`m)exBF%RZRVluFBeK;Z!KQ-#b#b{DPF^-JPUC2d8I!G;D9>#3#2Qc}^Wt(Ie?r+#%zWi98iSHa5T+2gOE&w&sI`72iv$6wUkM0g zYkN-k0KVYVvFXpL*2|e8aY^o%5&tYS|CC}|e?vFeq9@;e{9PK>Yo5dK)AoRgkstwP@b7-%w!4b+~IIbSvlMgz@<8%i0wuLw-4{c_K6Y~@7|b)z<>G*dW6HE z19~xL01a)y^FwXtXF`>#z)+S6o9T=I|;c-v(uu z4Wko9)!nk_iVunFPQUX5<$o`vDon7h3bqO9;62Whqv}Edt3m|lPIH9mp=-oJd$n`- zk@8QfL^a=J=-|DHO8d7FQ`Br$lH7V(Hjo!FZO?xxhR7-R{Z>Xj<3^Jvg0fK!ia26B z&I#+6SZoF#)8bC|&3ct} ztCfI>9PH3(lAq-?*WNMr9Xe(b(76g=ZY8f^L#?bGeZU4&71Vpa&0IGNE*uZPZCpr*F{;7ot){_wMy@0&L)Uv*R8?4drN zQ(f$X+|8^NPn8pg1CzAY(_}8%6qDemk3eE*YI7cpD@#ui)PGdL_{{XMp5gHQh=;F+ z{Z;(H&e_dm;KYl_NaX?50n;qYY~NgQWOgQCF!1M1`Y6HX7I6SaOLC7^>cDJgBZWXa z9MQrAF~LJn=Y6~fSRc&~*wSBKobBa5^aMzs3qabgsxEGvuDocHRGJ#j4s1j>Y>aV> z2SliyXZXSOz<*6&JM8GAg#0)OA2nh<+XST$b)JBmE!(EB3Eg6&(Bi!C2ym^_K5FiW z!~{_e4fTIr!)i!K=@Uu8j#V{}*}@;;7!BC#9to6}dNTiqKkWEtyH-B_E=7P7fn<`IAMv}<<-?jL; zr8POxS5gC0DK&x}Vtd?vQnEJV6d5Fq`MDm4bM5cak5<_;55`woF0W4aeNs_u5XF1$ z*VSd-8)~g_la>fY(Ql8?Zu+a9f~|u~|82aMegSI>?8PV1&U*%#Uj8y4Yl#yuEDHvT z%&zxlE`O5ROL+Cdt9G|pzC(^AFF2^jSQ64V65Q1J;Jk%&Pya@h`YQO0kILRx1t`jw zYM^TEUrHH$V=LG&Lgl>wUC3O0Oah~dKKMTW-==v7X=cJYUmrBK9{KwyZRJ@I+Un5; zu|wrKC@1~F{CbUV`-?;567JvzHi?fyZ3Q$kX@7$-+QQ4Ys67?;=sKmg(HRK6zr<1j z&Sch|-^*Zn0qRx_8OOATV;}V3dTBiR3CpL1KLx<8CKcQ~O$#d?2G+JG|5vCJ(1N4J zVHEBTdSP*`SrKUo;~$t$EKafn*JdlRg6!vcHflv?S!{(#LeAC@>nzf?;`~ZuRwlF?0>>vKrReJ`MvYMhRB5Sjolv5QH-2KlRRN2 z1kH*o&5|Ej@Ap6Hw}Vr-AO858WYn>;#olD!eh~$v?H-;gs|xwo%@zkO?Vka0ZzRcb znz^7!np23;W zGkQ_hBC0ilhmA|~);m%|Ip7=&*shAAI~ApagnU;&bIp5&^L`m*5*{|x;I21>qeIQr znx#i!-l>-d)L4%8Go?Mf{foX4?+uY*b`3m`;7jRyN|>c9M-Azo9v&8L~h;d8V@f_g|M!#0&%xZPhPD$PeP74 zoi6avVDg9H*q?PXDr2DcZmO%}%DtX3-46@D^&WUh#xhh9_{^QEn9e#*x9qotT9}N^SMc+buYak?NlIlvyhCR`AYE!Ks3wF*^KM9h0KdxHo@9?e633oEiK ztZ7Qc()wFGe3|9Ao__^5Uutr{zICn8KsC^q$u$4N<6R-KlWo_5|eC~oeR5u01Mk4>xx?hQeh#tZN7Wvn;-~OU`@Q#Iv z<%b=A)Gi$WsfqJAPGa+5)}EnG49o|kj??%}7Z^%L52br?LGz^wTuMRT)eJpBI@3bp zigfXDMl1uNmVe>*ZHE;Ce*NH8sjLNXSOGTi*WzklLnjTwV-0PnKR4A-)6;r-uznGk zhr!%SxMwU?cK+yeyr5#l5BNU2{J32lq$JKhAV3Rtz*hz`l_2XUqZ`dnl`Q^?6YVvF zX$x7bk8hl(48HA?rI}%LIuW;g@8`J_JX%?1UEuc!qkra-yawlK#LC?MNE7wEl48k* z=n9s-J3aD_+{1#I2cR3Vj=pKKU;g6#F6j#mWB$+s-GB<4yikt}udO*2gsp)+O!#El z?bG5_`B$bZV#`D`HZV$jdxu z8*&|Ni92Nu*40MTf+R#4ZZfT(_b1Jr79b$io8_n51a>i=P7CL@j-}wz(c7Vi0H@j3 zS;MeU_gn|YGwT@F;mO?zX1WCF@VsIC!G6`A#1XaEJ(e>VbA=cxX-1$J|MH;<<*p$9 z8-I6m+MJB2QPSBWJnBv~ni)oh`lH6Rs97cqr<*5I+*o+%43#rzUVvn5v?tnXdx=T? z)By^4x@0T9gJR*(x_@=ZF8V11JJUZ~louNzSZ$Dw|Hk{bbFL8(p*$gxmLNzagf9`5 zyD)~b`okNZssDhXhV;30xKG5KS@-?0q<$Va8_TvCLVsn9 z&{nwKrk4huwyxGP37TQGke%7J`t|sqJi-#?SLJ|3%Y#{BTQGGkdFT{x1wEgv{l$=D z_K+gP4xQ7@j|;jdpX=M77V_nrqrNRft!NCNp-pSp4SrD2Z3^QO{UnY7r-DLaSw61S zZc#I96;?$rA9 zk|M18D4{n~C24;IMRxV+G4dmtxl_5!(>H@FfkvHd(0eBf+ecQQU~Zx13La4ZAJC16 zrzT;h?h5VqL6f;AD=}H6O^r_9J%y5CEDd4^gqn&J4^g=YE-i&R4F~D!xqlAu$JlGj z)1*cf_)(xOoo}M3$e}dcI@Wdo9!OiM)?|9sW2rYJB82UXVerYDaDiN;gYp9q1}1OJ zzj0QRz?HD5lH47CAPGI8HJ`UakEc`^RS|csz>@dm&(QGf7M%E?t*n~J=i zT~D%WP7I4z#I~cVR#l}7D=Fi34LPJ{3GlT~VQVl07%h8tz$2}*i@Q3b8e zO)r>iQTzd%EAQ6t3;aL;cP!$xzO9_99p{dq5^S>kNW?Qsb zk6d)xIj%kM))|mAWPhZBPdC*cR#td61r1x^Dus7a0ZoMhmantNw#?+h<1tG1mb}v@ zweH$}atbWutP%8s08TC3Bg9cI@-y=kY-1X?^Pl14YRlC~+z;GwGKp0IUU@>*is<-u zEg1~UK%t3DhKR=`2kiqAlZ#30-&=A>1M{iL=Klf71$=k*{eMtWome!Cr|Q*@e6uxj z#InrQ?a`*yWm=h3wOV)e$`lXJ*FIYhuGi=+`raMlN8IcD=o4y$faZN*`e;(OB}+?e ztl36f4zyK&_X66|)QY_lUk&OaVw`2~8U z6$i;(A4Fu4@P8^yQ|4_oY^8eoli0?usZ-DvC`+;cPoZy-WV&J6HJbos!=Ue!%ura) zQZd7jAdOzBtn-Ric1(G2(e78c3R4RY0biVg;9DYHp*l&xm3wBTg0E++8BlslDuZZ< zJP4F>C^P~Zd-bY%Fzus@rj{j~7AWW9TDCvTv^OsfpntnZo#!~imdVK^JKp!`{h874 zTrmD=X(v0<(z1~*=cl)Prx!L0NO@J<>33khoR0er6VgjlkX@lIJAMw^lOwVsb2W96 z>npFo#jX&LQjiy?tjFiUA~2`kmeqd}3aUX}cQCLDESLlGJxD(isXll!(}^I_!%_cn z;@@|@uz!uKhPYn-*L12cEzg)5KSJn>T!^lCa{MpWiUh$kqXK}UX3KP;k2%Pn(p|iY zm+`kn=M$n?j;1*8Z5eLATZV~hRFvr)H7TK$)If+%EY<(V+&{FvNoh3V9OByPk!`=E zG!o{O)BQ$v&&_C1zk`UGHNFu?DSUL8NulrZU4O8xkSjln?j|S|EM^}SuJ3(n3X1^P z%FtFh_m*XYt+sh35%4hIlsNT1`2OH8z|oE~S!pb^AL*kock0-lq>5;&>vB?)74h9F~Fz>zlV$kG>_19!tZjj+G@Yw zrhjH6;0*s9Es0Ruuxu8YU;Y>R;vsL_cBU}=ji_>>Bblp<$nN}Z~|tYF0 zqRl((YJNu|datD;omeAh!qsKN3w1689#A?G@LVDb{Y6!lzj1=ljl7H)M6iV)4j82Z&7I&l?PVt@`cCW%-Jq0lg<7P3Y zW>oa~F6rPtY5cT}7rVnx!sgG||AOy({Ox^!j0v`e7~!l*+Ye@fmb>%>~GM|;09pLy<-bZdw zCak@ZlJW^OyTP(T0dsST<$str^gfG2;evcgg2JcNd+~*hHbi(dmeU=RA-V7ue}ZG1 zQS!y&77;ga0pU$%%WT8C4mm!7Vp{wuaUgwpz$|~l(OS(lbtzk9kpPbAs{(CDA9E}}R?kY=~5Pw@8I@M(Ab|PE2R}tI{=J6r{Ss(Y< zE|Mi|TXc3{Swi)}nGpzkh%onYrV9r{aC8ax^<&@!zEttQ6=KWun_7K=j7mu9Y!oYP!cP!^1S4 zEBD^3uq%YF4N>KnZE`tMrLAw$*JYsq5G@+{z5RNMSP+AZqNsAhhH=Tjb6su05iqEv z5d2%Y1+e-slW;2?7R}E&yvf(Ge2(M8*34i)riR?HCclZ;HeDyP2+b^VY!94(86nFLz(yEddh5-PT~m79umxwWlm6SMBKhkl>Bn zlYHMX>wnLL+#stlz_rAF^vRxGc(vMZlj-c`$@I0mhq?|8-`ok@ya1=gawz>JJ%L}C ziAU2jdCLcSm$$v3`IK3p8%(yJL#%F;3lol2 zCXMYV2xS`mjk_2R6`@If&|yWETTcv(6o&i9nSWfs1KMIJ7?@-gDKOi(g}kj}VMP^^ z$EI!OjhxxCnwyDAw@qcE;sO_FF(d9AdZ69#Pn~JTS;kvhJxlb%X(D(S#WMktN$L#s zR5XW0Z&!+CFB-(@vK#~iW#r$CJowayIul$n!M*!lYpjdv_TlIA?O|-Co@>IE9tlBD zReyhn34B}Ab@vd2KIREWvz4m0fFUksAj!Uc{`n78r9Nt*;0ixTxPaIZMq`ZleAYO_ z*ax))gzdKbKlXq5yh&~Of{sK3Xpu;}juHaNFc`UcEE9({eY?^vZ$yn6%#nAbLMgPot1*G_X&NzoTXn zc*lQkqHZ-X;Wg2L#&MDU0r4gf9(8Q;)X!NzxLhLw7QCea0sW10TqVUHi4JxN;D1&x zlVrH}F+=Rb{*FHSDmdb#?& z(3$)T$?GP%y5LKlVxT}q*wdZ=0B)NT?Yac4pT2&gi^y5SE@jy9Ww+2-|7Z@T!B_2H zm9jc~AWDy>UC%6~zmSIRP684bPi!C6Tfo&+XzvU6oq_U_)2P{Ad&fAIFQaY|1wUnx6{ z&jtI{5OwmTl{jB_TVY^Sq4JCCsvp^#AJzGS8=M6sY?3G_7xQ#G>Z;|jmwvnsN@Bt5 zM2nh@7C0hliz-SDHs3VMM}L*DS-coXGAu{_%5;&D1viWX*eGh=WUeov3fb;*@*dH<2{W2ZvX*AuSnjAii@#`XyVM^?|24O_XIat&P?^c)oITIhOT-EyS%1U8WyNLX(X*g1 zty5r6wd!S?lelh%|>^VAJQatfU;3gxp1#Ta} z{UV92!eIy(q%qLZZBi!`E!%@a*q$byIfaIfX+GKlG>M7+^ZyR1LZRO!XuFh4kJdgci z7rUSI(^vKpdQtw8v}Ffp5#C7jgy)%CO}ili@U+5n*6GNa%75(Ed7-ZQP+Ljdv6(BF zea%!A%IQBJt(gC*BJvDv}%ZGxMj&}eQSXbbmp3n!}BQq0cd+a+X$*9!+ z)uZgWYadU9wXxx-yu20F-^Szc%@9Ic8+lPnfml2w^FQWu8`Y<(j+ARnQlX8hTe;UR zXgM{kzONCv1%IhQN1VXiF&G1bE6@1p6-+F4jQpDt%~W7*N3vLo_^0EE68k5B-7=BXc)_!8K=@^eVkEE`gknTq1dPnvh^c)*Wzb>t6< z@U@PS2h}+LgoyOpHW#13tgd8Bz7GE8wLH)@kzfha1%D0~m#-d8$;-Y%_?R7O*}?#fH2vo z+ae~46Mw1M3KXahA6U)ZDlB7>%);(V}#5dVAl72z{!+T|7;zs>WsU^ULnEPrJXy3Me|WDkLXj2au3CeDm2+BB;D zn1`dUph9ISg=g)?#f;z_3{?b{C<3>WW%ZA(Z$=-x3eLz(v(o(~{QHjg{%!?o_3nc? zxUgM4P}+B_b0yD63x@=YGCUd$`!Zx9TG(VEBIa1jn(U#zKtx(?=VI^Pqi>bo%a9xzdG@fzSYXS=``k_z6uR^MBUhbRe&-{Z_nZ5&hI`of?L~V^yC=w-v#= zH$9lNqfI!i6uf)@R#&peU$d`r%2b|X&!rz){apuyHO^GRP^dDK`&A>Ex5GvCFt_@s ziywe2qFCQo!<0IakQRv5Wnl)AJ51;VV^c6ZU5(+gm&f|a5u8pLR#P}5wh4y9hJSgm zjKZY^P~xeI9LaQxcvIe0@*5eRZ~*V-dGBEOzfcl~bL8<3bH<#se(t;gM_;=|?OLC_ zV88#HV6p`iaR`rwkXSb2pPzf)cc;qJgV*dcL+3#`Znyb>f2`{LQvP+5Q|dRp*5Cug zDAxSj2h}ic)T%mi0qt=Z#lM!crGJ?V`kxUXAEE(k}S1;u&BlBT=x2}pD2E7iuP#l)Vl zz}S&Yt?)s86M~wyT6Ar;?0;tX*n=YiiAazQ&pf<3RZojlkNa6ZqmV~;9K3D$Q5Hbh z@HZ5GU%Ri^*b*k+M^O))t0lyeOyYzfi~7O_KYA7hKfl`_OLAQEnxpXAgBSX@3nU39 z*iB|3PWk`vb%0LQNTiM?g7Om=pT!{b{9I2v7<_5ZNXJlZ%N$SGV}G15XCMyY$sCU^ zZ!8ej@WUjh)ID3+_E&$KR!f+*?D$HPLvhLCcx^%7H#0x7vaI*NQh=Cvnub66`Y3%w zD$k@ILPkx(4ceIE)vaFi6{-gjG3Lekmk&ZHqHJxsF|ty@ZR8#yAg-d8ZAN^F&qeF>-HW& zM1@$9UTYbubI7SYG+(8o%jjYDvPDtWv-~5rT^X~x>0zRq-hbIDsmr#Ga*_;uDgQiC z*3|;mv29Vn@xfk%dWH2~bq`%K-W$fYq*TQOyLGoJg}G5dV<@2_A)*j7vRcdcnVZLn z`wE8nljSnGn~7l0hm32Hm}Z67bT+uiFK!bP3y zh@;IIu?PaXO+o)#0ClaN6~vQOCvMN65Gm8frXlNJ%a)k&7s8UGYcqnHVPMQoYihsY zV19f*(n+Hu;91uC&M;k@lpcW+(N+2L44Smi34qI*J%3wE;J+HpT-@+iLvf0+W+Um1 zJVb7GxL7_8NNxJ(f-cnw*ER~u%*0aiyLJaA-P6$hR7MMnkD3#YucQx*Gz7gR4>k4@ z!Z}y$>f`)-=||w5JL9QY(kOFNDU7_8%~;6`n{B!0%8tp*ty?x~A_K@V(EU&yJJt9f z?>&QzTz`aTlH+o|g*g}{EWYR?X>iyQ?<-3& z;S`S~WEwELskTM4n`<|`0fU$V^*;t*Z)A%bMH zY&c4Am9`!me>9<-XB|R_TW_zSd{%I~mQUduFUBqgK_X@zLnG|GAVg$Fs-O18+dR_) z2|?;+<>T+hO(A;~%c%1SLVR!VuAYhh=zlpp^M$EI!ON0#Fe>A2TzYyiNjuRAhriAa zQmh`S_9PcvH-B&}*>J_v0p)q6cmXD}?C{6)SEihhiwQgInELTYj=@I8{rZ!5shED3 zak?uI0Mq`>?LULFVBV=;h%UYyCoKL@Bn~AW136a=O$->|1Y5jv_P%Dy*RY)JJbzrR zs(Y?I(P;+iA+Mg8({ZsU6oocN^BtB$6x=moK>CrS@Mtov7ZtK)w6&g8J#H(j&Sq`O zll-~hNrAg{iMQ4)wT6{9LT5fFb&U!!#|3um_Mwf)9AaAF5BF4=N2jDa*phJ0@1%CzD;(;(S8NF6E)8Fsu3RFsSr6^)OAq5P>Wrw-q zi({H9A1_T^4)l&Q!V0fsn%&qbNiJO9LzVGG_4Erw0;jpdl9JM`b^VbMJ;Xm-y5BLK zy#=&3?u>X<${_A-QuDeR9BY5WE}FDm8<4C#7?e<^mB?-GRZt_zlzf?yZhz}2^l6oD z5WD`ctmP=P&kXCnDGKGUEa4EZm&%IU=Y|ECpbU_58skxT0V_!QEPTql2{Nrm&`v&N z_Py}}sdut_hpoJvY*b?8P2m&=+5gH@gQTQyb|GX}Pm8 zplxanUD8@lvaOb|rQNZ>`+sKfRN>=`FZqUIRWbBbuCi-ZKFT#RE3R?iY;L4-Z#fAr z5}_{%!Lp-@> z(WlFDe-k!X;oN(9slX-=nQ;dW6UZ5Dd7hv#t5W`5f|rgN^+kFblYbyfPdZov_!JTZ zYV8E{%{noH(#a_N7Txi_=)IrU*8+Ak1m^Q`sK0f!d(8qu;j13h&8@@q9jHA+HO7P| zPmmk=q-#h0+@Xr1Tp#M%Qc446>FPkZpZNz63ZF$C=I6p6p)pfGCP1PwPTR)w!C&kr zKtNx%rk-`U1dmA!c7IEI2>3D=RB<4_bz`F#YsYy*N+b2~*kdPv#{^=fSpS{vbPso} zHbE6&w%dPva~K4^1DOL4ylt#}R8w;^dup7o0%i7V1zyX)jN`e-?A7xYqf&`&@|cot zpB&!9H@S6i=8CI@D?pg{{c8pxk)74J4jJ9fs5%xa^A3sS6MwE4$JaWjJgqyTNTV=F z0j({0143ErE{+?#!2VN3OdGb2mMlw5qm`Z4l4=AnNez>PziAgQWagS#lW#CQESjqj zDY_=Px%M#IH(k(3m7z{>?x zs6r;uFS5%0d4H{Zhm71F)jIm_lY{q!o3z+O5pd$AKTUrdPzGUXB4#tq3M_%karCz+ zE9zM-L5GWsE@sNdR0ZX$)^sTu4&g+2OJmvL1UV|>HO%Q0V+9pAC98$B+0;kwn>pzBbFDrD$S^Mnly1_V4sZdK@ukL?$U$ zXokP`S>RCWIu|<^)(5Htx5HPTq+HX3HAjRYvlg9mD(OGQV4Mq+vTh*Oj1BXFzb7=} zV5{bkrhj3q_$OL*!(kFc*^sHmvRZ0{0XuHCPp|`VZDbjcS?t=eF)xN}F2BNe2VLyIL_%-uA8H%KJFAYB+`Su<{^rbCSm7kgNOo2q8F0Kue@Y9_j0Mkx5 zWpEgt%zM~GtSjQ5)JtC@H|WTex~qBm`r_=k1b@y4Xfw(ya=V%3$qEuExGkpMvqW0I z00pu#TZI2wJpYofweUFdN5JZ`V_=<)@FdNt$v2HrP)y z-+FsN?u7%Nm)!f_l=LdG%!ItQ%IdNQ3JN z=9&g~!nxfmmCY-DP8778uNtoi`D(?2DPFk|s*96v3HixSsDM0mQPc|2-g|14yjcQI%VBCVm z;O}}HM&f&x2ZTGKzv(QC)O*OmQYaAK7i+bAaQyMVn`6dlJuVsMR!UaGi`ALNn=9*Z#`BZ=~0bOVP$)l#DYCkwoTQb=rrA_v*m36NGvhgx*0gYC>YsI#Z|>oQ8yX3oJ6of zf0mPDFV{jQvO;)y2+KySOuOgE=$}HUv=9rE7*-&#VAg$w!RB~J<)z_d zg;PAMK`j3Q`Hek4d>c-tw|}?dm8&0+bk9uP#3i&!QYr+TSgyT%G7nhgh5h(IhzW1> z25{Ee>$Gn~2Y;33eEcbfj{l=_QHY_3)o6J3b66j5sT*nwfcy^*(Y~bAEwtmOvEthM zbm06K5h`;1*&f2S#{gRQ1(fcPWeV+Zb~@G;1o#+U#91KNpKJ{-SAP=t=fSuQbl7p% zLMHrc9ZQQab3&%r6@>X#;{+G?IKwza77h>6!Qv`3houG`#SSMX#-<^8ErkXmXUeC& zEkELAR9$%><8C%?sCXSI3wF>mWyd|uQ9YA|mba0E(_}XjsE()X6k%tOb%c1P{3W`j zEcoK5sMD*4R>F#=@-h%|1tq+-S?KXRoM`C^C!_o;^%>`VGM{)UhtA7$Wdr#0@HoD%fl1(kQ zefrJTU=HlrK3lV#a(K9alzUf`?k0Nn4M$l7J3SRh5nF?Ox4t#hy8SmqcC`Sb;_0#x zA@~*DAluK% z!QBIiJ&#v8=Cd#iX2p~;8ehPnQj8V?Y)&3y<8O*fAUPiCCD#Le}EH4c6U zOi?wO_j~;KlrQPus-@T{JtS>Iso~_}lO95Wm*DeGiuX>$n?C&qQ5KvEQy}eXzH;ui zPjV6yNPn&#Ly#oIJ_XpQV-?Il`@s)wHAi`@RV8sKIkzewb#V{`plmE#0Si}RMgki_ zvC*RJ8{x@FQ%;ZTf1^mfvq2E5d|{wJV=2(t*__RpNfq>@!MVLmJ!%153AjP&HS)2b zRb`9VdFEhZQ{3g8<^$-7Metd#NqB;=vWDF~qJJs}%^`K*$v58ps^aE0*O!$7r2^4= zX*9hZ+kf&o-484mb*v1*M9!~&7$zAPL&bxY#Dc!jM!cy4kOfQcIMj|3vJ`Nujp_>V ziQf;~q)*DrdbSE>VC?!{>!9)+^}XLarK7vKEwr0ggaoLxJEP5Rj4>V|ztji59(Re` z+JA@HvROa+Xn|`T92tx&v(24-^HvUkZb@DFN2`c{8KHS3Gv-ab)H-)rdtUvp@w2K) z(^Ff}x^FVg7&uZwyJcggPQHBeUa;UCA`8EleGwo(sRig7+%bgW-Q6F=S;b+LJn*d$ z!M{-j?72=^IJ@a`6er&*YlW4n+5%8`f`2peT)4=#2w)=4yNw>&G7(Idb4JV~hqW}1 zPGHm+g$Up6+7?t=MHd<37W|6bI2N5tO;ESfmE7+wxUS3GTNn-inqJG@!LheG3`x4} zvdRx6IiZSh%~Ph)oRNGrMnM7I?w!Z_0irn_UC@ms>O!!YJnwY{QKZ2?(|zbh|5jd+z?4wJmH|gWRTR zvI2L>FzWM4u!In8ZY9#Jq!Y!G2wW}&c#Bmkj{O~8KQaK&=e!+`yLEEb-+!O=t|o!T zx{#@rjZ~TTb3(P8UhoPo0&KW6oz0Cey|cbI*vi1SS%3#QFE2C8a3`_v2b{0pLmWV; zG3=;G6w#|`ESF*Is!`O7bWZ*16kb<$uoeyhOY$WAPvp|N?cU&Y9}Yzlw<8ISAZcYnerIroYkV~w47G_x3I0M6+X`HHO<>D*Xk8h!uW=EJ6l)@~e$++g8V=Y#fw(mB%}M(=!8zPLwCg~eg@iOr7CCv96; zPPJK@Ejlu@d13Y0Sf$$CJ0Tz@ z6Nz&pEF+E^dC>VNOBQ`SDy2dOhO?}HM?5K)HVT_NYbFzJ9{uf7U7P;s;C2+94QQ6Kj+L(_3jK&rZcMou`uE@zTo?_+3 zfoDGn1t=oSZdj#(t{*QE$izm3FdlyZGc&CN^wb3)IR3b~Ov$dI+88uU@H{6rjueK+ z5|Am=iOnyruz&w`6^c)b?J0ADd=9QiN1c>vF>jpQzsKRl;C0@5qYqHcio=?f{v0E+ zv;Yaok(OtEUg{c)x&WPOVD2cX1%S#==$eP;D-34;cuiK2S1kcF&=I7cjFTqRa16@- z%Jk2RtF4?-TJUqKys241KMb{DvRnE2bI;cj(VEa=V1Ia@9m=+ns*~ z?&@WyWiZpO;P~1h8Q%;LQ?xSYs@B8NtPFb?LL&kOOF=_ zwBl)-+==40w(A$0(9nxF{?WfXm_dMhM1Sk59M`lMltUkU2G}*m1p8R5l4#Xi zbE{QK)5#oyY)^Q3{#|zQOb!cMr7H_J8>4&Hbbq83uyB*u0!C6%kT1O;)!fgq&t*NB z)5z%#=w`44;Qs*2n0F|xv&b7q!FrDF>i^va8v z=fr@nr`Za#6>&p$9mxaWNV3HgdGR#CFeR5-C)Fh-FS2`ENCs(ojKFGcXpo|3FoAViH|>3{sKapa_bebuv?-ua`oZH$%Ae_Qvg1RA&7 zkFfN z2j9-Ax`3ysOdB$%K=_Kb45$sytL%@C?*=0*a`Ga+%DaD%hGudHfZCIpzZq*6g7j6*%4SSJ zHA8tLgWcKr8pjridu5@y>Y*Ac)PFE`THT#CE^JLdio`+O(!K5h*!$Hbg|>g8TAz^K zDeaB~OWwAAYa<)Q(>9R!OEe$6;ZyRndG?>CIH=$oFZnSUJ68Tvi2h$u_b>&xaE~y~ z`Tc~t)E*32{RVv{ug1FQ;ytrm?=ZNKZW2f)cR_SirG$7(rD;Mo?CzFrW`Detux#{} zaxdN=gdA2mIdfjJFBP@YYUzlJ=S%7zi@v7>HhZ2p zo%__Xw-7_DTq%fuz`5%O=R&wRI>Y5i(Xx%ifYujreBXVlsfE$ZMN;Scf;jxafj0L( z*;QM!vT;j#%&be0J8(i@)_$-hy7d|F=j2)b~rgfZw*5gRXu2rJb`I7m9jGog&7&0jx-2AZRONoBxSq@fhzDOFWGB!5LT2I+1H_fEyy zzea1fOs!Uc+dxcY*fq9bao33Dj6YsTJ#Wnf{k8;-`)^-u=E^~-SZC+rX25qT$~290 ze@GfoPOvC-!&C{WeDby?Evk9Q))63X3)c# zM}@1t>>dh*gP&Dfo&RSRv&BOH>JcUeM{VBcDHrIAp|f1?^m!QA>;}W0X zLsjAkZ43gjgnyrndCY&WM7d}Q>^>t2Iw<;v#V@MaOMAua&$>_70wV#{i-zFpw-LfT zT-oqbX3?_+XFPcI6;-U;k`&jyygYfTUezSh{-7K0Pt8NlUVTWxpt<_Fk$}L=5VsQt zhH&ql%YvHT6D;Bf>`%HqieX!M;w#W&)L2SsgcLZddw;83mT|X;>18d26ua1S@BrOb z$hYI~pdB_6^*hSxlHDp6S)=8zTHF1Vt0l5(u`|nyO); z8n6rk37^gKC8U#cqec-2l;`eh_vrsZ-1>3$)Jzc=lO|pU-^8Ay{)=kf&yS=N59?|+ zcgFy@MSuQvFn1dH^XYBt@3qOMo()H-__B!zN5Js0>lzn%koA%NEf5v5Tk_>U3(w?m z>^h8YK}({aP`H6@t9vr$IEGZ1zzQBJd$|0Hlfdn4Qoj|JiPhiK9N6n|f1pW7Zb0N!;mPQTQMhVM+6{G;Me zN2h+o(jq;*1_>muzsy(`r<*4LvNx5{`l!WI7(JTt+MuRCCi2Dg$1@G_@satyE@S~{ zjuFu`IY9`QtpIyJEOMzyIc4ua>y`eEgyo#$;=Fy>Cr{7<+`sQIhFhVWnCrlNONnqD zhJPo{hh#u5{m=G_AhFeOgR>}r7<`#XQ^O^jNNzdO6dJV5*3=mY8G#YY?VKvy%<_2xk%BGqIIe2Sz^yKrpy?b3({e{xT6 z=vp1G%nDeph(+B7y*;6k(9v3-EE4}OLVx7Z3s)x};!VL`)^0fuIU&8+-Cz0DX|mJP zJ>9K_u#imW^oSghk%^}OX;VGawr!$FTVHEih0L`-{ulO_|&pkn|z zK*qn_VjuWv2>x9}Lxh!NVd5QY)6skQ!|&Q(Ndz8kLEqe1pZyrqy-`{KcQO76 zQgTl-`#T$-kkz&1@mC)2zlnHXqHS!y(=Hc@u7PrQ<}FE zp>wV%u4VS(BUuT(lxDBgqU7!c{#bv%Q(zH^V^u!aDT%A;!bVb%AZXR#TN@L8n$Cw#?6Y5mQ(N__V8j39&Ou~mS$ z+`dFO+Y`gV2q0gSa%Qe6!`FWYQ7qIw%0U}L2RN12A}ZAT=-lk*mxb%(H?!`S|CDD` zN*4{&s%C7(*@4-+h@4`{%Gn@_PRsxvuoroVe{!Qy=yM_Es+HQjrjrRXPT!?#d?Y?R zqLVZQ@j^f?PL=#EvWBNdQhA^#N%uu*W)=pphg(FfCnIpTC@*JRW3hU2QGkE}&x`GA=#s!6M& zRWXxXb_UMtSvPD6#3Yw-rsJZ8B1KMZFO~72$FOdA=|ak7HVC+#z&)5TiQmjROXBL; zsA=jU;?ZZ|2;bX3@LYeCGfSbKbRcQziBEhheME2La$=9%e)8Ew4waCIMD<9p=x|6f zqy1#COAkU$PtPOl(HW@L;*AWL(=Q3DO2v65Aw5Z|J>R+)YKlYKMb>`@RrZpQN@;f=b(Q5mB0mj$bNa*&4*TEYZGzW6AWgOccESU~l&bI%rv17= zrl#57#ScqJ*Drq$?fS87Bt~0UKluh&+TAWSQaLNXXoAb$ls8Tug4SL^;=~Ig{C5Op z)JG~w_2UeN1DB}JbWazUdDIUg`xVG&tknpDzRt`gQ2ovm-&srZkPU%7-0JD2lZW{E zE+F++77xDsAQebZ+Xe~=#tVkQKSa%fIK%SL#(q#RzPx|8Tk;osRe}ewxESfaToX`y z(K=VzD32;N2WQ;G;z;cg%IM3l_VL`Q>kbcIXTB~{n-I^0^Y-KTE+&gT4T6nCyLXB4ky59 z+zpKf<4%9Zgg}QFcyz8Cb?NELQG_Tud08{7#rYcsty&DCNHl`#cgVbMlc4Il7s9xd z{|ihthGbW6RL13obl|)kK9Z)?WN_u5sz`ynto(Vtt8KB`IKV*^1b`d4(&zcz0GSX0 z%Mu#_wgvY0K$Di2Q{k47hj%?pMcRR`rjWfYUKM`=#hx@DsI^ zpsv3omS+&ts>|!; z-pqf*5|Ec2avv$7uAO_`??X_SH~JJk9Rblxek9hxfs4NwC?6kU6bo|P!pCLlI`N0Z zbkmmKr8BR{ogOidtk?u))}waZkE~o(G~2ItKm*l6a(56eh&+d6KK#o8pv-R^Bj=pK z{`CcPOn@hSnGSN!x%fPIgAGB)pX-~@=nQ{I?hYnb1k9o~EGTeeyUz1`8ZZ#=Glqqs z*eMjz(Mt%CaY|xIW0K~!JoM=UtuzTlfbup~PU~&}M5%2pLrArgRr+W&x=q3NvDwc; z zM}<|tMGq6aQj`6sYS1q>xeXZ$XrP9UawUm~-aD95SP)3~oxHKVk%IPin2Cbo!NLm2 zY^L2;>Aol}!sU0ikHrc}Gn`fIrMmyXN~pKX${#uOoS#||CkpHnmkOOm9>)jI@ zipc}JWI`!{%p~Bh-o2`jYLRYSTo0WW=6|Z4&C~)G9St zkpFcU0Hgy&d-@0zpY6+?q)9_^Z$2>v!&DEs8DIIKwtK?aLhoFC9m|n0WRE-#ELV$h zTMP^jOUIBgAJ%~Xz<#iy6t90-{r!E2i@V<|E3xL2huvWg=lxV#b`XN}w|q@qh5e)g zcw8Ilz^?dmu~6!hvvwhULjv7#YUl<|FTJ4Rabl4Mg7wh$w~KC~P7ahRu_BScAAX|w ztc6Rka-@luRx1zirBQwT()5{tRanfu#QP#ZiD;+Mt4CH2<5h2j{GY*HFs7I9AX0h!lW7ifjBPB+oV;rd0 z&aHjisJO1_UUs;CCMqJY9miUb&!m0rDtQ;Pn%1O9P>`6h!{|wGVz*#_oinzM$GZs< z^m8mtuF+0;J3o9V)&+lmeKsTzObY@g=ZDe2u?c4AGD0C+&xl|}Fa(Nq`2>FX)G05x z+#T?5*VIvc$ctK-HLVR}0VHv`z075tkyS=_)MT_BBt*b1s&|VpMLJFa%c_hIW^Qic zQJXub&LXLDVE(-0+@#JV)Jivm9zRGvv=!#I0$4uuY&ysWh^~Lp6kAHrY-z!CDUhGr z5?&o)AHonXHuq}G4Jt>4UG{*v9t<3*XjrZ<>cU{BzLUwUxtO??5Tt0i%snIIOopDo zq{FZCIKzmJ%CrxL0*~*=ecw!>dr0KwRA$F!xz>2 zE$D@&r>y$9I&*)aFVIGC-~zR@1C+tJ*EsZeL7Uf#$*=xDWVnVA0y(=4I2DXQ5s5Q=MVw@7qvtl26gv zxENzORSeG?d@Cdh&!=roC$ov+`>G`Y;c(jJJB0)F2mF5$v5izvnVUe~iG|%YLBpC_ zX9n3|MdENDq|VW%Yxw7Bb+2LZ!XNCiBbhaKu4H88;WOm@Rqqy|kHG?q|HOI8+%?%s zj%ikZ(oSi-Bb*srH(6Ix7nx4hz=j*za+HQ%?oQ;IbXcbd2fAYsCu;IR!>tMX27+&~ zlm=P`JQ;sO(4h&vA=m=(?q4B`8`8`>#Qyy95;%6gHpaaTNJo-Y)XNw=?OikB_wGe% z%xgXH?Zc#Ss*Z75!X@gD2H;3FV!W(CdjFoPwwVy$z4t8o#Vw+Atz32wAs|av6>^DQ zAE1;6SsD5yI9~nfIC|WV%~4(12r)|w{_banbi) zP=kNM7*v4CLIvz^{-76i3KHZTaF?^=sA69RLcGQ=#2nCf!ix!b&je`vJS-hArE+%$ ziP1;Ky&b(_hmQO`fc}<_-?^!B^-L)8Yn~Te^93+-Nsu_B9pto^sB;!8Lz-Qfk4yf$Nc=u>BQhEG0ycWRMmdHxTjQ zYylofq3EYWNNq;eBFYZ#0Sv;L;{cvdx&N=?08>Kz*t(L`S+p8(ojMV(6a=37fb<^Y z<_F@sLT0=SyruYWp@TpnJ@uQ38ln@(N=s-2+)QJbW&4lcz|XWe2$;)JuEu}g*FJw) zJg4Z|o~=ghk%Vh#Oz?_6D0=$r$em6KD^eh5zjDUf6*n5%)0?wkS$#;bB#^Z>@BI`Q z=T~%3mck%8?HUa_=bt$X=QJ+eLP7S7*VO*gttwv0Wx-`Y-+MsE_KNLLAPsGds14GZ zo1$qsv!Dih@Izr0n7oEOJzxp$@y34-s4Pv$SMc)b9w{bapigA04oYPr0EM(+NsSOj zK5+(U5!6O2?n#=RK^9PrUM zFp&1YICStrNH}`M4ZfN|*uKQfs-HuxW--FQ(C7slV}zgrJ~`T_`O#De@?U@UKVt)< zVlb^Dbbf<-OjIyxQlx+ai=#YO?uO9hjAecm&7g$7Vc&A@%8{gX=ivmy=)gF(&QFVg zT7W;A%<^bpk&n}-(e9NXmTnMW0b+jV`%Eji{q>f+9Z9?{ zn@5_DwY-8#Bbkj6Rcqa8!h=9o>+C|=e;p;Ou{2Zc0{pmw|sg3mDk2Aq*8E%=W_Og zM`2Sx+|@K|K>H5wz))iuE4!OP2zS&-L&9!{Q8+;OPNWu6)n|V{i@+_%y5wI!(!e8c zEiVzMn9dyommih7rY^zj%FYb9IEkYEsw)qi*byld*E)+QB7B2DX){IR&sz=C2|h{V zVcSvY9Cy_6S$9m?!A}HhwmZ!SK5=E&u&-FsndhR+O)!%z;@QWW?P+1(FIzxYQC(lTudVuQ6p+mExcQZenZA0_5r){bP=AJpbA9R&O2tCb@DaJXP zraQN|)6rc`_b~PE%v#!ZA^wi4gjYVs@F{&9@b$HS)|!Ao0|sPL6GsQxvx!R-ATaQ_ z7S;+JeLY-B4{yCHC(hYs05mT+zf!#OwAbr~d)Z|^Zt5W;g-S)P*M z7t#0%5Xw)kNbw~HI>U&_#aBtp=IA}EFWf|$FWj*{QN$23aIX7dpRuwRd)geV+2CF4 zlId~YJBfb;2*kcqn~E~hVTCCpMs>E0hT}yU zlz*zHvb3QJ`g!Rqz}IDldvi{QOnQQ2{;C@X^G_gWYZe4*#pn_aUoK{1bR-b`c2B}M zHQY7E-;2yp`<_5NLu|`wlkKz}i6vL^>IQCO(Njk(!wKj589B5tn&t*ZR_8Nv z!}$G5L)1>jOU*Mkj{L^x@EofI+VBq!sFKx;{QRjclf4BmH=wi6HW+PyBkSrF#mB4( zjbnY5_()cZX;7XElwm7dkX@|mWDWKm+39~5b|WA~ER%92+B21w05xHt1P{QQRgt%s zqrxMEUqL)5s>v)Nz)M*>8a=%Qo0lts00^J$Gr~*xJuV7hYrk=$MQL%)QdGq5%+T2- z7x3$AgL)s~?WONxsb2_kB5d_T$!lM~KO|>ux2zya3Cb8$F8zXAETv`I3FCn;f6#w| z^AVh3L9i$0hM3w5@)uDc%%z4Me`WvESNiJehX}o{YLO$?%uNG&zooe1|_5V=bH(FYunv~cB9ZJV} z35O6{;e5(yI*CHgz+Z9ZusXoCc0MHqMuVG&J$UAxW5W~v>GCJ8z=0mEN&y6JB!Pid zI!$wic20%YHrG>>B0X4;BduJxfuK2L~}kQNnc zUcmpcN5}6OK-^^bbsJBKwd-DxX?P94{wNUh8nYqSXn9>ZJFC(}O34^4x8)O#eVXnL z&Hr%nsz;@k0O@}LU#>+B{A3WE6;dvzTTOp9XalTpK|dbr zpXJYKr?dPnuB ze0t#dvnsq049NF`&px%sqgaD%Zo5Kl=FE zy?8`oR4j8f0D^Gi5JZxMaL&>KoAJ=N2?S1c_z!MfdEhK{9;1KRV?4F7V>+#ND`i*_ zG>~U|4=WnE1bDXU*q5SUSyj|}rs4zl%v-YO6wb8yc;FB0)Wp`I;Ip1qg5u+@|4r{) zd?cin)Mymcf!koJkmD|7312-;H()3MU3u3^80sUyCtzfiGaJ>eUR@8?79#o|6G(|h zRRCwnxthf5__2S8rRse+Wzx=a0Tu}uVv(Xb`YEADTp-3aYV?WAhto(24{3c8|MbvJ zo2GczmjZ{~oYsBRpoVPvuJp=tdRjvkP7Sjm2~|N8k!F~bu;YN!oVU`NXx#D^55cl? zyK0f@S9u)FT_)3KMQ;I>*5$n+K*2h%wW6^t8z&e8Hokv#;H&a&o?{(u{}aW=gud0_ zs`_mGgAp{JaTGlUkxE>%%J?g4*nw{kx7K`!cgcJ)tceD-6S_60`k$6|AF0j2#d6bo zW)OyeVv>72W7_H?&FDRi9OEXHg6>_lFs1Cdkz77Ml1;-$&tT`(Zh9bvYX}EUW+BI* zpJ#mj8ZUp!yOe!O&*6uvqyT2nex%~l;KWl{{nS^$X$ z9}J)aZxqpIdF2vudQ^`p4~p@6?@~^x#3RunSg8)`7+bA>-lkJ8eX!5m z3uSb*`C<)fh{F^824q8)7Rh3cRo<8$3GOin5Bqs>=`N{=Ri0zw=OIs!-?O1{lXx-_ z$;f{NB=U3#BQO0NK}ZE!<*n_sB0K;)-Zlwkc}xb7WOO*KrwFj(P4HW53;Nt6R0Phg zNUUwnMIC8qyadQ|*U6k|;#Xm-Xdp@tnhW9&j$CHlrjCX5Q z66>8Hwl@)D-*ma8pgco4wWY<|oD zeam6!*h%U^gqbR|jE0z*8Euy19CVFs&K8!TOi!KcKu&8osGavIFn!g^(IKh z+YEPGv6!tq`&?dhFND+|?M1Js7WDjCj!61YzlY*^LcJRnr|$n8h@OwMRE%bmf3}q zb>a90wg!K=R-IG4aC6anBfUd#4qktBh$0yMU^+=w(IwkN1JGZgDY`reG9S>H-f}VA zsW~cekX*;tQxkURR#ipjssX!SoeIj|qToA}WXX+W zr*<+zS7a}=SkmQ4CZ*Sb)MN4+Dg)O*xZZ&Jd)CiLwD|M3zGmo{kR$)oyv%)esn@hDFo&^nTIF3 z39zRr-BVEB{v$cN+U5-A5@3W#KHTZC$sCNZj%8E}jW{`7w|`V&Jsm*sq7fokS(%#J z>%Vc>uvaP-RTJS@Z*>G9FX(?eOe_R&6lS@_SuvRezW?Khn|*6cnzN3f5jFhqdrlWD zxj?MM^1_XBvV5LNZVEJbAr@avWTeZF*$2Z%4mRg-Qldg$hQmVc`bxp804PL$Mn|-n z06;tHP|CYO7{U2Pm;DOuEbSS^6L{i`Z~g)AW4x=B4Dg$)MZFE> z^mNMiekD5k(F7;)a?h5#uDwO$K3aEW-m4SvPF@Lp%gXgRKtqj5!Kh6;&et%Z{EeF?k^y&|IE|cDH z|L%sYz>$S}tSB#tLBrh&#?`+N$Lx6w`T{V#zv#Ev#UzBBamfahzU>qz-AADjOI}0c z=4xo;(x?1OqJ)1~tKDQR;4Ss&b^w7fPE4V+u1lgUED(-=;(9P)<(S7;*wC}=Z~{Ii zdL&!D`|RNv+M#C6^f0K5%LoI=#Yc<4`?!JMV$9+}d_Dp6lXNaRtblhctb5HqzHnY4%n`~1)WTkDr#`3D0(JE0RrxfZ{*V2*xa%J%1D zA9?%=!H$0x%|xw;vSOOHkkf8$VyESr;E#(^C@y$*1a!(GI9@~Oe8D`pH}1!%MbXfN z{GwnHuD&bdPq-Ye(|v$hmAyR|@n7{0ctl~!AVyk4GP%_WOi3*u-txwp1UjgA0rm_? zq0aOa45NH*IQDyhCg)zMkefn~&_%Bc|P*4*bJLu4L3ge*CI~SzVdzEUh^lylKvloVtLmPCDoSAaDvKkXV z-v@vG{3^4k5Y$SYE4;ew=_DslJ+LzkKDFN^0f=*ux6@je2CU$d@0(ttODWS%^CAc5 z@Zdwqla+XrF**V|#L?6~UNs(l^f>ncteH_6sYtjBfI|c|nz%;TYLZYKI$iOv{xO_8 zk(7`945YJo{&7)X5;TY{{=n|Urj7W`9EN{P3iazYD%LTVh#@O@UNL-T-<_K-#bjQ$ zkz;e_Tt51Pev$0N{~Lrz|F`C#x5xh}kVI<_P&eloK5#mX$5Ppq1F4GQY<*Qpn9ti` z{|QD9A2N!nHM&_pDKbU?>_C-rbuebWy)^iIloEd|olSj9R$-wAjg1@dy2U_rKZbwY zEi}$2*~s4Z6Y8*b9+i_TyqW*dl*h}fHwRS@;cv&{aHPT(+i~%#H}4!2UNuyb>&&t2 z^X#3Z`hsa=rgb?HVNVGBx^IBp9a;*Krs~57`ydLQOXWu+*jEpG!=OH7>k1LR(k-fE4K1-bdeV~6l34>v<0l;x`uF4G1xxHqK(^HU$Vof!<9n@>T z?bpG^yCkdJ&AGMtXK}0RvKJh6wMIk9TlrVeV@84LFWBWoUnxze196^s{FOPZaRjvT#XZ*gKs{pbKwdpYj;iO$={9#BG_nk9UN(S zJ-TEgu`}Anq9mw{@k)VM*w=YEck0*yIR#p6BJPym5`z7f@bXDZ4rl&kwP4SMT?q?Y z;L7(FaPQP!bbG^M;TtHQK6kRwb6!>KijCPzpS{1y&ni` zq$-xh4kH#$YkTo6*Z>P<8k$RNpkkU7bv{X*1i?W@Ed|f?0MfH7%e9E$P?xRZGm)yM zLU=XSW3zBScY{s45C?yi!E<4S1Jum@ot{mLX}y~AUJX7Hy`^pJ(i1fxumVp(8ub6P zhe0A^XgnI|H*M8-pGk|3cxR|y8S?*@D(qJ>tB~ucnTBzJb4}v9#Qg2JF}x$`)_WfB;7Ov}bPGWzg5^eJm~ww)KN^vUU(1UgWFnQ( zINre){K$>*{zFu!q7yu_et&F-sG4O=nb88A{=u}D}VOK5y6y4!L)GTjo z-Fw>I^IqDmN}I9U(95hamz%PbZjc8o*MW6TKgq=9CBLrzA&5Xi$-h9iF%0pEKqXb)X$e!SLnjUV~N%7s}%rB&sj3UlHiv8h(}q@U6{Soq$J zmUzNAS%g<$W#Z<^0hN;VGAY|8EW%b+Ch+m;&JL|A<@2~LY)w7oLr}-~xtl{I!OdDH zgD3ZmQ!$3S2duYx>F~Z}4B0f=q1HYXS%MVp1B7FM(SLt&7ceQ7b&>-?MdU!iyaCTi z?yvqqEW7iGmwG?t3J%6^97;VZ%^yg&zWb1b&14;MKg!l*77&4qlbapw4(uMr)ZtSM zbz_LcpJo>0bDwhW1n(@o^xFVM?#WQ^U*trKq^Swp%D6`GOKjsHJ>%t`QKLlE*5!sE-$=V%| zj0RrxNbNAiMZL$BRG9b$$|@OVBY>95qBNF8#W>J6>EEX`al0@ zhUqO1(brRN<+s!*0)AR#1 z<3P@GtKfeJj@gP@O{^|c86c~ znMy$5TMKtPp2A$pQ#AsjFWzF_6QxM%0_<_ z`EbrpgrO^nmLJX0=kwY(m*L`EwDQ`;W7Tfd4^`Mc8MJ#n@xVUU-k_~)6 zhj(g^q0{8JCWKKS>^x7o<}A!NSy+Dz6Y7M@&D;GlKk+_td7*TMi?~DMg%7xyr@48e zSG*ERQ4~eR2{Gsn_Ju8Vhp8~^#`l^R*6rx?_U@lTIX2q|N2UCd@e3DoRjO5?N)L!) z)^{Bj;!oHO*`gr61>@igAdC|6Un{KukktgMcc%@hNHVy6rx2^d3=!C*NfCd0PGOCA z>R0s}^uB0{vM?is;GXbcnDi=lXru>v<7HigD%F*^!)Tz6EqRAE z0KNNs5zb^=M`(qA-dr5bBZz-`CsUVYok&Q)pU^%m2n>8_d@S3%U`!*?piMVZZv{#2 z`tMxqWV`h**&nWzs(|3ZcJaKZ>;N-;;pB)%+02@WxX|V9Co0#s3I~Z zW-(cQCjVw7gTBxj&?pXhKM3z}}UHTJU!SrLCODyH0;@R&IT{h|t+ zIV_t=hH$Yg^mB@GFf+yYXs(Mnz@(mr%yiDiyO)Bumx0aIp{5xFbGLbWl@MxSj^ zfIma1YOmP=U>{B*JQ2)dkYa>PX|5(z;!mDBqpf2xe|Vu%fu-aQ50BN`1= z^%zU8)DQWJ&GCP-z^R$*sd(r|t@pHWfa$a@p{#c%F#Lp+`wimPOla2TPx0QI9a-ooLV88)kh5 ziuMI-A0S>gI}9>rTXke?p2!S6BkwV`tU4mtAv^tK@Tq^<6Kq+HaIJx9B!JJ%&%tdv zq_u9K_~3n0ZP8pRp~%3Jem9EEA9OD@?C!T14T`8!nx~7tM!1(f3 zN{ru`9l8r^aJ80p?P<%r;Ux*SIlWmIeYZFsOt9SD_FSP@W2(V2&d!{CK?AB~V)h@@ z&PrQQDgJ)~fKIXkx#njWdEGy!etZ%VL8SjKFFGSq%|Hl&eRSbsv@e+nLlGYH z>QX=X5}_}AecIJ-O;(2nqjf-6s_;F2t7#1QQk6nTJ~sO1Z-=y$0xV9Au!>8>CAgs& z9LS?vg02?`N6PG$%dY|p>6uEk0t>@^XEw6lHZ*?#uvhuWzmyN}o9kT_TC#EZF2@Gk$Nyy$z* z?ywdBCzunCtFkl7{&g4bUZZtzP9iIJg>o|mD)xfci=U2ZI5;66KTRZX2(LsOMQ;$B zD!hLtsabRsZf_Kb3CZ=a(vX_e{S`MXlf-E(Q;WLG7KBbzDD6aedzTEfCVPTeyv;V= z%y-waCDFjl$wX?j;GO<(Tq@q`tuYwxb5=9kxdx@Hi`E`um~c>EX%oQ=c9y89I<>Cy z*nt#yhT3$X>{u0h5B!H-L}13iKEBE*Z{L4$qteKjC#`mOd>HwugKGSbGbPa@GssKz z4h~;3GbX9I92;-3GqxBsu;?MtOjpHcnZg)O{Jqn24c`)%HI?; zb#wn@zsAm z_=1U5&4g+(Wo>@BL4#4Bn+|GNdy|~$AAU?Pzn4m*ymyFXK2ehhBjEEW#&85m65mUY zsEr8Y*XiQwRdG2lN_FZM-i#5pNY-%N5GNi6?fEsgY4NH6{tt=93uL6RE4wJ;FKho0 zfxk{H8S??vm8J+|A4ABcP+v6m@qLuOBSR`^Hv9V(=Qk zJSp2&R?iAnE)>;fHAl=g_9uiUMTs)}Ia)dyp0t+wu7R+w=!3wk75#>_9?gGV0jM)n zFnBn>$9n1?oz>XKCl_cr^WH$ydnWOeIft=VTZjdFGFAEYs0$83xrhQk((w<*$nccc zBom9E2?@|WVDWOYX7Yv$m~6SJbBMn%gMPi*vo2cvca8pGTzg?v8RQh#TFj(*ky z3Ngttiv^!jNTSN~_CZOW#1nt~6jA{Iem2;zT8*5-=ciK4n3 zV9lzNa~s1misjqpWvvxm#aE=i9E1PnrHSq^~@*Ig@rCTgHj@tGj=YiG?Q{s#@yS2lK) z!3g8>ypy2wqlm1cmv>gubTI}?20Aimk3a=lNWO4(#RKxX2R z48U=THLTl>OV})zbx8L%VMa!35lNH#XU8zkET+7Ip0v{+&+>o&jl#CxTq5LWzHUw4 zBZh&)w}VuRza8cyvcqr6dnQDjaYV}a<~08{CB{J-Rvc4S{xt7kSS9a3s2B(Tvkmma@@&(B2M)NE4=a|czE zdUF5A`nvd`2_%20)I8@qAoGu|NJ+AVG^I1*Rx{l9`Njk_eVmg>;;@7s!sBG#+U9O` zUuIr3DiL@;c?4Sd%9Q@r*?(V%6;mMvGGg}LE58*oh_%pARg1Z0m(P$t0ZnQSkp%g_ zD%OK_q3M}sORDJa&<+!uI77z(_XXiL@l;dIMYXYT=>~tXMsKeD<`a9ig-1pGUh?w` znc*K_p68%9XtzHh)=g~%yT1W&SMcpTc%0WHJi?ydh*Syx^LB@?P3ZG^eZB6Mu`z+_ z-3qO`NLOmFn5o}0^!daa*59CI5sYWGC{0wC*0RL)96RC)5mL)s3;0e;FoUvwXfu69_FY`8TRuG%k8IFN>8Xo`Xa_AWtD_s zY%+QeYccbL_fxBg^|4D|vYlZWop@-d=_=Qd&IJL8i!y5~W>)o3!IepuOBM;4<=yqZ zVh4YP+|u7(u7c#YBqu{zOT~3c7;&iDL_?~0Q7j3&N)wF`;=h?sZb~gUS&@c=VM?y# zh!)-ZdwT;1=&!`Fo?jRW#HfSU!V5e)nee=os*~2UWcZ}Qi1yWM=&w+rNr|uoWJA$~ zYPC&*N|g=Qo2hdb=2g&KYp$OBRgx!w#tVO9ouqMn-+q>#IMc)77SuxYr6mu5EnMw1 z#ZyfFAT$1x$`t4R7h|QI#75l8fdq)qrnq<;a-}Y6(u2aT@Eo;q%i4doxNoZo@H0-Hs!@If*RSVan66} zDOo#emLlpr#cK zimuj&(bL!ol|nceFcbdgxdP|r<=L;Q0Z$AgVukpjI0N71`fHTrX}}SYK-g&0zoz8f5RtVc-?_pRi&1S z066y?R;a8eR_<_0lWrJ%&C>t*fCv~Ms3i1(4F0$8+DT05kvTbzvGv$=6bF+_NRlGh z17Wh)U3%zx-CqH4(`XCCzuhC?C!2L39!syWGu+>b`q;2AUbmmlIS_w7{bbKp^92o} z0f4Pb??k{y+*p(WGs;^NCfUHk-MTs0X{`&*hF_ zuQ?!diP986Z2_UajShbvu(il(oLweMhZ$g6vG8l7-AErLNO2>n3`2@u@Qi|iPxWua zD52xoD`2x=o8S#VCU_tI!P<3psa=WEt_v-tkhBWG$-}M*b#kgX_$Vt?5Z*F81JhXqTMSC}YtO;#Bi?E_CC0K($;GUfQn8HPD|P`+h@~r zDiJ3Wm+;O`INMpR6(q^Lh%ya`BxKW*fuiZM3i0*(7A#PLUg`D!kJ7NUd}ieLvLV0t z!b}Bh_Fb^M`_Nd|f!fl25)ynD4407|3AYx#S*n-8N|b+`+XRt>(P+kDiytVNwp3qqSn%9fV3mM zesuE#6BvK?g7OIYf8yRP_a30y}f@vAc*ncP}PZHJr`EM<#Hr+`a< z3gy)MBUq}CvkQZmG4#kK=4K~_R#fY5^ihji7hGm+;d{8ES7%}4VPlXJPWi>r*Z{UgdslBU}HkGh$fXEpd zNPd4xcW#N8{M95?y*QU_#nI|8qSeC&-pFZspHKSsv{A;=M#C;-hY|l6-VRzuO{=w( z!P*CE>b)E1@^g;&YLl|IBR9F|xqzNQH|0uQf<=nXye*@<)261bN$tVZJ~${_%Y-3a+OA$xo!0U?3`TAt{KK)_ zHj5d;Rq``xOby;ywwoTKNrb;ITNRx&kp4u$4ePI%-&9*ZyONgYZn2-oP>i&!@fE5J?>m0nYSLIpJzH? zgJ?|S7S{GSJQZdU=o%r1!BO|(D|yN&ox!?g$-UW)M9FTm|EvfS1P1j8*f{fAGnZqm zDpG%{@`C8>XpVLdt%cb!f9(o7P`-ae@f*pT>Gp2KJ<0wKIW;f=*pZkQ^6czvt&o_% za^^G7d(5P-l@L^+-saIjpHjlnZo1{1j1WNyue@k;D~IKnOVN){p{|$xX%-shhb(Zy zo%hgd^!D3KW`IO|K#D5iH5oO>!D^$v?^QsqWc!V|C}hAJ=zdd$NwRa@Q~iJP-d}_K z4?=#nsw~-%L++2amC|TPU4Mn~M8>cAHy|KlEweZV`Y(uhVpq@MPF5{%)B&>s=%aii z2vt5>uV>)(;8#89*pRDGIB;~|A;{>0GolT#U<;X+^NPHmI}^p-J;6~Z&DCfsZDrpx zIIxZw)o`A=2Y^v+vX4Y7yUl+y%~oNIqBya~d@ClxcSmsbt#PREjnuV>b^q1)QyOD) zbw{5O7#Cs`R@VIJMv{sb*YB_xBT86@)<%|tru2I+V{X#uP2}=D>N<Hq!=)yV+ z#muI(*<%T!h0F;jyft5X4Gh=vz-HsdsmT;ZK%%Oi?9#UDEdIJi1Pc!il z)(YwZ*H!C&1-YdHJ3@at-ONs7nLcvUad_ADxuGFHX=(6%ss_%2GY4SPmRSsiYAzy3 zT^;j}C-FMGWWt^Krzx)SLt=|#DWqvFPJ6wbPL*yg{3H*yO)88F-NR}0gGk%bllZa& zF!fE!sof4eB6@_s9MwaX1P?4E#W82GT{mCaI)5UYU_-{7nz4WXRP;BHg+1K(T1?7} zGqnC3Zyqx~3`d*H))3D&EoKL!CL~Ix4JD@IPRCcC48ysxw0N`hZ!FqeuOQV6%IxU) zO%WS~BW{t@zKQzqENm=;WaBKK3@5%`vZ@F2@tY331P$;7o+xe%k|!=yVmjjPIO5EmW=J;6_u6EDX+#ObY7LeFUE6LCyQFMoR%P=*o8C>;`Z-#gX)!<6?GJs5Bm!W4f7B<-bP#%pn1y{gS_r-bYT zm$?j#7}fF)0Yfp{SmJzdAitJo4oR@b{D|%|V+TuBI450#0#0JdJUr!hq9d{h^HPRB zT-e;*kRZa8z0&_Dc7jBxt)QXl4kG5c>W2xD)I@syo@SQV)DNP7#6BSR^qFwzM7*Sf z$NmecZHa${WFExu0Z1*k(v8C|W2^f+^?sE2YVHK_RFaAZ4;eWCldq0i$L((h8o=+& zYG@51h!{?>Oa%1=pP*Fls@ zD)J5Gf2=9Z&Um_NY&%TNXA&-1=v7Y=wVz=VX(c(-YzXduVGqSmit`Zq-fSU9D#3)T zoHmD$d%A<`a zBR0Ee?{}=P`TV0vtosB1A{5%VYdT?HdHwyGqA1 z^SVPcipdB3W`-kI{BP*YZ}W3TgfK>gaF3XjR2xX z^%QX-0aKL>IT~t1hT{7}$=BXWu~ZXTuyL^sF^eq4uxtgq4aBY-`1PP(`?L_9(|Axfqq&h8qpz4H{5iD3seLPk0FWi%=7+M#u0KYgLW!!Cb_w<*(w(e|t1rJQzu z&e+v7Y_i`SVi6?ymh1H3P;<&=R-<^SPrjxlKV-ZXi$^8Ka8 zC~9ADhi|)7(w=9)IP&??<31OCdmDBh)QQ*<4a2pT60C;nk%3pqej4g*cocp zPgR$j8YH;u`YcUhnjG!UXyk<2dFlASAGMq1QOAl;r-5(B*pMCI6_B(YdYw|f?AO&< zno!_LeJVxv4BM6`6Cc>93ajw&MqbYe7+)ju7~+0zA9e|*7H49lGpQ>6w+YfL)3(Ub zITw|Hx6E1kdKDR=ZlU}O-E|s&Ca$~5fO;`-ysK|wJ!qGz;zqs5NnYH4$Nk^8e+~25 zpAT8gUei`c0)MVgvu21QN`#{3m&dw2{RRD+e`~+MP`i>qz$T6F-A8N%6BST1kKeG| zu@?M8q&1EQP0Mh#f|ZR7OFv}FC7d&^%XH*zS)N0Ls>7qp{utS&1(?uyE;V&8ybPJR zS?mt?;>Q}$NDNV-CGgmP5Rz_+o_&*u#Pef*%@(s2VDj#NoipU_60Pw>XYS}!mnzJ$ zFk#;kZ}Rj%v={-B3GFOu@} z9U@mLm@ij&{n^&nOpQu)C&ZTJl)*w=_T~FB|LNArIW2Rn^#zj`Z-;b;~N~ zT!9=BAybjErS$T`-xTXzwocTvni`#Z7x);#=V~XD;_$=N_6`GGpg*tlq+|axNfNq* zI+CwHe`A$b;VdOs!rxk@FJ@A zL?qr*ay9mjV}$Nc*~orqMbr{Y5=4vTJ-2gXuU>@c^2e8%v0MLL+YJ=N%}=weF5YVq z*v+y6XHIji?)zo(Y=iBU*83c#2~{1;g1zh%O+pEV9#!IZrD@venJNNw0dy>ZDuU$} z+?m{1&jJd6IGCM+;{h66*(K|TDd{1brkrKa%LvwAh)35PJ6h!2v&DcSO5tQBOfvs-L!qSz? z!x4VPt(FKd@QxI9>|=D~Di>t=e;Gf+-MqHcBb?`t>1G;*Qz(AUvv(c^5Xd zvJX>sU;B)CB5?Z#YJEW$W9^IrR+)7NX+d zVdu9FgBKMD%1V8^lWAGs0|pRS7jPez3uD^|z-Lc87Aq?4*WIW$$e#vBr!A!O=e#^e z3;2f(wqMl>96Mc~{<{Qvhb!IT^AmOHwO|;7QYypzC3R!1VVw9cqYvzkdz60Lr-@2` z1SYvrg!To^P6o}+ZM**y>xu@?9QLAro`jPT38@}D+J)h!3?c00Fc!V zeNekX;I`{6v<0&EFA#yMno-rc^ce$x|5}36(lMjW4r%hg2X6j!fLIVFaor`r2|-F+ z*On0=dW37V(d#s{7nR@AZP48dFj*2rj$wJ2-r@d6f7+@D_sD9{jPkGl4d~9;iSx4Q zU8Tg`v1>Qx!TFs!F+&%0%bQ-f>;y4heOEI2G5!>rr_e!!LsGLL zeLvt`x|8oer2-IvCy0^(d|=^!SkUrrTPU3c;6^<_Qqk=>@6wY7tpf{Q!>L6ag`~h$ zHKz*BClrj$@NWK^t!?julHRc`Q-)w=fU;WEZ7D9=I`lonIv)YPevjE`=IPE2vAi7t zi=F1m<9FZXd9ZAPbi9#H`-~c(YON=K95AteLd3Jg zHkBlcG+XguRtxnMAepMr-F0m$4qq0~-C&71c;Y0~gY_U<)IsvLtxucEWS2F~z?rh( z&zMZ$Gi6FWa=Kj zJ}8MwW+?kD$E{Sa`aSf2GBND0s~}FFnVJ7WO~2eRlxHIq9nswuIS-5y=2z$82~E0r$skI^3xuS0&eTehH`j+fX*pf83{9#CTO~n z=H`rWmbtn^e$*r#8sp2IKc&lFhXs9LqWLnDk80Z1<^siHt2X#^U0M63yPhY=*(3^g zpObHTB#vXqMJZ1^Yqb(cwGQgU^=F(i)ZUXC-2K#-FHj&VzwFsr!ugnKN{A zg@^`n{C)~gfDQJ49DfTpxSnN@PL&4)6nl4!7tY6fKf>3Xx!m6kgrJ(ABUswQwzf11uObm=wS9xohD7qfk(AWgYK9oRfaHQu9sop@qKs0n`Ax9Qp-e8GWR2yc(lvS0W9CMk;`g_A%c3V9F`PPU3%E9K zu4*Fa_fWQftLE%j!56}IbLz@rNewPvf7wTn?yAQ5F}@V-{n@)Oyc?7Z_J*`2YthSfl8HKt&k;rmAfKjwyU*D1kx}3q zlVK_bQz?#;`W9PcnC^13(**Sk8P>>hspH(`k;23^7RM}BUERg8{8n3AgLaM zy^aJF0El{U!K?)aZ{@&YM0LJTxn|0Kp_Cv$)e?~P)M@RWv}lxSt;$VrNo{F~gWs#$ zMu9FuIIKOhzjeO6gy!QF@^M(wdrf+RxCEPjDBF{vk;a}HDDw#$R_1;KRr$WhVS_LQ z&&Wo1;PUy_OGu#AMlFH-rYmSmSW_LQisvFMARF&LiS*8H*oidbT_e?uJxHcddo08p zjs$HMU#1W6BSynrgJtaQ^kxV4toEDMW)Huf3K0?<1F7dfRKZ92#|+4xfwJ6z(qKVb#s*RtywAQ^U_WiC2$AD;`fWkjpGC<-%gFMJ_ME5i zk_Sf@XHpIQsdz0bby7`Qgy9+-9*vm z)Y%Bjbs}NzVnZcaQgaKZM#mWLOBccmr@82@OT@X(ndf@#+(=f+L z=W(w(%IZO%#^ec{4{MYj@slt4W-xQ`O?mK{l1W#UkCHx89_z z{YcM1n=ZX)^mu+j(k-y#s$q10clN+-KSgmHF6`!KbWpHzl)RFlY>rDvJR-CPw0V`N zGq=Dn6tcmsfqZ0=MS(wBZ6`YN;=pRr@*#gV!J`yRXJH8?(jc5wSFMJuZ8jVPcXOM$ zNWqOv{nkZ2JOkT%i87+W$>#ohYkn``VBS0V+WR7pJi5)CF&4$FFH*~Y1@7J1j~)Gi zXc{o10433;n%Za17v(Z*H9Ns0VC1-+zF6ddeHgH*F6MA)({}3E`D{Z*^5?IN2aD)Q zwUuZct9=*hWP{0~h<3dIG8hEeSmd`~*xBd_1#I`WXtl(s-0KC)s{!;YLmEEXQx>vz zdxDih4)fcei_K{-!9N0j>=TO+r%rIR2ATstS}0z`AxSQJkHp=4s?JJ`vb<$FqY4By zr6((c5Df-Yj*;*r5#W&t%yvADU5t!i;Sz^F$&=yoIS#Ke{iVxlH`+Falg4P(ky6tk z^HuuE>*T`x_t@DPhc~fn52+XzUIada_NavNbx3yt3z1p%#zbU)5hIFFDla&7*VjUn z2y89tTv2!qZDIdZmyK2#U1BCpAN9sAtJIff-=+D1)LZ5^gu^}JXb!r-n{7Rnygd{9 zu=_5ZU~B9G-8oL%(I!v`g_R{36EY!k@ckUD608&FX!RvqFCMjc!AiO0xn)GC?tmLQ zSTIayMpnaVC-*UbQKQ=vkS@rV*M)n$%sTSU7}%dHHogyTS>}R z&YAp&1J_UNhI55Snxvbn{^kqUvP2eifKJ`mEb={#vhU+u`2Pzl>FF#Hr)K=Gp2YtI z$kqpQX(L`=tV(Gn8%eG>LoeJNB9wkI4;3DXtH*XPXi)cmL9wr`V2O2Srb1US63~@- zZ?y)|Tnv-MJ3)?mxCguNiCtJaTt^WnLmC?6;mynocCeXW7-*TE6$#**>H8;bCMdlb`wnU>G)EggGU!ayihVp3coq#&=HT<)lW-TE zhiahzTp6gLyznddUS6-BilXf*jaPOY{%aLf{kQyoMxmseCvo?ez%~Mn!01lB#Gt@o zw+TBWvVE3WN=i!>lbB_vq#4LD&(%8U%%VkT<6Zgjf5ZoBH+5xlBs&7o`_%Qtfj7m((0YkboRbVs(}t_+Sm00ZBHHZK){a5`8p0b$#O(e4R4G_;k9y;x zs*%lqmGG4AFuzE=;2C8ls;t4nIhRiSF$2Q=jP6ux$F^42!!->&PN>oze1v0fkba^1 zQ<72GU&hKn(Pj+T`YmJ>1iNLbf>W~03i>E!cgP#aW139r%knOqh_A*zLB8mZZrnlP zxfpEx|9zcP_GqxCuJbQWp->IY8DsCPpg_ETB|m{D*ILTIV1fX;HT&$nrIl7=i$Mgi_p(xjrVq7 z17Jt^K&`b$jY+Ed$Gm30z>TdQEJGdod$RyL@HUx$(MGh_8jEF>dVZjs57m9 z&$+!^x-gi05yE);DS2+TG$dDLvdV^}bK5YZ3y5{XHbu?ZH3+A}F1oN1_(cVi;PmBD z;a5B1U%&I76W8ahF^hO)-epBrm*(yDM#sOP3c*3o=Ukg?SJ4tHE<;LN;VkYW;&WtF zZn%w}d=3Vt3?7dd^f-s^GQhEYt?rnA7Px6SspM`M zO{vlU=95&1Qju{M8Nt9k0vxbKGsr+dpc-SDoSY1iFf?JR*hsp77#`qCP6DRSOjg<^ z810UR7b90=l?fT*ZtF;Nk|iHUzpf0DgagLGvc0=$pS5sGs#0c(mNQ1k!9SUQeTPYk zH&JqlT7<@P^1IRKu6n?v0-B<1*)O5CmFL}A5tTGAtT+AEJRmwykq6Kd%&Y!cY2-Hu z4!NP-9kPgpG{ZvHIg^1J0EMUIS`w%3;FHk-iL$w(zid!bVu*UA=|Rc}3G?m$X|<(; z)RUghe0bKqIw!_;To_}J@kCI6hJM}QOpc67}d`47-S3Ok%Ld zEE+b8?b5RO?-W=IONMyQ?9eli9-mwDa%x*3G>dQMHfg-INXujpuOH2SZS_sgB=VM4 z>jG$n`!a7}9>QI2>T{ta-LJ0YU_JQ45bgN?v_aqLidy6ee8YwQ8eAw%^|rJw>1`S{Oqp@lta=k7f`P zMgD?{IUR<03$uc}pbM5#s6ij^E`wmkDS(p6h$!zO-v3h!e$nxFX=A@-72^7etArns;06A)_2Ll|)T@ z3)5s5c(m>v)A)@o+R6$FeO4?W&n>R0OpPEeK%1sy&wfs9BV&dg)2YC?vU4gm@`xlh@36W zT1;@c#aV7yOKbeW;tVvWdOGvB5mIafsMj9+3U-cvnw?HV z`eB?X{igj35!Pi0ijm!Qc;ZX71Hv_P5_m1$Ovf0*7(<&!*TgcV3hBV%3q?VgcY$oB~XFq%nU`Fl#={14dTPp#A?7U`D{ z;MRpfC^b?hBl=%ZJB$E(dyu4rmDGguj1acIVQu0uB_*;0LEU24t#~fMBO$65Y8IS- zz5jW0=k}z-I*yT#bEE&Zl3e6dL|uCCA8ohhpS7_-Br{`MZ1c5>6JNO*a|k&$(a{h+ zDM?qCJiLPU&TNHOPzPdn%xJbw3Z<|v95^>=WwDRV{saj}4E6GHo+YOTjLv`m@rjH| zP5q9OT>gHOcJAR2)ax7gX+h&rt27vYlgmuriLY+df)@fgt;xixN`Z0aFHN25oGgdR z4~U5eoI?t8d;}4ozgG9mV&hf37-a*tOhGMsSW1}OFr5!NHIpn3v)#M;>(RUJL1C<* zWHBLxcE=m& ziqzrg@UgGN91;tWN?szR`iSSycbS^bu#oobPP>NXd4n~k$9(9VMEFEsj{^Gu_2=x~ zNU7q0MqJTFwsF2dBHjWbM&Dz958Bl;}>p8WqdN&QkrVo^zY1z+iG(3gOh`^M@`8-LrN)Y^duqJX` z_6NHo?9t36z_9xGyAN7_ik}pPyUB`~dn>iaYP|gp%<6*J!zofv<_ueWFBom4Sn7s2 zu4wTRhR9L6J;U|7)U+5qmt{EtzPI5C!Kc7*ov=B)+DP6mQPH;rd@zFyzYO9}p@EY)JkRCWbZYHXt6bvV-J?Xlwu)_Xbt>Gy?sKtfUpM+LKx_;#;H zT1K4e7ow`WEl(k3tm`+H*-CplbTLE^@xW8E3Q)L6+}(BrfU=2NIvBW@LI7N}>xeLL z>~5xVs`r-mGwdDg8(?T`AWrpBtL0*%#<~3?f_21fN7e;@!VUJ%KX$Z-Ydk`@7OYSA zTzoYiX)H#3He>>tg^OsOt(TMz1MyHTRqAr30u}R0fMBN#h|&GjrEjIi&XAKWo8Gkg z$_dxrA75Rc-#cE2QVn-!>vbj3MH6*8)ma;_Q;eyPs4QT;&!ulITCw%U3j9|}mW%~dq*VZ8r< z*}V|o_M3EdlD_#_e>$4q+F_S6Evxwe*$3nxX9iseKtz}K~9hPYPgMbB*fO;EX zccA7AFXRW-Tgi9W*FLg;h>B%g)0%Lv)E1|#v~~7CSldBvM!}uPmKD8LAgHRCt9IH? zfB%`RkR5!2RKSt^;Kd;g0{HkbVcE`TH0O^DI2cIM!a+Q~@aj~;EqN65F9kinpT*OE z4QPanP;#~#K7fn!BA(#AWXNtOd#y=Ho2(TR_b&vu<~Lg8>_s6n6n3McOw;a@u4BKe z%?mM4CX5U}ES?D3sMdjHI8jE|O1(b`U#jI0XJzxowE`1@{gtR=n%;Ns>_ARyFKhiuQGMS?c*TMiY(w-Wvgbf@;00Cyi>L57oIDt%umn*Pt7GYEG!kYA{)M zzP5szE7<3Q3Cn}73)tSGpzCGE=#Xi7O~Mf1M#p;*a%u(g+x@-xONFSH#fVhCNj=Z@ zNWDV;Sj8jocO@YR*;BLMu|@r0nvJ8JiSd^Nac&s$X6!4x!?2Iq^L^sOi~d>zwJ zM;6Q0323lkT`qmE+Rt|BO6Tf9zl%Wd`SM4_MGwhYckqm~AHAl_B2KNrM%iQ|Fxd+9|&s(N%UNI3+4H~p{ ziC}|et^rHn#aFmOZF;NNNSwLapS*hU4G7(V=;Yi~*KrvP)O@E`drI(*cc6AdK|*Mu zt?DH|LfDBt`3s_BIvNaSNjs`DaBtOSg6;#s4Zvnh*=x7qK_*Xnso?;BXG&s!Iq*0$ z0lHcxE8Z%kdleK|%XqR}tY+gKjyJoVoE*)(B!cqiU#hLIYzJ%T8|4@0#$-T(*8UbK z2OMW0b6^x?wH5_>8E`34S!+Q6Ov&NPUu6=wRWd&swSq?_OnREO#qA=UL>3+Q$O+ncAlKX82o(*NK7d4-ZqR)4 zzlESjs6lEfisCOzyR#*iEBl>wctA3AVr@3$ii=`c@sB2YVMgGDGMyelWzfS5g4-@x zUT%cl^g82i-#3SXK$^k9w|ukUy4Q~6d)*o0Y`vZ#26 zuN-DcCXVRT=*T@dKv?P5>?{-3AtCuw(luRKy+na9p#gl=%3k)Aol!<%OH=F)Qy{T7 z8Y5M7-%~s>qcFCA+Gii3ltm&aB|QoYU=3-RA>-O=%6%A%AXL|+BZ3qI%~+T|IYXO- zyzQz=?pf(VPB2)}_i2ZU-5(`oS4z_yJzQ(_g%M*uZ)f)KjIB&F<5+|2Wqa!86diRlvPUg!=i zp@==2Ykq&lr8X(n2`LH83rTE-}1KKPS%We~zyqw--+wEw>;<=+=A zRhBTqJ73%6e1pXcV19{Ak(B_Tn`PYlDXmi6z}O^zbyQ!5q(UA3i5e3UO@jhiWIP?) zQCAyV^{?XjM<}d&vkk`lHqV={Op>3%rnkz1;V3Sw$J$_g@570f0nKy2Oz>H}=6PC* zsNle756)1k5Qv|@Q`iQHZ*XX>Rbzt$0bA!}-Snvv6ql7jGeBr{5*%m3A~=xVKsw3^ z<;n7Y?HIvcLob_lv1ZLtSy$`tiF<&MH;Sl=`ghjj1`*UbAie%h?`TgOuaNOd#hbbO z1iX(3_2o`&y`PgOGqd&Ib!_66e?4s~dH0|G8C9pQMQ3SaNPT6TK`eJ@GVZ-2@ogNN z`Z#5LIb6I$+|6RN!~_9s5@%K@d|XgD`#{TojuYQkDiD5Ni!sJrJu<>0srG-$h?-?S zV;46~QHvG1P^g4LAN(Y+q01O~@v1EYwjPY2->ng($h6NjdwDe9cveV_Ky*YPY4`j^ zlzt{#8l?Z=UaZ@hQaN&2>qarbpm-czSW;QE*Y1qdd982>t>X<;9}bdhhgMU!4BuLR z{Bz{erUd}ISM_v>4$eQK73V?}hyk9+08N|(m#X&qPSP5GG3q3ZTq)r@wqHz;pXpc> z2x{IS8fcmM(|N7*um%c)?&$%lDuA3P>T+r-!_?p>RV=d|zQ|pv}pv;nuAq)PzD+3S0J;)sOF&D)77kCM5X`XK* zPhWb8qDjGE?=$CuPzsV==9F1i(rMTK85C&=B48jI36o1Ij68-lY%3aQ*Y{|1Y62lN zaR>z>y=9%m`DNE^oc6}(3Ve!E#%S|5%*tmeYeD9Hxe+>VnNaEAjdCIfIAkY(NZ+pw z);*DK?lk;UxMe>gphDUpn6UjP7<5RHLif-3N@^VVbu;!>-Tnku~dAqips{w`$P!oD`XnV zN>@ys&0=lCcPj%h!nzMl;-GBd&=t-4)#da-AchU$opCyOdgM+R7V;S+B;%vU zTCE*>yU}<6B!!%PFFu~;;N3Oj!nv`}K-(Bd-4vp>O#+HLYf(COc3)u~##Tq#CwMmP zz)4@q=b*gN!RaWq^P{V~>?dCGQ)x6xv=`*mlL)qnUy|z;`4I!{`3P@+*n`VGDfL{a zHOxt*StD=(+KJa3-j@}C%HVmQJ_QT3XMl{S0b#lyhfg=#Q=0}|t8!_f5Zj!mnm7q5 z$yHA_EM`#VKy6$HF3#`YD;T0*VVc`-^nuc(+(>6$2F9T5yoP0|3xvZm%*MPu+a|10 z3{T4g#dwOF&&_x`gJJ-GAN7Nrll5Mcqok20{>R|zQzfM}ag@-u+&NuUe$pP9BEeR?4$dJpn&@Y@g3JjnzVsWSE1x75;2LElEaV<%4dkC=c? z#)vRh!qsFR+6mbRt=x3EZ*%>FSs>hdF9~%9Hh|oPMS}nU09Lda>Hq=m{sq>IGxAR( Qjy^CAivj=u00045S~FM5ae>wuc(f4y^^-r*U1JuP>$Qz(nihW?GI*R(m&27>#rW+Z6*RmHm!Pl}siSbb&vn6RZk z>&dVznyM^I`?=h4DU5#x^WzscRMjx`cR)ni5GqS~XjFBKcX@l%0SJlR5{Q%|wX9C$ z(wc8z*b*D1EjcLI!Fhjbz#p}-?Et>)on#|D2%t$##l3SL*9oCLQp$}*(a!2OEQ3&G zfSwFr+R}Unft*?9)Cz+t?Agp*N&h=Ue>YnDUI>8H4((|(7Rl&RMBpSj4WT@Fv-h+c z(&gF_)!W5ejJeqX)RLS20yCvBBP?PeB)x#ILtx9vJZ)S>i&uYxhEJ2@56Ov2nwFdg6hHf%QsVz08W)=d1 zNcxLvjkDI`G&01ht~OfMJ9@i4g>h)7g?HWA<3AaKUjWlrkTFS$mqs)RVmu~THEeWKLVi>EjKjy=nQ)dPuyGN24$d^yIX z2Ij-KVW{8cu9lHoT#1~v(DJ4>EwnlPzl!=OmAO=!XCt{V- zLG$XJ_;9Tgc?{DT^$c`q)a#$zi>2D=APtm&{X5b&6~2FV1F)N*dWG-1cZz+R2=oKU>?^o-y6=p7*e^TC7A*~^KA(!$gfmtEI3t^KspXd1BGTNfb6!Hv~$wo%eKiA)1-HY_++QR z-8|Y$T9b93u2R-{a`O52A`^6bERBDAy~FbD#<5UkX@8na&x4r8z2ePiz%+4j9QeL! z)$DhJZksO69V#y0rDYF$OU>HYGhdflE`k9br4N5EHH?LeMoJ|Yktc77c2ijIqQfOB z%nULgR~+ESN;^Y}>G0rPdwI_j(E8KjnTVieET=zG3L z8hC#-)ITC98z)Dn#vgkoU0PY^#2D%-5s5EC})ck7|*zOmOWHv_8eE!_CP zosAo~)i^ZPKR3kb&nCr&g5^cBauY|1(x^<*ek$gKA9?heGT9m3W;Uou`_tv(S2X)A z#&m#aCS9o@xaunJsl=<*hS<$pZx*nB^Wb!!=ie4E)}Q_s=&ou>#R$v=(-AuisG)yg zZDvi;le&W}Sd!6!X08UF5BogU1Tl2dB@Xa7H-l6y>TU^l$bBbXiS(UY?8I5hHE<+y z+I-pIn#v8(iv4c_!9$HB78bRbT)O6M)pj4psZ0^0wM%o0oYMNNVh%SSG2@VHLqvS? zO!pAr+t~jJ3r{s;l{9_n)331xa@~JpmB5*fn89^_dhkX$llBd78a$Qn;ZG;ZimMb~ zv7|!RKF0ZOdI0EcDpCJ(c3siaJo_2d;uL2vqB)m-8q@JnSiFDy&CRv=4{SZh30nq1 zL_%IAcRS#;4*zcETvaM5wRg8KLiX*(t>lY60-RXM-0Nz5>aCZJfD&t!&VGLaQBp81 zU4$yHPzkr|?Zk8kjGkQzZZI;wY+*cKYBStta&0o%S8jl3JVyU@XaYDZI3PsOT&bV# zxrX@`h-EW)1Q;a|UsAXOz&iY;Q34A`KG32%@&TsX^tN4ivNLn{K=}9`w-BOXz+ZPd zCl}orSb~Yw$4i%MBm10n%2$60;F?5Xi}O;y)h+r}xncfvj#$PJ8*J_F!lAcd{z7$wYs{SVL7@*Qhmy zK=^eJ;2yIsfoxz=)(HrpQzP>XhWn^tCH$>y=eK7gbJ+!0lRXz&p&6v&Xq)xUoHu9b zJ!NSg`6C6xOaLSdS_3j<@-Ju{`(6c&&zABuZnEPTdR+Sugw_QCX7-$pgJrt*-bceP ziwCu7aXekMjM`}e_=A6@K!&VSdPK}B=E(b?aT4uE3d=Sy)8>~r`A&68HMa9SpVKs{cyWzK%VUef`0phC5|>jhq``qix{mo2Dr`|=}BXmqErZ&P9 ziG3L)3f1RfEze#9G6(~2;OsdPtLtZD*U+XLW)<;L4shs6%^M%o7bm*W4}GfTh13tELUB;?7l-*1rFf>A0ta zaKxc;PlGAA{aiyjLCvV8Kc90(wOkn%!Bq2nQH~5fz!(sie)1UY>9eSy zh4Gvfc3vZB|qdQEfkY2bb+WNI}%pj)g2?T;?$$e!Jp7M>p z^{@VFy90mKP10a)lORe>zNPH`nSUQD`aVtUC~bmf8=ql0644e^1W>6kN5THvgK0s` zZ&8@<0MJJWR3|RZ;LgbD_hF#|()|g$1Ztr-LdgIqSdnYQz!x(xqO3r|0>ycjl|Z?T zW;m#LvH^wx_-w~NtM8=zd?N7hM2@yG{HM(i&u4!*?8(R#^lJM62D+UmD3uskJE9BA zI>bHn2!@kbX0|QQ%a094R3^mnI}tpB9rW19b&izC#Eb<{Fr9I(_q(3kS3aZbX-|={ z3N@IjLVZBuOU~{BtQqd!^Y&9h>jv6fA_Q23#!*xIZLl2$Ic_w?%NN0ZZGjmln-<}v z#J+#T7sk7APJ!`9ZwrRYjm??P4Y(5p5-zr_hobFariqunMT&b{#8g%=`u zpl(qn(de*58^5IQ%>kAH;@*q4g0mUQfFgh0XiEU7E|{|WSwDm7(?|J(pI4*I_!^DW zzJDCU0~z{%{Dub zsAzgy|4}J{6Bpq`wHL-fQh*MDere^RGo$=WvP$HYueobFkU-Cv2K{TRtkLY>tx>nEZlf{2!mW2<8EsY>d1|@=zOaXK8LN_;Fd!{%O$Yt9E zkzW)F@Wpk5-xWnjCjG53yZRn5vaF7;Fg5vhCyFGzTW#)$MM=`MhruxevS`7-b>oQ@ z?zj}7{uK(`;RVMUwHiX3%x_fnfI8ZcXfM+^ag^z1^>CkK7RN(1G#TI<=-7WLaASKq zKTl|ECLYHq&cS=XpMMGucCz$QF^j8EUPm*H+qlHW$l%=+K8j^6ab?+{wWhzu9a<%F zdy+CVC=^mmUIO2p8Ul{`cCJTo+?JCnUs@cAE}6iJe*r~iu^FB)+%99)T^hDGMxmr~ zEfexj>#r;7>+7z9GzxnpxS4-2cR}0Lj(Mv}Ju8h~q``j#_%kaoNNL_rmrrpIpH;h{ zM}H9X7IvRGL=c$A8!$#V=IQ-j(3!m@yTu;tE|g)LVMAH9Wr7Z+0&a~ig$Xoo#c?dH zv-IA5e9`0-`Jvt;7Q?CsN!o7pZ<)97Dfd$n`L1kS{brG4T=LHyS?Gvi2<2pGU_*2UEVk|WVynMMW3HyChtS@z#RfUjw8^c3J`vK-!Vs0h@k

oN(LM9RtG*L zn1%Luz-@|?ZD-uR&Q2|feBy~<=4vg=oP7;Z+7<`^A}#W$EP>VDvJTPRU>@`z%AO!k zkGBK?9m%&;8g&_OTbxprY&%D!eurZbrGcFL;wt2fXh$hoJ0QakC;$J5Ml8m$_!#xfluQRkK)$r(hrGi8oe44DWE~HpNa6cNH=ztS95y=aZ z$__nmp2j}upIj1%ZdmB3Frd1uzWt@2p1EVXb@=r82$j*5D}$?6+_>i>qp&%TX5^r5 zTiNSt#734g~$ySARv5rH4Tmxsi#je7BM^Va*$B!X1HovHifI4Znx+}JK z3o@gHN$fC6pY>9X5*iak`e_GT40ULj;VX(0qNh~S

hCYa%#`vaUQ!MeXiCN*dBm z#mj$3MLG%B90xJlRGshsnm#9|dOV~(GEdwBP0Mod3jLQCqkuj@_(ABU*qzH}R~P$p z7PIX*+lfa;^?pw^%u~SK9+S>iu>Z243DWh=2_^|0nQ)_iamXT7o)nCm*O>F_RjB$@q=%d4~gGA4cD(*@k?R@JT z4nrXN7h}%1ua$d;7ox7vu<<-7Q#mE18tE9n8}(+Bmu!Yo6+ySr-RuIVq!u=>c>407f6${O0#` zZ*2KRm)sxxT%c>>1;k+E!8Nt(LwkSD@)A6@MPaH6HLAr2Vy_;_kZ}==0jG5yEqxQG zkqGd#)Hd@`6!qXj`k{c@)k-G?YvjNzVY0%KDrMW^_~CdM;zXCWaB)nIYxYY{=uU@! zz6w9J2I#bh73Q*ZEWe^8HD{`WXTClp8Vt%(A&u85etd<;O)ZM{_h^3wEChdR&C~(; zebgorYJyMJLX`5_^DsHW3>Q$Ac_{!B6*_9l&-j1m%Durf(fjmEv5T?0I&okf82V*^ zC+WfG+uX!YTVN-Le6A;>$gkN#(&W>G)b-Z-E)qKeRTrB&>b#x3=(0FR5uY~t zRx#}4Wy=-!zst5*4Da@c@Rys)wKZd3=XcvUkuJ<6>09`VS-$D>X!~0Yh3tF*1oY8h z9M;eN;H-OF%+(ye*pCm%KK;G9b z@eTEQXFn(hk}B{Vn&n8uj)aM?5w@CiNpG1O%SYr{7~Pyqra3z9_O5az>FKUy7W&o7pn@&WOAKK zD)RkGPAIA}LVN0~D#6HsbLI_{Ks#@5k$fs^ZX^;6wldp(rD3FK-T zesQ@aBPxs@5Ty;RTlJURzHi9=sS~%{=X8fN#XhiEf){@xG*tl)8bxkLBeibuc*;J` zVSMl5Sd#1|&@}DSrN%+wi1rGKNF%W{Q$1sT^e~enHTpy2mwB4og1x2DFF5Jx4->mg zBBVk?Wig<8LQoveKxllZwYxE1w%GjUzJ)_U#8YPRaP+Z+z+ciV+75=7^%em5SumL| zR&8|ER$zZOIf77Eco>(>X%DM5!;fOs+K( zJukUT2rInVbp@_8Q+^wHWKx8+JU4(mhi+}vq2hl#tu@39ru2{`$R@Yz^G(+fBvJ&1 zwP`kc=`0Pr^z9w-KG?LRbleZ9T49p-hUh00t|nIh%?)`g@1yLK&RrDxwY!48?@P>! z36_*6<)LJSsX+VQ(G3<12zGysG_OH0ERzb-k9;?WP15+QI%VCxg(zcOmV?e^P`9`$qyrp>cfi^!L`1SK@4Z_KpcN56jX{&3{>=vNn!-pEvj}wuWj|*n->Ij4-Z+7hvdH#P6r9bW2Yv z)^>L^CD81|RobaxkcAK4GQ1*R>Mgz2s2P7NC0(d4@yn0uHfq}4#66T4+?b?GyCDC5{($q+wL>yZ|>FRjpbV zoWfx|SLkjT)FqoKQ6vqAGcrV)eRj<&<(+n(w_EGqihBpsir)>l0|q=p-sXRqXq*SH z)vOrXm`iJ^!WwKB8)rR$M4dsG~3e)yLOStP;^x&JL3|Z+TyMj5Q&zj>oZEXCz z;pdh|M)Lq!ID(d$O6!8*7f=4Rnj5cQXl>u)?mtP`<(WVqeFRap?!yy~!C5vMtjxe& zHe@I6Fn;_sU10eFK&cmlYG;3VV(P=eeBswI^(704rYI1sz-Px$lTe>c_!yHJ%43`9 ze@s;o5DB-Z0|+D~eGq2qNT4O>8I6++F{CYIQ~NtoPN3q7xZt#XVDX=U&@I!GVC{K%r-m)HH!om0ns{C`uz3Ii`A&i>1&4Ju=IJ9}G~7QO zgjk>7IrefnS=l)O`O~pP>$o5rEolg3lB#}gFOJe%Gm%D{rr+#d#JsHXV85O29X>99 zF3teM6~BAxir0T%z3MuX8n}>E`Zn37K6`iqPtL#KWT970<)Y-(^a{V;ol;cX#&i%m z3{!N;w0!eI=o(Wqh>Dy%ZHHslB1q(j-pqO%AM)+i4uP3*I{eWszAy$3GjWKa)I%0z zY0MiSpPF0-{lzQJx=Ay;If=fA3QBX@2>1Z%cmtE+i_1fA!hy0m69Ee;oyUClT}}td0q>@m_v?={Zd|PbQHToF0M; z+7Lb;@nGc>pzV(ZQ7LfLeE*!QL}yZRCA?KH8n1uC(3|^c!hF!N$cvH0C;zeZ1cyPn z|F<wI%4);oQ9@PtnCm(eI^82K1J!HfEogWWLe-!^1t>oVEgk3|AXt5QkL8GK zeL1r{e))1Gq37KyEn^FKqs*FfB7r~r75Lb_G8Df=ZHh0sAGdB$P~(!{0l|%s=w!GW z9zx1`QJhP)3k`2n+H^Zpf!d0;I0CR*EAfBj=qZo_6d^%Fu`3v6N1&M$fK#*S8CMiU z2S7P#H3?sOep>R|w{c)q3~eB~+5o()Xi;vxS$SrOJvnEgK}$1Qy=sq(%LGn~gPNW$ zF(IDh!P{2RlUN3P7_ehw%S&r(Fp-D@5chwf=4a^>_O7T=Oq-o$cAOa+2D-sSwvm5f zq8;sMWab#p8iw=EhB7b8N>gE`*5<6R0T@D>35Kr%l^0yJMd^3~(cDSQF<3kdHE0EY z?vD=dr=Ab5%3r5cQJMvcYPI5_ zPZD%@_z%tfh%S0VQSJTuxNp2wFC%~dv;|cFjyBTXuz{F1E;7|j-de#lZgJ9XjEGtA z5hZu!1(hGydVaxQaEXC^gWK&^fFHA}SSG~^K^(h(x$ECtW5m8pc#BebUtsPjJ@oz! zeqBLRq>xo(I1&?^rwBpI;wTeU5v8=^EB;sB0b!N?;SvZpW(d>dxq&Vp!}EWw)dT#C zIar5x{4IDOUDsDP=tor0=VO_?rs|577>w%PKs&VOCimEN6VC@sr8{HH;F3mNNW? z)qkS~gU4dzF7-si8fpZ{D}vba)?qA7Yackw0pQ^eYzuUcK92;NjL%bZSO{J?Ligmt zK#}ZEJ#?^TdP?MY-;DGo3*~>o=e2pwe&WFZ*+u45z~l~-Ur$6At9V*nzb3OrIT+z< zB&e##eIfDhFhuD}=8sdbj&4L9P+)T0e#%xnDh&0|<1iYWZPEIQ#x*!Gt(=p|MBTP6 ziKs66mRyLe>2fo4I8T?xK@}Qbaloyh$)`f|Td5Z4$u&cR+rRX6R-Tl`>??ewb2r5YY1I^%}yQ2GNOjR18{=>xxDKu z$AN7bCmmf%IhlK%%87r|ub(C)V6Pm_qt%?x#-5lSOo_aq=-ruheY6}O9G_tZqdG+^ z__lYFR8f&i&Nc*7;T2q3K3#i3yvOHeT0L0aG{Bsd^5xBM~H^o*VzI+y;%SwOi@?pOpCpLP-sdVIu z=WY0+$k~#|F??$1rt2a-8{$fC=XB=kAB~R&8rSB1!8Dw`u3(rjP zo|GYXB*LbshZuhoAvx#{Y{0t`Z2&)GQY~XN5_QVSzCMky6lB0@z`>v5(X03xPO*kf zOzvDwsjJ$rovpCI?+oo{noL@LOP&)`q>UloBqibiErXf^|h>dYaPNMBs*HhrJbbWNQ5S$WW0Zj?KtWzEz!LUwjM?aJlV}8 z066$(3Jfj*&&mZ!a`zY4Q>P{S_uugEcy0=6)XU6g0`H9!)BtUY(0D@R{|J^*9*%kb zOx`x!uc69;w%7aJL#m?Wuf%a4q0o6HmZAw=P*p_E-oT z?3AQa$sd2oo`7gbXH(A;KBsJvzcGIU2Z1=9S>7fxrL4g!_-Y8XLuqm=O_jtpxy}%b z9yqjBV&tPn|9OXz0CO%+x3oAcHtsy+3I^EFqkh2@m>($k(T{WF3QffXUhZ6e*qDlF zD2FQ`t!-nJ_g?Zx)eu%+?~wxMF}^rKv*L=pKe>NIMx}WGuu#^5e)T$YlAhD*5ajjL zss4$ULM^Mr<4rb7COq|FtJYM45joh5MeH?45c!mkb+k2?K_n>AD(++02$C_z(GuP#<`x2&EkcKvhGxjkBUu9}!PM&-BoH?EeN>LF2*h{}0{>$r1G_Icqx| z{%ouKjPDWSG2 z$;$XB&}^c-TK*ZC)C2{;W%rOGLU7j2m3llf&y)ex!w3X%7lZ?V)?ZJuY!&oowy1q= z`F>Bs_{cyuMuX&kxGQWN9?QaG?fr|*LwB#yFh_>6ndUTGGq}{0(#T?;Zxi<{baOG5 z-A=J1@-X0NGre;Rt`b~viV2t`xiEI`WObgZ7wD*9D1xQXb{ zVIY!(o1$Z*H!mR5$>x~=7LGz0bR?PTW81r?Sm2xok}+yT`(YpN7dTX3 zyJL?{^Ixr%<&zH^JFuSssx^NtKl7lxMv7hZ2^HftmSv_${F&vOX20Y*g)r5)KYR z6%8OfMdqa_;@y1VORRvCj@$FRk6j2Vw#EbUU$8LIE&bVb-Om{*h&_M2&|=u-!yolmxK5WDRzRDAvR)Q1y%0@Na=VKw%XDkWcFQ z0CT8pU?DC`LC_oOzM$Yq{t+@1*jXAeoH(g@4cJ|34>!S-oA-Zon_9VN9GVXe*Xqna z1i!=&&I*u$+H4-)o_-s`hl8Hge@;%tNu02`b+!cU9QTVzzG@6=U;O!cP@2+#Eiy%- ziOoLQ!Pu>{$AW6+P|KHo%tC>MWP`+FGvmINv*yCP$W=r$50cn)593rY{B%96E8Lne zQ`H+8GS^|NS^0nX%LH5SD%O7)Sa%|5&k7y3W(vRQhcP41T9$T*W|3;8hm{|aKq`e8 z!@kOPUyt~?c_>h$4OgL}?$4iNf5nqRxza_7_e3ztif>$|k&Ei=KjG)E6JI1Y9JA35 zdASoOcH@ZVGdre@4%$`f)lT@X=3qbCOChAus&YVb<0pT29KZbN{b*%7phmSf@Rym2 zEBE;`ZYv%s<7&Fio^fvlp%(ntd8VItQ&AL#V0JK&IaUUh=zZ^iToxg4G)(qcAStx< z8_xe9nKzb?=dp0yVnXVc7@-IfBORAHZ$aBYO)6Fi-y${qRW^P~34txe3v%`-U)*(~ z1J>c}DMo+qCAlHxBxR{JKRS?7!*-0_p5&#z*JS75rFzZL?Fe7-NZEwBE>4FBZ00ky z8(wW+I#ebc)Yg${RPmfJ)x*ilY&H)Z1S{{EEH;Z!d2qMVY)LIUroq|)gaDXS?;f65 z3_L@~d%?HC6#K(z6@uf{UTjV*l*U7V)ni)I_)vdzc>;X8oWad$+sYk0)V#pdNPfj< zQw*x;cy+%tPiS6?C56xpfc-SzwNA&g%L_*c8KK9K;sgyXRiy$Y@?y3@rj>;FY8 z>viRgrKI=vtDnFE{6lQK`szuSoHLojV}fL?bL;*MV+eaqG6C8yf|5;e3dt_g5JhMr zzKAw1;yC6i$BS_0=<^^$S-SGb#-1Em?3RCLL-rZN;I+3iu&|{} z{WqUIn_hP8C3AF8^mF5Omye1pa43KEmcUx}7-oVy4tewigbz*z?LiO_py3MJFi}wi zL2MaP_D61s8q(GS`p;qRn$mo6$#ESkmm5S|??pz5{MYh?YU942I;>1*I_ zsMwjR?jR9rhGWQH?>+i9Z1UA5nH&F&3zVo0-8)d3p8NHj2`nkvuXfX@+GKyTR|kL` z^wZCa`^y?rkUqD-Rr_R3tzO{QR1FiGnLLkD^qj37Ko(W=bOh%;MQX2KO8N4##3;$plQ1%qAc z>1lae1trpZ2&83@FX##wI?{j4RF@Vbg-m9ZlsKqrav)idG0zSPLR!?!cT6a$I^Ddr zKbuABAY1lH3+H2=y!WBY6a-*%kYvn;{P;+9uvKyv~2P{SNHI{+`Jn z5f%;>#9akO^OGg}scVDb1EBVNB!2y3EJw6x?7l7LQzp`wb{^KkZB8bPM1qewqSqam2(foc>BBkB34^Y z1l^?qGZ45{pTz~@;c%W>>x}7CF@=DTayjvswTC){ySO-81YoS0IaME>l`smefw6%V zb=yd`i+3@&m2Y1+`>go7-!1wWhfOcqlLAV~;2%&s>-#3;*IH!|nVlwcg{mSJoDx9 z7}#FrKH6UpTao}E@&Nc{cM?0>qnhr5qUi!Snf?dAF-~`~ z%*nD{EFS!SLAMh8&Mj)(g}=M;d95k&2K@x@HNZr#DwaHBM2nK zz^7Ecf|7s210}DNu?;~|HkUQD{fIo2V)>vDa}FRmLXme(E|jmj#T@(9euh5bWv%${ zHH&T4UWCv^HLC)9pseQ(Nl0HX9(P0E^V`=?G!Zx;IypeR9Ro5wHfL(~SRvfX4IUyO zB!6#p(iGAr3Ak#&HFeZd{Zqg9T5D9@)?;Q1Mz{(JIM6)nNl;JZl{`V^euUs6>`ldV*z}4lKadKVpo$8PC z6==R^^F18I-Q#I>M?wfl%B|}K1?Dj`g>HYHkm=X%rR$Y8VSt#aiu_UG7TEXuw5sNJ z@90hiR>ksoK>vX6j52zjnZ_!BhX;`lZJbdVFq8?<-UtU=c8yS`H199qM}I`--^~J| zGkTi)Py@J3byrXNc-MOa92_y|(Yf2Pa)M;tj`EJv0O_<2wh5U;W zN~D2#lYT!qj!$B8U`fHXA42MP$?K~^>aYA2mRdZg_fm`##gRIM!&&}AlWIC|B=gE6 zo3pm#9os`8L47(Le8sXOQ8`}#B)KdRi;8u?6BqBy>Aj3yHLr9KLsT)4voRo}KQW5d zKHDSpJ4oZ6#0X(@Mr`TVaTAnWEZ%<)QY;)r4kX@b8I)pG7DcvNf>0=&7_DihKK|?x zTQ?XGw{v_XPtvssAgAyYh6CO4Wf(+ERBT&e(E$k?Ojf>#J9auRk&ixsNsGT-YHJs~ zQxSDUpt%{mW#Yw-EXk^J=}8Cv;4%r&gAZWyKA!dt@gRvl*r}T~A;@^oDcye;go0t| z7CMIDDs>jfpH_;GkbZ?*tG8HSoLBG@N{~K5`d79IsyeOFYh)gEc2w%yw zCdOGTt&${aNWlnDU%s^bKf`~Nk4Zi_2dgrGqev7Q&@H?U=w3Di<5{3It56lm>tbQD zK@g_&ykTnL`qD)3(@KToZ0n(=E0rNJH~cuZH5OP8aws(6eG!T^>S}E6i(Z;l8LsiR zmX=@aEyaSEdIa`FDU2s!0gow2T=0wL7`!lvvNGnRUfuPrYzS##XWD;`?p_m@Qh1gi z;7CJ^k8VMVW*dxSrSvGS{oA3E1){Y8r}FIS@NKn_CHk$u@j;~z;>G}TA|jF`0M3k9 zObWJHxp2X;!98y8izg_cnyhsceP{X{rY( z1z*fiuX*w7Z}Zw_&g}IU3lwP6QdmKOXp0j1c6>z?58s!HpyjMvqrQJNuxK;!Jxm!( zeEQ~;GRr*VG7s0m7VB6A`(k=h>6mjZk~RY)QRP?VX||+1#%O=?J35Is&rzk=g!z;5 zGl9w(B^8x;cqEKe>Tyn8yijlu?O(US_=Io#)oU&gNi~-PShgN7OaWUrxyq58d_I4n zx#YH*R80Z`2|gX!PD6(gv2A8o;la$5$J(j}`Dwskw@IC&D?sOVG`- z%eb^K*j6@If3<(sMHM7~EZk?Vt!S*Mfe`*N-;H<NN<6(IF+V@G>Gj@e%1c5HzC9L(l}NfOom~6=_l3BRom%~vtb!W=?1kn z^H@s6 zaKlM_=>!reW4Vh9QZ22R^mTRSdGBP*kMn`wcjPPpA8&0w_d*KdP*7^0SU|ygt*7~@jkfM$-L+v>f?}zm`TbRlQJxt94b*RF52CM*)a>u z@Nmg)^*G(Q;KcUheQ7QmM2Pg-UOR-|j)$K%OHsTi8fF@@#?}D51t*7qd=Q8wvQHcO zHFM|ihF?sjry@636j5B$lPUag%j|!#&LDg%1;3=+4wEagyy%n0CKCRX%E;Yo%0%;) z&rd&J!R7yfF!OYLJ~g2~xq)ccTUhO&0fa@NdQ^oe)XV*NdrY)ovGRVuNvvr%61}DP zRLda1Q*oUcBuYy$skYVB8_5yhx@acWOHE7k>99urM}06CZ-2B;Yx}N*HHd$wAI7Di z6)7*fei0D|>FVZXM*KpbeBMLM>F-3S_li5IFXdQ%5}{c|^(TWAka3#W73p=mN14L0 zmGHdBO^O-(j=n=uiM^mwi05N{#@O5&)o-J-Xw)q@_Rh$0o#?{-D*7Q&MOX|a*TgW#p>q|mdvabjVS!lEAOen@;>jUU4J`hrG36Xln27be?onmE81o0wTjzT*m z1$*3T8VN$Q9u;^Draj6U3tUczD=NuXM*(7d(cR)?zLS3Qj&k)q#<+hev3}l%lb`TD zZtJixWx#2_69r$mV*ZH~Kg`+4<4}34jZU#doXe`vNofnkj+?hZo^Jmh~(zxyuTObGhM;kJ%`jncX z>#P4fx5_1Uo!(`(0J#cGdEMtCEd5Odv%oAypG$uiBxnoM3b-Uew{>Ia={nO; z?AJ8o%2^oHd7prE>AifA1ZPt^m-|ITV}YI|O&3HZIdNMNmJ&}Vib1F2nv1yB(Hemb zqQa6Azgome>X+Rq4WrNJ;?5^>daVH;Z^yxx6i$bJB*Mbq`TG2J+7s7A|x;oaZ`hU zL9g})EH77}CBKPyxtCNWlkOFeRwws3@Bwfnq(hvRTxbBAgMJ2stt!?xyWn`PW-Uk3 zL;7;`g6N-@Pv3iSe$Qy>$en&CDSpat1*=UM zr{zd<%F#*=U&;V6zns?nYkJCPl=S0;#uiW7q2BZqFD2X!(g9#J^mus8z4Q@Oi5DB4 zR!x71ZJx|Z%99>Kub4L5Sm{n7#S;So_lzAAS4IU6j`s&MiP)i_{)lWodW?~3R0RBR zcjgvqu*G!{$^oV}-JM$@P4QEb&k{6h4F=kjh9sJ33a^)(0U9%CD=pF+4(!^{1GT#dom-zd6)A5r7mvewFn%Y^vXy}f;v4J0 z>nK5gufW-r1NhHJg3O!qjL!8MF#m&Qn@iWHFIDE78gh<-kq)#j?9gzr_Tp+zGvcrQ zsY6jLcvBkR=T)rh>t}GaBf89RS8Q7`xvw}!qrR@b&~)FU=Y{gvcX}5#++BQ$J;szn z3D~)(vs_%JU{V&gq7P!bkD3AWT@f#GOYQ=Hno`jBNgVUcgH+xgoIp4ItoVbQ?eu8X zjPs5BXyY54k*O{I70D>eEcp?9>pcF>V5I`sddo!grqY9p>{be+XyIXV9nf_J`Zj+h zFZ2U1PCHbJ3p|=RRcA}DK4+JWN!RfL!~zPccP zHi9G%RawO-MTX6Bk>XFNB{F!#6d>*34W{>66(s)9w3R!H{&z!*=6CiHl5&!*!t@k zvx-61Fv7eSa*e;=SNg_G{Fa1&^`$-{2sQ^%A=;kejzbsO>Vh~-3u8UBIvN9bLL0lG zYWOc;nN!k2I<9Dy%xpaXTvfOyZ#~ui8Y34y-f_CI$D(h>EKD)ExbEFH!oif{^wr+m zun3Dt3DOs3N158Z6noN-5RxDXewn&3R%Paa;t{bVPpDxTbZ*=(G#1(e6_8~#3+T*eIbT(;1dj2FQ-uF4`1W4CFualozIswE4#BY+9Z+cXFNK8;w z0GpiRIh(I%q~o`q#C+(ikZH6x)30F$&}SN~oc#KzX)6)=#uTKnDpPX>eBPUb-FrCq zoY#UH$Rbhbw)0OM9q3u~plDGW$ntM@q9`iMpLX z_RFxF`8hF@vJnf%>9^~Sxo>59P`(7PYuYj*{0N7V4RGL#Rx$L*cxF(+?B~ecsidx6 zniR>aSO0>$M|y{(9>j0wCfNEhpDzk{DXP6qoC5u)LDK?6Sn_0r#neT-+$J*!-++c^ zKIgDO6lzT`cV5E)ql_@&}DVYSJ`+t7Igr%E_hb%Vq0e{gO}w z8Sr#MjA!;&y63}IJe;tkZ|N5EuzjyT1t#ZdhRKSTy&vB~PL}e%`EOtEq^vQniJ$ll zkB^0uV~VVUvPp8rYfBHh<8HPES#d8R#{G+dPfM`Gb2IxvXP9VlB=k~`&5>Xjs}yVDqUIWKpUF5guc1wJEFlSNK6gM=qSSOm=$t}tm~0MB?%(doc{J1tNkc$GnS7u|l6Le4j;iB`0LEdgM) zO4O)tpz(Cw$1?;T1kb$?SeOj@(b}$`m_#W0oG!ixRkdM`$PHULG0Cy581xgLvpMO3D?W3#1SaZJ>)Z;~hW=O=Y zSB=E2;S(z!AwGNWW!m)@cnfQP8{nD~0OMoTURGa-(&52`f!Mbc@0O>>YN8J<5MMf# zCkO1AQa5oAdc34Nu8XKa22GopCOch!SBuz9o1B-@8U~)TJJ-jK2UX`1mV_(^&HB*c zMPnPF$)>XqmA{QD;9dCBYGaMF!2sS2r)%p-v_HXSy){Rrw&Kf_sf#2nj+3XvF1QwC zG0N+IX_hfLkj+G|&oOS4>~691OdBr6DO3Nn+}?z~-Zj{?VpCr8ip9@La4Wli{p_*Z zAYpLI{9gy@Yg3~B4(V8TQ+{|yuKO`NRMiKgcHK6aMQ$t3dgma$;p@NJ-d)O^)J+bu zGT834jy(*~9JBlml`ojhVtHRp4q4WZGsYvM0iefzQRE6Do@KQX1{NY0Y|i}n05oL; zJe)Rd9Cm1q+5nprrxIzwp%)^{6o5xZ-(&ufb8DW}I31dx+eb}g8 zEDrDOU%JtT+oFyHa?d+6GmM*CZQz6W=yy0bQE}ZKdA5eBb?g<=p=3us;4{vCeu~J! zh&bV0#R2)Xj{5I^dErBy1YRsfQr*zk#Lm<6h;wZ9jDuHpe^jEs@kVZcHFYwr3^$#F z_&z!7=Cbg9Ixw!J|2#?6`Bbapdy;ZMXM7#*(P`84g{}eWsk##!6Njb2Lyk|M&WXYB z9woRTbaVrVKre1{I8(Z_!qyMiLZXk}Ol6s=-TF2aMJ*=+1A;)&Y^#r4oN4mqgn?ai zW{>WA+!?fW3Y*dB0J5ZifG1f1{#iWA50hv+-ui7P`$KPB%lEZyc<9MJ5LV_RG=@F4 zlD&}HOgD4UJO!p6FK)i!j+H261TBlqLtbWizCv>2Qb=1DXKBdUE@NI~(t2|t7gws# zprcms()J29aml`aou?_HqbVy=YQoV1u~%azl5o|h1K76b^vi~SSGM~gy2UZ?U3udF zTqy8QskOG|4hHuuH7^+wM%3`$od{4z$3K`pz#9LLRq|lS)i_-VdJ0u7kN06^_2*r* z@OOVgKL#@-lhGP>)FV%^&-nV=Qa77o_Ol7X%wnUk9og+$SrZY;&dig|UQ^vMhKySh zN@c_&)l#d>E5BoZuFgf9jcR)wF7~I+`Ls#Pvvv(q;g?5V%|;rA1Y~o3CrT4Ei!#;e ziDgV|v0e%ek4q%TXK>M3+d+!Unyo48%2y`l0ae4dg`46Rn{*`>g*g#S48EF#VRG%+IP%RLZ)ckddx&7m)Z2^|+mN42~Ufqr7#R6!#h9YOGSy!QdNwE&~wwEC2NKV{4VZZR*qeapZg3&@R8=FKyb} zLI;I<(9sF0K_+G+94R7%xCmayZsinsu$;%52M?ekh5%G!f3M*lWQ0Bf&zG|SqTmTM zv)~*r&pX3Ry^sezt+c*qAP1oYZd>fy`;dxAiL!Qo+20#GpgVvwpZHe>AP}zslPK}A z2YZYnGzi zn>pTpin)_B7YL9xxp=CiXJ7%i9cdwueS=%?am04PvosrUZ7^h3a9kIIi314%(-b@4 zSMuYLr!jaqgZ_^ssT$w&TP+~V7Es>flS{(gs@f_sX|q4(^Hjo8br&%I?8o4iLG;XL z@ni3dX$Wo6&U9XTdFB-!dVy2*fNLK%RNta$f@NtQ%_6=9+)~^nf*pMQK z<60}L@CSpF<uL?i2Qk-KW2x}sm_p-Bl z?wph#x0UlwCc@lpGAW6ngzvpsJy3~%nSPb!Ae&K@)Ad18nnAgu4&=bCNTv#wYkbeA z9wI5O384r4U?I(TmTOhPjJpHYb`RXv;q>H)xR>owk70&uL|-cC|s9 zVqtM$p9Ai~+rjN*)o2n<=ed}F_1)p3{QHzjwwzvH$zSCH2MsD${Ox@j`Bd8L;btx) zU%nPW+d*Ey0_^#yLV%tMUa}9WcgKob769oDy8C%*wHfLw+R23RbR|AO3@U%Y!Nvp^ zO~P$Gl$e~ldZ<{&**d=ynFmC{vKP$t2yU?rYIT>Z9FUU z^P|yLd0~BG7x)IHO>v3}goHxT!h_pOZg0Cyr5O2FsJ7{cCGZJg+1>c!=Rx&qIlcJ< zzUoZjU`<3ntQ!x-BJa#FrN{J=1Bd-B6k7Exo^Sg2Gvtad-ZmLA^+mi%w7O>P&a*t* zfZbpSQU!~q8vGla6iHcs^YhXK#595|zhJ%XNL0BfTtl#AyP5(yc% z1!~|hba8WnW;QYjgHwF>@?&n{j{W+7P_7G^bwc*JedawBhgwH}=7GgPtdzF8U3&{i z+2T%gAjj|98mDb`7Gu6`WPd3>{LRAoM{232VfWOxzS!Vqd>N} z{e5?y_0U!%Uk2q9kABrN+*__mgbCOsoP-4Q!Je_yrb#{UDOKF$2>2o}=55HlyF0iB zFrN20JcxIJ#qU*r-xaQRpRq`jrrlMM zR--XM1Y0OS*6|`4T3RlNQRcfm$PXPcRk>>G7bY~_bVgCeG3!?hak^b;`y;`||JE)a zg)h$)=L(&FlX1ev3BFJ~o$7MZQ-mY&~u8d(Z#KJz|W z5CW3ah`+03qW+++AqJ@uJ=58a;Ekr$(8QQY8R-+<)kEbiI56LsCO*bYYy_3K`FY6D zz!w_j2511i6&U!<^Tcc);{TkPHqGU&agBrO%`x(!))q%(I1%-Xf<*4JYUtnq$psfm z`8x4`*-_UH9TIVpZ;MG-oekP@sC9Z^H}4S2OZlF(=8({&$$sF9z)S?sG6zp9-qlPo z+S$fvV;ruE#xxOT>{JI`csp;`K>3{Jadm$fGrAV@!MYEl`wLD@9{3sto(|IM*m=!|NrWmTE?5$);`aduNmEdiWw5i5Rlp13GTQ5?=@p=PQ#7Ss;_!U zT7~Z^HWyaDIJ+8l>6cebN>G%eZw1SLNOidv=(3-#!uFLh$H^o#0Qc>kuTa7xdC3^6 z!A+_T&(+Xs#X#v*urCVyOL4D(g%XZNpJt}rO6rr=JQ{=$`bjhKXPpBpRiwfDYRBwj zr6AMv%E1v6=jCg?RZwpOek}lMFp#MrQkwZwcty%6=H(N4()|2w%v>DX@cE*D5dI0= zzwH3Ipus7Sr*9j*&ktc7(Rs*1|4O&adNTCp*Qc-1`GmF{ML36Oi@xef z)Z*bTL+7lzLBV{ASU>HFi4F9B95$9BuAL<*Il@@4Y18Va^`xY*s5J}0?3g}%kxO1r zYeK$PBHp!i)1k`T)Q}>%<+!W#LWb@YlGNga|7>3FfFb2R{JK|sHf44$iyItSwbfiD z2Q9sru=TC>D~O3B)jXbqs13Xook7rh1qtOyB`YTE(X~j#G$`s#Fr6TOXDE9aS*t9l zc|XVd}#T^__Si#c_rFz@}9Pqi4@%5W?%xTT!8hb$V(pu}; zkfh65KVv|*>dhhN?fP-_VLaxw8_?>)T)lGezI|xXJv{{=kXi;ie)4O-2!^7nsozL1 z)0LSaOOLE`-Q7{ZdRb9_!$|#-$>z#OKHPm{OQ1aosD&EaT004H)(&_woldk`b_~G} zR1dHB`mq*V2=@~i@W!XpInseTH1jFugnJ(*n16WFGgnF6y>qmsWAg@ z`1QEW!Bd3U$spH^{}r=|h0@z8K}L2x=C^GjayzA{0jM= z?&b$-8}*MC-N_(-X=GWY@ThRqkKpZNq)XonQ>fuM23dJJwURn@w6y| zlJ&`}kVWXfX;B90~N?byVNRx~cQ+ra_1@JbqPehvbw? z-f(C~wS#ScxKC6CqG{RyP*YAVl?T<F^aR9u$%yq32_blYj~~Z=;S|Sw1HvC9>x3W-85;DT zMfbijB#3G~K0Fcfd0qP*B;ool&p(oJm^T8LB9=HJVlsjgc2nEPcDZVTI;DFjI=AV? z1084gNmHXUfo8BD`c1C=G06oH|6#}) z>;zbUOujPI<^-HRE$aXlX%9-IZ*uKlj;VC?9Llxm9E|XfUwqW+EZ{o`R60nj0FJmz zy(e>i=Zo-%zMC6|+>URFFdDQDiY$e<@Cu*FM%>3@h~0<0zqmdx>nZ5FU*^FGqK8ES z0EW9WnE8Yhr3tRQZ$T*5aqCmG7H6f3O7_2hr{(nZIlz5OnCv0zDCI~vhb@%lvp@{I z+G>W*ydwL>8G^K}Kq?M*DhT@wM8UXHlt@PQ#|ngoLR&6kF8QTfi_qA>(dgh!5`~_q z_2ZK2g9k3c(ifuUDl^h*0vOu0_<~Tjad3;T4QX55O0Wtbd8$Oi#b6?pT8ubkPmoxD z@X>L!ge;AJ1f9rtCpVD-w1`GlcnU9I%fF6y@!!}6os^}K^A!Iegsa@nT_s=st4P>E z8sH=P{|D;pnu)%m_rdt=irxhgpBO#7i3O8~D0AcNbf>-n?CDa|1*PqiZBWc&SKol7 zoI8?%O;E^}jdEN3Fv-Ky7F1>X@9JTHg;r-L4Z~hTX@%5>Bu)_x{qMs#fR1W3{d%=s zHp3#mePP1DAk$W4Osq`@xYnItfqO=g@Zw_c%>L)KzyIYMz7iPi0+{0sRgFVH^cbWJ zK&jZIQ6i&jBiMDI*yecChg0;hSCTR8j3wT=c&{rqpTV)WoGK)J<_?)kB2t)t9_lFe ziQG^lO*I*3eFsKtLjusf20v77XbZ+~;vV3DNoC#;jASB^mBr!gedj?T@T-T;bW0r+93v7vK_KpkBP#iFHF zLj*si%Ksc4sD7cO&S-cB^}+~$`OqoZWR@VIKQn0mGEA`i=fMY+HqPhT;N{{~xdVuM zAUpRxi_Kqx&tv(W8J_2GZ&HQt@6@x50%rS(yFdVy-B&b{)^b`s z5u=sgbLJ`M1-ulZ9;k_Bl|k3LN|W2@a@qUR&wG?X9=isvRi&2F!H&g$M|UDBZO)os zn^7A=U{r3J<_d9vJ!T;@zzox_x!A1@>`Ig1(RMd6J9+VnuAIMs6T#0n2^~ccJF2x= znL}|0;_1P`YHoq~jp~_WFJ~I1kEnQo)q#}J3pTWIBzQ^Z*@L$SUG^b0U8FjBx&box zwgSUy4S*Qmt)hmx+W#7VG?~0?NMmn0kIbpZZFn8Xi;R-j=0O%p7T(59RfN3CXB!e{ zl7w*YJzA4eG~q>c?E1)PE&GZ1)$-Mx-wU|Taf$dG>|%5_e3+luT>IK(w6)ZxZy7db zHtGDrVcqjs)K_1?&TEbEOGi^ubswJD-} zHn2@a!6dy5Tsej$ey<$%pqnr+AM?d`42F|1@G0^uDumKY#h?l01PoLbp~_ zW2XaCPUxBX5K7L(W;l%7$wiPV&AnY|6c;Hdz8fD69IrrHAhO!^_O(0!!sz`VTbW1Iy_O)iY7TKhbkddi%j3>CD1=ygti2Piob{8~+JLAQYt3mE3z zC5fUT-ad~FJ64Z1L}hS|nk>(<_NU`h!2(@7wU@StOkAGR~n8%v1kpTM<3^)L-SZ}C6Gmdy=SSj z1|GrZXzTY>ec$g6Bw}W28=?)gyRXUYxn*(jdMyI9<7rY{!|A3a-yfLm$#FNlujfys zC$t=4MUw;d&d@>GGzadh?RDLLm|ucMLNB6g#SsC2u7Jh5wfxr)#>CVy^Od)&p7Bz- z-_~&7Uvf$%nfF7N&O>5@{d4v*sw02vPP59XhBnLFAS4mYJ#}hGr5u+5OUc{QmoT4) zqO4K7lEg}v0u6_h$?ex8scij=8xiW!Zh0Fy!L>x?As;+3WkGEBOQ8CO3akUfu8WNT zoP$$;HH}-jTR8#!SQ{SAhmsoMENr$7Oj8lZ0lGQIIajy#aj*eTS3sN5^&oVJwKj80v9(%TvJXx?Yg*77Ut)`FwTI{x)g_Fm)0u+ zxTH3!g;~ITjXdMN7Qn8F-?<`yN?o~$fI9{GORh6}F$hRWCoC>RFrA}*U=_I5AZR`; z=bTuSvT&a3^8736TT@9E%e*6{d-{)m`Dq8LzOiJ;feR6ghDWY-N+01tTtk5O2JiZh zN&L%(wTHnBNPL5|b|4OM*hJk+&@}mTQ@tBqi zl(51Rf6g_&VDbw5{TolH=!<;6ryp627Db-f#WoFx3SPoC%2re0@Of7gTx^{n?0X@^ zGi#Nk+i~bYgoHcWH{(hn+o3^ZYI;|-iW1lGY}8qS*@c9-X|waVQmTAH4W8|LXw?ovs9N1V`r8R$LQsGWOqr*uY2VuQknKEpq@$fvSIc34W8E-W?&-*A zRO;QVO;ntEPYE3Xh zG`v%Xv_)MGLe9BQ8;81lJ{??|r#9B;zJXUWAi}*&XfSG+^SQWz;)BsU8Q4 z&h1z7l3BfWE3P-=n6*u;OYu@BtHtKKGN)=5< z`whOYcZLF!&Sm}$0{4wmB%|Qx39VK9bFY#A1qqY8B=u&?s zk*-+s8%zf%cHtzZ@ms%Tlxhth+} zi;mnTN=yF@44ze&98UJB#`MAWJh&#<15!*B3`i(^0`TpBtrja#FfNB|0T~teEIk^G zm_JIF0xR#$BkUJkcA*&LhNfX&E0KH~#08d6)H7YZkS%_PDcTDzLmi>K5X-O|u4a@< z--RnWKmncgbYhJtsT#+m`zCBOm>){Cp~McK3BBX9$tCCWtxr{MDBfm-Y@va_ zRv=eiv@`TGg&TW4{-*CKMy`?F)Pkg|*Z0N!59DAy$=u=qxlcu0`BPLw+-hI=Qj$ox z&CR&^IU-xaWn@T9wQ>5gzY!KA06-(~0b3K=2K_z&0qI@*zXC*@V}|s zA?YfDnZrd#ji3OP*rv|!zkLn6dDB>chtLOgr|ZgC;Hqk~D}YQH>*0nv4|^qOGV4_R zl1hYZp>?Lf{42}+jauhqqz>01W8yLz*E5K(0R!uar`bcpiO0VK50yW5S{GU;TNUtF5VW18W~dl86lQj|1ILibXuJNnCO zI19oj-Y@yuT1%+hraqhQ%$}oXf%y`x4Xa*pkZ;=XSU#c=f_-`y7|sY=>jJcoRE(1H z71fS!u~6|xl%_tY;XoNd(}37ZIxoaQl;Ed-z~|OIGrw=opL* zxzX0b%|mu>VCmp8pbcbmYm!QAv!r$U!{@yM4gx$-*b|t@x=R#5L;;i$Iar1UI z!q4G_-oai<&X*<81@!5{t;6UJL|YE6O%qsU9s?f2jmk|zx)NA7efgi;_$VeIPuMws zNJ8+teMf{j-?Yr|Fk=EGbo?#N=;NUL5rv~!dDN4X_etF;U!P+X@$B}0Tolir zXCduze5vb|mhOg=vwa)Q6Mypw8kYcNPxZR+2td?)Lc@4uzO%g`!j zLEb>T+!L@>iMD;5DGRbUlJ_Ls5?g^t0v&oLi@$8Hs>|B2L_<{X1ZK5nAh8AgdQ{jokzldcvGh0_K41a z7LR2I_9eRuj%koK=IVTyl&_r*7@fsZDj0r>WcDc*^gZoYB`Tez(^jt`D=UXw-m)*+<1l78?fUi~C)9>ZyeBzZ!}eh~P|NS!+|5ni3ySXNv-Q z8$hm34gW5xskNSy)2@7f{OLtc2{ddJZ;Q&Rw`!Je zsQ0eeTjaJccjifa19ma8QD-o>M98=9-wU%PFFy)C2`^{1)Ur550{~=UgY}a~3mw80 z^zNet?`mw5%W?T~x$%Mtm?=(sGiIslwE{H4E&@WMAfK!K%#KZe4T0=qBAv!LC(KsR zy#)hnSV`8{m>DrZpH)eoS;LYZYy4`gISee_$>52@ zHS7wY;mfTO3r15sbZFJfpjGl}i_Eh4($&`Q)J4zdNWO$I{ahwe2P7f6q$(zd4Vf{ zt{Wkn5NzwDJusVkl#*}M#J@e8QMD?7@LS6EwoqWkU;pY`(@BEW*O<VOHCR`pI zh8q_RO=yjZB!IJt{-278?Z9B=dIxtF^nP4p0d+BX+JyV;oaWj9J$O>7@*yJ5Gm04_ zO?xyP**uzmmIhTyi6DD84?=i|i3kjEHMmNs=Z zcRL;wfdCKwMv>80*$o#j5;K~jsi4uLa4P*}#dNMWc=Yf5BG!KLB_}dD%5A;c{2vRp zI6Lxd4vwy)e9gFs`2F0<-LFa#M7fXw;WBL5^jx!lE#ZIv3FeBro<3dRK<)&`c|Ons z;1vFh?9stKv~K#(+*~>;eYk?M8W@0T|7HXBTE=z7F~6b(70Ah>t{!zS0-aM)+VGYa zX*x4wI}MnyQ9tOd>lhYE_V}|H2b9exVqAMX_qBUm(cxgA=^Afb#pSKWU-4lKN?=M1 z^Zgiq1Iw1GCj>U}1bx#T%K>WXSci{4*R=$!UK+Yjqq?!3#IHJVdXL!m(kw1p+Xk(3M52H*o+jV1Ll?gs>SOLvHn^73ik6*k+X z(6@K8O{|+ zc=t^*g8(7G-Lu-Au>naptClJbt(MbDvRPbdcPCA1aEOqwJAGonImqAi0nmxNSWcAS zDfPC2fFjw3mx)64SqQh!V0_-y@9^^>a2vkcqatAEK5@R{8v4D$C^XN>pNV4xUebqu zBYxJgI7+agfmITu%{ia_$BHvQ0=@t#rY-($;x?%zKOuLxMl@Oz)<*o0mrZFTE4u71zN2RZ%HSKVD_7qQS&q+X{CeEuOD%?x_K~XvJZ{~) z-iZKsAjh3PqW7PNG7gfHrtZg`!FrEXE^E*klON5p7pw2Km(+^RW}{#3b@OPaU_uB| z$4vV}XA8D2@x&ixMP|9xxu0TsIEKx35QllCk~f4{T5?o;JQA&L@BR^g+;?M#8;h36 zh?ZMZ9uSYiTAuWuPI?E0eZAM=vac%F%W4ANI#^i&-5J6Wtq1H@>h)T;=~6(zIunAq zs+KIZJq{udMZ&pnlyaOm3Zz0#{4H91F~#+IPB{TQegEolM3f_4#y=mP9tTsp=UKjf zW!+pCl>s%=AoLp@E80?jJM9IjI9%{0{NKp}6u?~PWr7J9-{LZL+CW@#{Og)z)yc@w z&Y7nAI=P_jSpD549~rYAY)s0l&f?Ro$MonwP=gN8Ke&*+AWqb#@k;RBs!&ofA!3qv zhs~~yocl}i6!k)Ro4?wV+@=i*dTv8|ZD(de)Y`P!JCv?boryAk?;=nf@h7Sv@KL#j z1OR77Zj7%>WO2q?*9VVdIQ@Pbthgx>>&&=KSdcPzXh!rGw$v= zTx=#OWO^GeL9=+WLY;{_JBbvJQu0e^%pvQvH?g%w3QXp(-N4?e@NjI^p>Ti{q0Io;By`_kY|>ax7wA|L7Ie zj=#{olI__Z)D(5Y(us)^>Pu(b@X4ajyv*cuI?tUIa_MTxj3HFq&;edoh+&4IvD9nxjq0S-B6AK!DMTuN1arH77^#0SefPVk2 z^A(LZt7g?8xsW;q@c`_w#V>?HxUk*|y<1^P1(!!blsrcgg+tM2=tJ2#ZRRCZuAc0h zu$-5dQoqbSL;-hDyQ4v4HYu>A1j|xi>Z!x^cK3LWms|`}>nI5|TAdhLVy{|eZ4mHl zJtYfCqg@ey^saqjl7(=La{4m@>SxkH&4VB?KDnw|+az^&$Uil(zGh^{9YTut-Av^D z9MXgQPMhL*R4H=IrBB4z*PbFBZVZZ!(Y&D5vB1U5W72Krx-)QOw7mYZ5)xCR()p)|wSlZ;9QSNly zYX>=-XJC_tKyR=1CQ%BeF!*%KvRClQFoegoESAx+fmAJJU|7Yb7RNGno#*+Dmo@&E zfDvqe`vfb$i5UQ&vW#ZvRi@cc#{<0^g0Tq>%M^tcJHE3QFlM|_FQ8zLEqKk=!O~jy+F>O%qcIT%73o7B7 z*HLPQLR4I-C{&h6f~&0GDS1Is9+&PmrQPv=Q(5afT#<7ovH|hPS}0&I=Qk#cGwoYXA{+~h9E_2Rb0R~q3YrtRbU`CWV@^ucNXqxWk5mz5@m{& z8aneYvk9|e5P!zqk(lx=S1C~SARBB?o+gd0gy2!!3u4aNQ%HSVVHyXMTy+#?SIgf`n`0D)q)YpH?M z@aiF-5WH~jt->0EoCM^w7sZBl!g8qTC|oA%ABx^&P7kA)&}s&ISK%08v=)ZMq|?NLZ4Lvb%ss)W~*{n_u`==Veex1Khq7!=QewP_H9581z-k| zHXOqNNY;Fw0?PR&gDr+gmYxeK{&usVpD-z2p`+4tA@9kC%6xw>3~(A~`BZ5cFNIsa zaEAJm+-nfDpy;y?Nb%nav4y9oB$`-I0b`IJ$!eFKE~^t_mS3<9CfCyI^W7~n8peBs z+h(5XGg9{7z-va zh(N)mcgk%r(4~6gGTfLsDvfSXTG0P-zaJbG6g$Ka`kjycx(zr%AH$6mB=j}BPDx}L z!DsDqvs9V<7kb_v;9dEOq~C)HhT?j|sLZAhYmr-^Io|Oj&N%je_04O2_1siXXf+4O zsIB5rMtu69M=%2C0Fcmn+$^B!`1a-$~CRk*+FfbqMIZNZJD?J5(`rjxI*)W9(FpM*U8j-!cF0kf?mfcZV(N zzB-8LSGY@AMMjB#^-)y_IY*5?J<+@^APtkCLC;&Z9dtt7QcZT(5s7VOK=9jITHoXDptiAZ)UBP0^Av6b6QD@tPbSmHkorC&<{J{ns_U>% z?=lfOuQKG&^InEKi_4cjWu5$aou!dBGTL3Swz%YA)79C3_4DpcNS27J?)z>~_ammQ zTB1~jdz3_n71JuF4_xG0jR5u%12G_p?V&D1aE5?fst8N8r>OePl$ehZK+c%Vb;}o92$^qq&O0Ql;_9z zbcsMHicBj0`vYcT(*0Wz_)5>I0EN;%Ox=cF7cN~jsGYdeyK=_@TFsUkn{L2eKKQX^ zHRtZCk>~`A%lC*A`%AZzb+CeVA9|*KhzF#Q3eSV^Cq%^Rau@H<%+b*!qQ^BmAAstu7V>2>A-myM$$D0;!!TRd)PFUoY_6*2(?i58KsMgcw! z@>p?e_||_z)p*guH5Ya9EElSh2(((!9tutE%9!Z;%?^R~X4{OLn*jNH$F( z>c%>W=*Dlxy#;C>NiwkW7ZeL?3>tI>8$8x?$rD}mb^^WFN|B#$KuncZhKMcLnwU;f zudfs!^m#+oC)q=kyZ5J!G9XLD>L?L^z^=I)68c(G^nj^jVP!|3y1(5{e{ue(*M_I!Kksfc@fHMSo7Xoj?iqpW@PmNk8IlR7?}c5!<AS;VD9*c<{Ithg%Tw=pwPZ&lmSKUpu_Sh~J5vi*Z_q(P;5qar8GhF*n#TTnO| zzrJ(&Zp?*(+6>c${)IU06$E|yT@Q=FI=Ppt5h@s^qB#3%fymZxYRhD!?bRxSW7DzC z{CoveNWRhy>DL(D0l~+Sg0dIcx>fE7iGegclKtsr*8p5 z4?0>vBs&g=KA{w;k?tFoE+E3HCPtNgAk0>EwJ(4?rH3tDV$0}5{z>$ER-JXoMkT$`=c$fIT7l0vuiOMa7#SI~F ztOPI4j&1B8go4=MBn?FA4ySBNp{=Bw!)j^JS9G40h6CP78?OIjxyIA%S^3GmXL%eo zRL?3Lv_HssQFRFl5c|mKd$#vDLDs#Lv^SGOet-pnW~=j1er0tpptC>+e)$Ck5(Leh zuEWD2%;(@N2POhgPG5F^6t?9J*1-5=E7X$u21P@OjS~Ec;2QH&$DrROk}zoA2VB!7 zAV>ia%s?GQj%tx|e#ar`GqJwB*}(tvoe5)7)=W#KLn@n5wl$-t+QhJ6H`|%sFWG~R zLLx0r%Aa)#kYc$bCU|bZqXQ$4)#9mFlGQBP{9`;AMthgcjQ9e72uc&hAR#wFwIomJ z=9$XgR$K#-^Oer72L!^m7iQ%H3evm9b|v#WkOW$%8%G=bBx~AONh7qmdd^8>z+s^N z^~gf+w@;qX8QK?5UYa;gwAoWZ9=?_K>+`o$UxWK^r8hBDBbG%-k9ubm7WGE^+}$%u zS%4=zi9|Zl(4a7XR}FLWTE%N-^Xd_dD!gC8RmEHfTAujlstKfu`1Xwi+h%1m>=TpP z%k$>Lx)s?r6)Jf2mPmKk<4@E;j2c;f3=6Q!DyBGif$g^w9LpZKh4iJQI`BX)JHWEozEt*P;SJg_F;S(>0+Nk;v}jBeJ@kha zQa?61_w=yFfu3a#LI|dSORliJWcZP)811#RxO2{f)G${fwLtvMKP{h6wmj#RhQ%P? zOpjZGa0ypT^Xg{f^E-li&h1k(F7uCZ&vB3_P)Kuo1=4Yq|fejU2FVt+n!Ol4)G`H^xpij6gJ@=^Ec2U?%SZu|NdCYE580S{$2rTXxZS zkyNxO!dWn9v5wSuDP!fNXHZ=zRY@m;(ap_#DT6eI0L*w{e=fjPUQEn0GqSk;wLPk? zB26mE^To|sjo|IIfao?nLO~zn+R=tg!E_&)c;FxtlmR#W>WU4YH%HYJC+;A2TJhds z2Oz;;hql{t;X@+y3VKdky7Sqj{r-3ihx*GQISe8V^!L_)Zh(x;E_}gkMTis?(B8+) zmazJg@!YIHf0S->8Z>iZ!CogHtN3k|6? z=KUvn`ngZ3Au6eeKGOkMMLgI!`#urUy4(`aLHQoae_YUq(ey63Jwu?X3 zzGrit`3ap}7ab@*^sJ{HIjAU2n~Y9|){GC3#Xc~@A4p$LplI!)+-i`OB4qz;*=YA=F-ZJl z<8M}lmKbu+yi7F#p7$D-jd;%Frkbn%31Fu-+X$66)B_bXo0Rc7eEm;3ExN1((RVtH ze^l<&u40^BY?a-|8OZfDrlu@CNA6R0q95@6H^q(fDG|h z5kdQvH!LGHk3>a%QbOHzuwPm$q#8oy8|MJg$54^I**CH{V`Fi#Ofj?0Zoj{OQ9O0f zF~WU}=kHQC9%JV7a?K_5FLPKGs?evQf7|_2H3Db0o)`C!fhG6~RG{P)KHpQ>TDF8d z9Wn>Kc)*(@=P7}tK7x+LkmDeFS#IYbAMH42%S=1@gE}~%W%iS|>`L-bYIfi`AT_C8 z%&X@?8)4Drov_q{SSw9l3v~mbGCUW!P*7=ri~r0za7ukzfm9tmejFif`de_ef4DT^ z>@5>%&?}zI(^7-Ds+;We#`M5R9b0)gmEqeeGXtY$gyzg38~RW;f!F8BsG;<$Y<*=N z@DlLnm;-7L_K4@4BZFfuC6uDm)QtZeZxQigF#7J-g26MXK3a;JT=M@89@PBK_opYr z2~gv}0pIoFDcnWN%l5&@_~@sSe{(7;C!k%U*EUA*$RkaNOmZp}osSIw0WYs^Zs@`6 z=Zl<)wm3UcIJXF_<3PrXz}eavG@9E-d;F>gevS*=+u0ZM-A}N68b{PnT_8o@oMMqp zIEThVbKur^ID69-<4L4c<4R#j7Q&Ot_{le{ARXpn6huIc1LRMmyBhX4e+R%j87-j5 zv78ETftyhTHP1480hF_?1#K)3tTo28R=S0roodV9~o%zZk%j>J9kxR3=va7 z`|hT&3(8KD6E8arm0hMy(srcu%u)EaP0(@ChI-^~%wq}3YgPU!^m-@x@F3E~pK5>= z+H+n^+y;QC{9UDERkpyeGDn@pqnag;Jug5$x;B+ps2Gj`e>gu+t9wDv?_;`Aev$roUhX|Y9_GqtVw%1~-`y~}h*&S1G(;3GI34{2BCB4|-P-QGrqLWtw|cP7 zxW{j3%~UrX`Xp|k0;DJw?ZPUJjg(T2?NMp$8mf=Ef%L$rc;Qe7!o@kq+4|mTf36H& zf`I#5|BNUSf4@l9++Kb8}r zWE(LJ%;8qe{#}+`FjciqgU}7iMMoq%P`Z-*F>~7gOtz}WhNS;7pzY-^&q9#|sfBDrRjGj0}$BI9$>{mcv0E9lZKlizX_AhBJizsQGlY9~fe`L4XbF9+`lf&DP z?hrrhAkcPROA270ghTAfsLZvULUxYSsOfPOKg1VG`x z%EnI%p5I8FybUnKZJ!Tc5(;Km4Ur+uej25>e^|7ySI-sPe?;%lLk};`(qRd4J6qM| z%Kx|zNF@wDE$4023aiE|lCykJ2vZni)c$Ij8T|{3rd@fW zhejI^*pG`g874mWjdwajc9k%54+Ud{eboG#1FzAF{s19w?mHEW66d^hOMh$~NGgX= ze>wotV@3f$cNF&I0*prZoUL3X6e>_?C(|r_N2KMIo;g35XZ+(i-!HsT2x<9_Gz_-y zCxd}?s+<=xtd6Zhf4gR2 zWJR&J(N%6^2Vy=oh9pO^y+BBOjG~#wtKof%8@g<78oTO-Tn1S%JK6xp&>6$k+V3Ro z=^=0VJ!-IUefS9fHw$@Y2It&!!W)!$C}pr46N*9IreaC*%s<{(K3N#g6W*p;`-X!L z+lGg_SDMw~y;j2&Xt#!#Yj1&*f2-%QGSyz9%c}EEfOAYH=KmS(vYm&Ef<(EO+j1B0 zYJ=35qB8MXA1uK0Hw(m8Y25g9^9mT*fzS{-SZgO9d_$0Y~f3X$UoU7+G z^trA{9k50TISCC?i~Y$5OKHVzP1#WG9(6}Qf(PDLM{i1n#PnX znX0;$feUgvEM?J|lAlG)2qP!B5f?wtP=LCC#(fpU1qZQAE?Zl`e^BnaGwW-pSU*g1L-WhGLv#?hGGfl2 zuRd<@rf_nhKzLB0W}<2Zi{YlN-fb~T{y=`zzGl0Dr6UvtP1GS$% z!?SR$^JW!PM~%DOy1p^??%wr_a%}YVF<}PK7Y|YyyM+{BOsshDt3Hz7l*6$tFBPRg zT#GC~vu`Cw$5oz{e@V0C{EFNi6Fvo6WrtMKdMU4+ar`};XUic8xOJ80<+l+0>gm$4=x&TTy4jC=ZBlD&wn1T^J2^2Wa(kA`qFUp!LH&xe4XR z3dG4~9**!&7tW=>`C1qsDpL$#QxTy9W|L{8o1adRtM2pUdS)^i`!d8X+ZQ~Px>;d%XPrqH!f9!i}L1-BX$TOwsfgxK3ilBI{ z#bX$Oa8ED&qBRZ6ZwOebPc(D_O2ZHsPCnhU5?6e!EbiFHpMVOkj$dR#9#engTAk)M zrlye<(*SzQ@`T2cUxW^XxJ;jMism#flnp~GWDXsm9g6SJ!QhBT8e*CpUFv@1qcz&6 zIbF8Ye~x;5o(G6V9?Uw33_3usuPPRLw8a(spVVmGY3HfoZ{|_AWNb#0FM zZvutSDq|EF0EzFLs5zo3 zPE)}Ij*^v$W-rclk6vn5EipgJyx)KQGsTSo_}-VCV~}PW5Sd|)A!grB=Bd>ZL!y%1 zfAEz)Kirqaxxp=v>$7ipI%%?xsDDV1na9guP3QxOsMhYHRQ3> ze^zQE*rcP>axDTA!zYwV9Ce(3MYI|#xq^d?-zh)^H@~}*EIasLwuY|wDM0a*rC#)7-!eeba$h|e*Ub2-9#G$suA20E%WG}H)uru*W;`q9Me_5wH zJ;?VdY`Api8Nm4l`}+ACv7^NGm8{S10yH#ybGcNo1 zV+jPS?FI2&Pzb`ybi!s%TRH2+V4_3LSJ%J z*s5Tf;O*P-vWR~vF}5R)a}CLKPg+~^AOBI>{JR3kfagKKmNPnOZ|JqeGg4$$pFmIz zWtrMSwLr*&iArbQwlUUz;~Rg*)unaD#~vhXox&~z#4H9VjNtX~zJ$Ree^_eOfQc6N zbxlHU2k?($4ktF6q}*)^@P8oAa^NznfCBOx19M0ifyMvxla1e|26E3GnRu@0wOli! z`Y;222`H$vkih!!z;kSb1l(JGwkVIT28Y?t>Xh)9cZCJ@3-&$O9P9jZ4(jRGa4dVK zHUp)t8CiOw$n9xYXMMrAf0OYA;3)I^OC**=*=84&30!`B@?B|*A1E91^r%2WDYnkQ z#Hd0vltDPOns+Eeq|3B`$CtYsp)_QlM;N8^WA{a0kP)L*DFBfy^Yk99EOdVGKb7X zi)%@Oyg;HPuM0f?e->DnY<@1-daJ*mOu+W`on)ku;rE}Fuq^MHO23*n$}?0`2lTN| zS{XN1otF>+*Tswy$@|x&&1hkZR?;k<=LOAAa0@q>TPzUO%nY}QiPz_<#2q`=ZIJpW z%?1}x4{Q=IE5YfbK3MO}mX*tPm+HDWP|7gCI*QNI9xMZsf0A+^4#GuJ*%IJ?M}nRc z4^?tPoC&;|;edMz$~z*K%A!{Hzx`!;oHx2)+C!{1FzJki&YLGnF8B3B7vOPb7R}E+ zGB%MAdL=4~$W8l8a2wExY{+a;3gQzVGmW_)$txVhDplSTIVwf?#u z^*jXmCV-&CVeKii@yBO+r%5Iwp^szFC_O=#xm4Fcn?SVX2{FW#z6>Qw)+jE@!(JoA< ze=??KI<)(iazPl!W{i}vQskpAGV*i4{M%z~M5{Xg7*pfoD6$&>2Q2K4^ZXKN36o1t zcFCF!>F@vNl~P0mmU4HBFAgtW4jFO3w>Xr+34-+bPh(e4gaP<(dxYUDtlu5)7%zyF z?^7H^#Nbi2kQ6IvSh#VdOAEj@vC9PYf1en5L&~0-AI~6nAVzndC3U0ogubQ(?=ORa zm-o2{x49&0Q`MDOH64bNPkq*fxJ^%%Bf*q#MiWI-@z6Ak(d_&~;g)=#B>y&sXf1;7s zPYQ%DH)Jl$j@F>uSisf{vAM>^)sWBFnNQWK+Dz3XvBQZh6xI)(nDx7^{Hh*eB9QTd zCjAkH|LDHg6*=i4Kb@c`E7&-~u%aBWaXZ-2`+?Jp10sRZ9K^D4l>2NYlRa>Hwyj_2 zQm;YOkdj=XOK8N9$NPthis*+Fe^E{d8avi9lhH_Ej=7E=^-*zlI>%TlY%b3fwew%> zs3XQcP6>?zGw$XbcWFa_zqDwC^k&$Q1{dt&VKeq~7<_w8{k4lyyz+Fg& zBNQHM`$MLI!C!1(t8$^o%UEQ3MWdmxQQe!ZbGW`JgL)=?l;0M!)?D$^PrkZU6}QKg z3DOtOVct{CXCr_qMl)fje?KRL>&mO7S_jmD@xhmr0xB&5WlTf&;vzKmN@}A)ZC&2e@puoh!fI6raSx}c4fx+x+V@IiJIJG-1IM*0e zT~>tV)Z&+8XZfuI=7{$wgu^egn2%Ceht61bY86J7sr>;Lf)}o#Co-7ZKJE!|HT| zo*c8FQu6HAf0aFjx=DMyWWNB=p$RlW@xYpE4z)AdJ>AI)X>d}*jDFdZuXQJHCGdf1 z!xlE0H`5O4e3*CFWI)Qfn+h6hVe^+-h;ce}DH<0FIlVLU>KQ1~Bf-82?kp zW#m(MrXaF*kX7YRW?3m_ZfesjqF>@4xE$W@EQ1*5@wS@QOn5=s?hp8DJ88Z_@ua@o zUOeN=LrrT!5`zoR=OfNRrm&+WrwjJj-@%+aCfDeX#R-4_8@+?@tJpop#hAR$=#}KS z<;ac>f2wRiP;bJ@5WnnIC7wLn91&}AWMKpN&YgyfYy0;xqOB`9Gy{`$hHtdA;F|h!fmWOR>r)C(-E?4b= zCWVENu>;*NzQMlG81UsE8@@B{M7l;0TO>DUD>;*R;*U?{9}Kj)YOYTB*<;5FR>Xi; zL4LeHRIKvTWTo03jd#rcwWRaeJpbdzzUkW5x}kA}zjDM@QzFC@rX0QQ01dCoROQ3? zf9b$X$Z+x-H9hKr6hkkrhbcNUK4U){FXvP`scpW2VQtCabiV5WCy6pRP3`v0EN zs}Ct%e#JxU+<2pGG<^BcR5(x?QnQJFj##cHt5Hta3#8Xs$d#fJ;9m>C`q!V%lZy;y z8M$X}P^~j{TBvFOrlK5VT*{XR`NSL8Xu>jnpa}kBY;V0^EtlfnGOQ&g>w}#f&@U z>gLe&>2xMxe9G?n1rSB4&w?8?#G2i5NW@~%7S-)Z7{$8i?V-#`F1I-e}Ljz z+S;l}V@UrecVVAB&+(;96LEr?c+mL^fe=;Bl<>VL_AXYZh<&DM6P^N1rbmu>_p2T)hlPuIoGuO-& z_5a%=Ud>_|7mw_9);%l}+SLkcp$qp>{(`x2V-J_+kgl(~@qi{yJtfM&e-s%7%#Nn<7*}2mXs{aLxsq=-VHd3 zv%l9bWWqlYAEvfY8Y4}?dOHkZ5Fze9&OM6F6*M)JNi-951w!N6bj*tt;DOGw{>02~ zO=jlH)a9pCk_j!BL$EA~%@OxBzA z0mnStO7&`!$r@XHE5%8YdJY-uh^m>~aFEF5jIg6Fv8s<1B3YlWe=MDNYlzxM)FBbE zu+fI~N-FZ%;<)U@{&0huH}}|CWcoU{h0?B)RQ>av^m%5J{rl?sA3A1y1WsN}rd9kl z`V0C|rVG)ovY2QlM#q#Y-c?d0Gt?l#m=OG}zwhn|R6F*f^;n*-qInOJUiMtLCq@VXJr{aY;^(v|sTjPO*?N6a#9=Nq-(Y`KAB60!)c`B_ zi_G(1LaKWa8r2uQ{p!TX1*<>=I3l2qi7@aTub$_Beq$ore~vz+Ld_i&r~CxNeaEEy zwOv*esC7Jug9Fy*YxRojqo=Hz|F%y|!TDC}kvy@W$Hnbp@cx`Af+z|KA?1nPvkUjp zR&8UDKH-CXj3Jhe2n1CNXYdt!#oWmtKoz`UWWzRs)itUrlIhDZwvE|2q@-yuCSY+O zS@!Ns6`-lZaO8K* z=FTrE<1Y#nu?KECw@$RVxIV*3ULjegt=;XKen0>=f7pPIag;U$9b@@51sWx*t;5`@ zhLxcKdkGj7ML>U9JwZZQq)0|oF-83SH76|cCz2uZ0SsY&3WoJIlN3~Ur8DAun2;bA2< zqk9DZf7>=p2+*hHe;mHi-fWCZ|96eY+bedC{$ks*mtYWad+#;&itDH>{ZD2c~ro zpXla&=gthl4)U-NK^)EL963{3$}ZYiZh9;HqUH=PTc2i&6>q{OqZ zcf<@V0}PHOdLC`Qty(Ci%ByT#S%^&D<3@0t!CCA_rD|e%r}l$FQzD=(_@80}D;_uc zeO97a0#zNPD|)+%t||^}NnBgD3uLDmF@R0+qU&Aeb$9X6JY!eYlu$}dAQTd4z9ht9 zf0b!vf8;&xKvg>?jdZ;oDql>?mj=n($7h&3Eb$eic5fIB-2+7S;ngDZ?sQwbSkzqa zQusoQHY(o{38v?=s75b6bp6tCSXYEZ+6By@Hq+O6n z_eF|kupdwoRW=kUHW%G|pYA8}iTz1Dn}M56fw=Gp`L_Gef70jd zEIKokZNQW{D-8)HjuylmAGrD~t1TlZ>UFC5@5Yl>`lffl>b`~TL7A}C$tsDPNvb{^ z>EYZKWeX8C2|g{NQ9OIL!#hI2bK;L2`d)^U-zqA2z$$3bmKb*VOVN7L&?VlZuf z;Bz=WQCPryl(_vk2H9`QFBvg$f0hI)i-*^kh(jlc=+w=F*!{NI6e+f>qYKom=aMRz zq1|hKWuc-B>o^S$(s~GuXnV|twrUGX?uD;t)rFXf?I#Kfqx41P)hKIW5NJU0%(ONb zKY?+t9%IgwZz8;ReLaP#Bsk|v+U;4c3)saaw1qJ87Z%da^=4qas$<~Ce+6r>m!4YH zNa{4V2%AW5vg|2{Fp&_yh%O4|h_S0rDsn{5PdSOD?h|;KT_JWM#mUJkbrWZM+Wwz& z_SCNE25!1-R?R;qc@e*f5IpA;j-L?E*M{#o;rmf(`{9vq(gp?)0Am#L#huhr^! z34%Vv@!*HP1Ka0H9PCGTe~1cru0ng1HM`z23%*flSr!O3ehvZxBcs$OMA>=ls=$j3 znu%#rf^JPS>m8~yG;ll*FnXYH>2o(d3x2T$bQCv?hbwtG8Hew_XU(@FB>nd_kj4s- zo-m*anpV3VCURYk_OCL3vr(8!tkELFrCqXZ84XuI>aefISQ~3Re{gEP)8k-`*e3B* zs=Rrf!fl+hG5=Z@bAnC|I{i+j{#8q+4d-~U=daIGfU)I^%1!0TsTA28KUq6UGjzZs z9qv#gG;8xnkC?$YyLO%UiGWP*<5&AKjFnl#Y)Rbt*|a0p!-Zs4&qY=^*Fmx*oP0SB ztNas*jPA&DHIK_1e-lM`)|-f(z$r;G4KPI+yT6zzPQ&7T;6Tz6Y~e_To7)D1F#r2X zfb8Fc{G71@5qOy;rJpBdNky~(gAJjeu|_+7buGXagpr#orwT%ljjySqIVpq&<$&RTh8_uZ z%vpWn0&8pA zc!YJ@|At{?2OKCa(a{o3_w_igqb`m$72!o@N%tv8k4c`Uz?XuFp@G{}(&N`Ss_5_# zIYo1Xd;}OjpOWfGr85bG_yg7~9Ij zR|d4%gQeuH-JAlDcq-h3{;)+iqDL?@AlH|jMLc`~ZbGIDg+IBoXxW)W%2*zA=sJ9!PG1VY;u zZ=-fPfdm6udh=pOg;4!UxPywU-SeJev`2=e*nu#)WQAt?Qfa`YM4_c&3byLm(WL?D zW*HuLB5ToG^D#f`$XEGI(q@E`%Ad^;e>B6|-ApAtV!*O*1t*tA(0{^4E%@^genqt7n+_&Bw-u~(p9XFB-+*HRWRe~ceY zujNsiN_?<$lU6O`8coD;ERAVY&zn|rD>pIzuVhH9LIR@cH^GC zUrMMq$yaEGN!NlH<(~rm%YK|Ee}Rf9F;p#MeM;+4DOiy($Vv>_+b23Cr;@IxcC#Eg zzHp|xd5*iTM@pB9mg{r_jN*J;@|*A7FA>9aRGHH^b8v>fad-Ag!0U*2YL{{w0CSJ< zpe93c5+3_r69yw$Hii}A{uG(Y@ z&v_HTio*fo@=S#T5=TU}xr~3F+Ik4iL~TaT1Whx`F#Rt)Hlx(~QvmXRi}~-mVE0wJ z1upuVVv-@b-3d~-EqR$Ze^orJZKaN)_sQt1orIcgWv2=)2|#H40(oFAHfL1@WM1k1 z-I0F%MK`JiqYkQ$b|amRo)q>nKIHZiib*nnnxBr)cM4dv^{5GNm!b-+5XZU}|4oLG z(UjRW{wiYOc?|g zueE|g^$E!AyJb&&3}Dth8jScH4$Ld4q??E^?Nf$Z1-HCWD2CsrPf5tM?4~C=<$vy% zBwD!a7ihj3C)uN0P8R?2@gElRFB&M?fz)`1`C5|w+BGdSf0(9Trc{V-w?RlE#@W;K zu_5lXj^`7&)(0fOC0=*0JBqVix0oxn9~#*ZEExk-^hoV|M@JB!AEV6ILkic5!+OfR z7Hu(zP4ce^ffPyvd6cg>OF!<7yQao{Ng0LP0D!AdO*7@*U6rW~f zv&dWCL4zYL1X9j)nbpfQvVhFz#=SX_%=iUK<;8H2l02)-yEPzBKC&RO63&e1!l)v6 zscM`q22?Cq`*bx(B|7QZ2jK9)7&&gM|5215?fnO?f1Q|*6{0}pRQlN)^!dsdgd@n% zX!MuyO^XPRYOEm%Qvw6iG9?J27imj`E8J--GJBE2yZhpI_NOygsg6(jqmp_x*klMoD^K9H;#-+La|TyaYSbO$}+VuuHuG*XZg( z>{^K!e=mMp<@rx3>If2ndRFOI@&rWFyB^##GjehCE`*v2o=z-9DM7H_vL=HyXM`EN z=oz7&PIV6mSBm7xZ5Oy|!yOzZNz73u02GCXV?owcxnne9K9|6r>@mMEy=>T%xlKd8 zh{@WK?W32b)$z5E10S4Lm-Wab7%^hTv)sKGf3ydLoK|*gShm;iD>V`zOYb{3u1FF~ zLFg1&3J^YTx?0K>La^1cA1ODx=W;k^a|E ze?>dUuL-!vQK&2|e2%$9LCwCt;8mp{<0N1Z9g@`!!iL!;IJYP&OjfjMJT93mG_)8ftCZalVqQ1l}I%yLZGzM)@-{DS1 zqRldu#FK2lbc2${E44=o(O0iPT=+uNe-{%l;;WZy*;`6caR2-Fn#fvS@VOHkJ93_z z<81q=H42LFz(q^X=|e_8$BgRekQ`F@J`A5*@&IyGy6urNMhL=JjOzEEZf8zz} z+~OVwP~|@KlN?RuuYE@J$3TOBzC5dsuN3bw;dCbCj$>zDk0ovAO89{v7 zhH5X?`e{?|6)`@lABMHT0(%7g$c4&Ih(uT?pLFfd@7J`0zCD!_B2kW1*>oa7_Vb_Hf8|8p=6L@DFX+{2WSjPA1KZy4{OnYy=A} zf}*=?#Ax&{NxlOBFv8*}@1Sk-$3;}Ss8z4OZ1tpQUYpkCeAm3vGtR$#{48U54?!(A z@*QzV;M`pZ6FT0W37->@-+b?1RyDVDIBY8Qf4SZR)^T0{2ylx1N8~7tf8Ms+VhS{1 zsto35GYV+O3{>&59)Jnk-3+jZ-s0DStsr)E<-l8tuF0+Fx`?6p8;Y!v!Q%txWK4}}O8pQ$m?elszoR8DL4pP&MDkH*f5Wx`vmQRq=GNMh z9lOH0llU_b+GY=v;fJdN9VHudVYVcrzB>~TUP%4f)5iXOSf@8PZ2a{A`r%Wu^CFq2 zGju7Ydq(pUN=r>gzJsINX^44VGOb-h)Z1U*7rwdfRz&-S%P32&YF=105tld0%EAmK z``fO)jPsHqhF=DLe?QauW^C&`Z`FwuLWBEd8R$N`~-;26z$vwn;>Lp0SCi4HFe|$>H_8Hf^`=7WRruwA3 zildeD#{_u6UkB_4tz)zLu79#Y*bA5)kBBZNR)JR8 zfvg;e3k#@Ae*yQq{jMp)k9h&nvCfgQaEzgQ0$xil&Xnsd>$y#c_=}D11Dbo~*iD3+W8db1KR5!?79|oQ9BwRx z)T2x2Qriu$DV@rg(_gAv<=<|BDP5W{1{+eu^yOK=f6=15dS_|wfye*9K5M206Ep}3 z-ir8)Ms-Ru=MowTLyV=Vh*H_;Vc^1 zr88PHf0i(no&Pdwa=Abxlc-%;mXd%`DUU{_hFKxPCTp49mNy7A%c*c-9NtUqfE^BXiQB=krn2P= zY65D>*=&t~uFN)Jl39Znr-H}kHr4Mn`k<%Ge>)GYtnOe8JlNe~R%JDHJ@%MZl)}7c z0SU;5QQCsIrB@-oSmBJo=nuN18BRlZ8`Hv9$K{(rtY*(gP%{T+LOv3CK+J%5jKBzm zn60jc0Wo@serksV7$=pgG0o9eb}#IDjyWJ-RhvqJK%pKlWF*m0bYbx6<@7efHbp0S ze{Sy@+fY^jb|Y({1XEPKD7N6FIZDq+TRlz+1|lahD16UT5q9wtbqYB7>2~KgyCW$uAPT0U6AgUmB3-a5 zPsp6G9O7%gC9H3Ij8rctKT@P6dcT&Ze|Jl42R6ga#k!>9cL+-^8}emFYR(N<1w}3& z5WP`q6->c31a<9Czp&K&aET_&T{Z`Q17}b&G)!2G zmG9JtN`TmO3T+F>%~&2Tr&vr^;sphD1$Zbps85%a!lRkFuzHXq~ij(PG8LCdx$b$BWsKYyki!jtCFUO?(R?xo1+wk2m zKNdz3#$HEV)lFd;wgecPBowNKq6*>lDXAWMlSrHjXbPz?7+p5p|Homi5}(Tx^Q(@YzidcfaJASS|FJ70w(KjU3+_cJax9yQQZOdG#=Isu z7tLa5jBjl!G;@b=FLc(TCza|Xw@L{Hls2fcR*lpix64^N16+zW7y_>U9Z@dDl<5%F z%oMe~Nkgm!R13e}AExKVZ-QbUG!Yd=eoD9Zz^3g#3bRL4e|0{x9f9poqd$C7nLGcF z>fju}l^WI&IYki|5T0{8n^-tN=?P^U*Tzpasgg6B#~Lz*w-;4lWZExu#0h&TBfF0i z=b)rfOz$@z8hSHyEb3*>#W@GT@0RdXy8`sC!dcqxHI!1anZ*$Qk&rEg$Q|aW)$pnT zpE}vyW#X?!f0s_@ir{pWRjly2(D7TzsQ$J`*T+J&`)Jg5%(cS(vYcLQ?HGz;ibo0W zZk!3fDh|G)!AnK=W5u)Dscnnq#gqG`Hqz9hfILuP!?-7ny|-howC|e}5zuh{lR3aN zk5dIwqF89;ouS%9rYGMWk4?*RmfF$q=*R1%d#wf2f8|6|V7 zB6Wnp*Z_fr$3y%wVU2%P-}y6W{%Py028=S#$HpuubJwsW5|{SOiF1caqDlH-Z|r~F zMv&&Tf^$*!xbG#)YWb#})7cOP3{|5YDrIk2j28ndDZ{*@cL)}Hnlu~DFT*Q6Zj&d#7igeX8#>pnw&e_cBUM7S{4EzLn`NHb|Jd+L%|3d(3F zay+LYJ5U*2IA(dwHpLzh9K-|o)MYBJGQ;1t#$Q(ED2iMT>p}CldYTfvu>ddDSCuDt z2FQNu*icpDMd$_yM>O42*H=;aW6>>^HL-%Vs7vu+37Ira+-W+t5_TcmkZBHa^Z}rt zf3IcS`>+!6*356fq->5y7Ywq^;5~ObA9K8UAjlpGOIdlNN|Wv+TsuLCw7po+l~4Z0 z7)TL2IljTo26f26bBXVcBxDl~^**Z=rV(D($X4usK!`XwQ<8O*jhA9wT-!pUi*wHY z@5W(p7V!eIOvKWXpz=p{*E-Mv|KYP+f7{qVhEOZ@QfzWfZCx0^$XGj=%oSJ^@W}}Y z8ma>S#A80r*KkWi!~CG7e}cbSJtu7(mbp=jqidM*FN4t^oaYIouU*tWW7#I6D; z{qEMPG71(V4#NFm-vcvB*ZljOMDA=)cn&tYJtmL3pQcQ7wao`S>AeE(5?WOG-Y!c0 zA;;#Z@EVaeWP;{eJs~?A`3KOke@02YkLwYP+;Q=9P2i^$!XF_=A)DL`gmrwwL7jrnsQVmUU*U8Q6K^PO%?5A0@~ssTw-nvn#4u*pe@Iq&i+O=< zby+^A=BtQ>4(T+`IDSu#o$#lh3_to6c+yw?LQFqRu_ik#mtD>wVJIM{fa$AJr5f=Z zfT!$4QZak!orqx()8-5=`2UQNf*$)6jp7xyufYe(ovC7WM26eSnZ||P8orUK07XE$ zzli_pZgv+dnOYCMjM379AwEn4CVv>*s=>>YFtK?Jag41_xDzN*1q79x0C+}&QaKin zJGpf-J`nKM)wk5};nbtY-!~MZ$Wv6tNGxx-nVC|IekdAs9i#FjvcH{WlAtSsyN5Te~SO;Y+21H@4>3&qUV zi(9>qZ*vx7Gs2QIGcM`Mntyu8POFVbQgC?0x6i`(1+)AW1#T>1#YY+57R;48-{11U zm~*Hj?iM#a#s&Ruy*S0v%Stqp5suOq@r>?I*wMKaj$k+eQM29ZXW!p4+E;L&I#;*9 zZ2?d&qC8TlL{r6&RJ{-2j%8txw=~JkL9VJ~x^2t@s{2^@FK%|zt$#n`)m86;m3r<{ zUo{V1$J~&Ikg5k2%u#x3yzaPe@aYNjxr%B5`zF``{Nk}qz8_z5Ftq=NXGSl&L|ZsV zEAyef5isBD28$&AdnzK8rUsPHql0RWV_N;sC_9$i)#)i3tlN6E+sA2L`RCRq+yP^= zj6W;yGZdl0%9i+ZIe$bwOX8~8NTTy8<>LQ-9L5S^Go0RbRYPhwaA$Yn<5afm*>$Z4 zepo*Vojwg@aH#)f-dwRDq%NOpH+!c8%L0G* z5+%b4gWtjsiKgk|Ez7fV?P`ZSh8&)Op2_e*=?il)-6}tC?|*nhXhelMY8qWS^R-cs zp-K?cNKkV)BAr3em_hM>zl}^V@AhzlYVc^+pF1z`PS%J#zX~tOF-vQDMgQjz*<%MN zKo6O9D;RCS@qLE()xs=-joyj^aS|gd01=R!gz9)%cpX1HQOi8LWKyKtcqayA%T#O+ zJ>Pltt3aQCvwz|3iPYJQ#O~^z_)S_8>=VbD3&5XgqsWG?e8vDwm7PCD%k`%;<1+EE zXk1Qq)`4S%53h>#wF|6OM7l2r#xg`kn~9kENkZ!ghDSArIt@*OB`(04&|h^P;erZd zCKQNAlERtMXF}DW%aUXD9VKA%>g32oWe$LZ1$poSsDEGU-zek5C`#RnQ(^TYTch~$ zER#BZpy$jHwX4eBOuI;~wbK!t)W0DFDDWsrE!VfX;!?gwWDD`iNLpXdGiR+ofGQ{< zZ{;z~g;28}LlfSJC?sSi_=<_r7B7f=^YlCQp%>~*4UmonT*k(SOxT(jG&jz$m(BkU|e#R z=mJHgFT_fdwYlc|#ccQi1ygc47s?4TUxN_rc7GAaSK%ofMaC|Q6P*)sxhu<;qj`}3 z*K`QlO^LT`FFru5la4&058bw`ZmtSobt^GsV9ji$VWI_)%Kyo(20V}H+$^N#fBlaD zQ}3Jfw3fRgGN9<$n?al^lMJo)k(u?dU3_p?LNv-({Z9?Y0RcL#mm^01Xs?iaAf6vW zdw<*6VG%oYm|GL=;gai`F{XL-V4Da9Ec8f0A|!?_3ZFUhJncOjY1rC%7fI-Cvh341 zWR{|CLm)g#JHuCS=lygx+9{)Cf=m6#4F$74Yq$;v>U6pXIHGKPrv8#^Dqr50=*Ncj z5YmxGO@Yp9H1hIXg|y;C-e}Av42;Bl0GE3-)1);Uec~yw+f#PgC-f|M4t>< z@X3bk(4Q799b(J^l-aJd`t7PMrNEX#%yOAKuA!@=1gwtn#YGs$6B6}4je?2$D00w3 z+;XZI;P$@SZGgp%;db^3DHJ+2zD_$1Mp}?4_=fU9RBI~qI`Cm~#K=0RbeK?O!GA+H z4?Hx7lC)lK#0?RC_rMSySS#NOq`6$u!w0cne!=zkiEXfc04ei@hKCwB<)s{JxQiFV zo%)e3H)rf0VW9Fi)kLU&rCz}mhN$~Lp10y9%k zC*XaXQhIoYId_B%Cm&}Y@qT)HjiGW#N~(N@JJC<%xE-MbkADY;7Gptv zs66saoLCAdWz?buIXY%n*Gu{y;BChsUD}{dZ>b8MSv1G?(|8XqCEM?&U>W6o-89~_ zDui6`)4D=ccsz5Pf@GfPT+~4jBp=g>?9ln(D2ElY+F(p+Hu~^%PLXk!zqomlm&3}! zfXr=wed)SCG>C!P2pEXx| zWCA-_9ikMlTKo{f%fjBiAeo7fJ10Ud|62F3GzRxD0su^NO&;jla}fv|d@N&Ikb5J8 z`1+}qMPwr^Rqmep-SED1)|ht{aD}r@0`~^k=Sr$-3r<_;-Fll8XMYZ9;aWBByQrRY zGHh7Icm(>RZ>*7p5pX?<*a%2uD$F@3x{+_b4hmTbl$o;%x85QT0LV-q9ZWiHS6iww z6ARZ5OL-9pCc0o=O80Q%(nsMn05S(vs@7H;iVOuB?jcVXj;hIPmH7|ox5{@-F6y?h z#8?lS=L}Qw=0=nfjek?=MPEIJX+~5248S;YSvV>ZTpzZ zDL#ObmK1%VBt-fO?mzk~5e2@90LTG2L`qJLPE?Hq7XsGBTu4W2@5 z?5Y2@F34y^{R3kDdjb=UpLZ}a?IlmWNV_Zzd7G)X?476sa@VMS;b`Y}HYM$iyz;Bu z)B)ciFT=zi<_rd$dD)!yr75xQIG?%Ggal*mZIhtOrTy|nr$W^Y--h%FG$0#Z5N*wd zsHGmUmL+6{^nWqGUex}Iyl$QBn>;d}0JV{i)j!d+lyZ^Q8ti{zb$jrg+R z*cB7hXenAo-weK4vx}SyGG2$qH=UG0e2Yw9;&cALM1KKn$W6VE+gEf_Ma*I?-8!!* zX$ee+lADr)nwFwWYp4@PBW}oei(v{<=-d2hG);kcqZjADFjH=f;YA=9ele3xZhuNaRT<knZPxu?I#8}r?zlH+9^%@JqQwAZnVQo@ z%%y}oTm_P=Bdh;|P!>!mDZFuJ+@ahHmc=6vi+?hth9#jyByEXf+1yQbGKgI?qEdgm zkQ!|-^hDB|(w*4HzVDFqPv3E)qm_Z8JJZvaOeyx-eH%LgP!D}9s6E_z`fiL zqoStgWHRLN5_SgB?Bc;a2zPXGo*FJTZSn^q=qVM7knhH#{-%5~;|ic#jUxN{i|$@d zaM;r6XB{L~i?ldHS-kLy3gm2oKvZcAb_K@koiXNaV9$f2z@9O0Zn@{P%JU4}r8S27qn6VPGCFn)`kiO-4gXMghNs=P@=%s|UH%^oMt0mq>_$>6qeEr{=6 zuKSO8MZ8{BGBQX`#vb+#8H3NXL4m$A9ZwlZ7*<%Q{R7?b$~EslnD{klQE+*+>A2)y z(vafDj|+><*dE&=&#o27oqzvvg={x8eAO-g@hC%E&*(h=rLZBYhnshKs{Jerl(=RV z$&dBPL0qKPuhy}?S!%ANwWDjOsFwj{F?@D^4%&u^+JZz{lfB<1xZN7JEE1$-vbwgg zLv>A3BrcK1Pgmpo@_Kw}Jgd2I@J9jzyXtGItulI$R8_<3ICm)2GBVhZXR zv!!#td|LtIP*r}uJG*Jf(J4e#6qwo@1QlATv-Rh#nF!r89cQ$f6ARQ^z@zZJDMms3 z%9E7p2CCvSqMzq;9e=QQ?(WKSPvKYJyTAb`+!tL{=HyyC6Drd$E!xG)7(z_hFie}h z6hd1Fc!N=CFiTi6VDdch?0&P)xe#n?Y#Dyq0P`>tDL9>YD~3`aL|XvbE`|N0zOLwg zMMA&WR$P#21;>Lhlc+>`Nf|aD{)lfBCvBM`j4uxLY-!s$$A4@d#Fk-&;aM;pQ3~x4 zZgQ?n)$vS5gpq?yZ+6jy`?sI6#1YG7&#*M&I1tS2j0AY-)MZ26wV8;VFm6%uIUF}b zm%4^uk@KTFl_^BUK4vYCl$62lkL4POgQG2OqmBt1*X*|hTZ$p(zVpObcwsj zp_?#W<+4$ZM1NGbWxeMdx8|P)FGWS{W;bSaw!o@qTd#;cNLPy!{}+^X_GnUDpbl;P z^?a-}h3+Y_bH~#hTf=a@6k(mkdc{m63)}GWBRel-;bX%tv++Q10J0nMd(G!Afh=jW z#*K$#%-|F}q*a8VW2EcCb%BS>D1UAoiuOa=_A-jCVSkup2hPQ*vA)fT0O&zYz8??o zB3J&mLd=p+CD4GwNYFZMclCxWMExQjag1i15C+E)zT;?KXQK2bvqn7r`H`167_EXm zo0eTPeTrchqE$iofU=-@Cgc+Lg94@0^67G3UIPc%^X;nwdCT6Zs3o&)5t=E1;eg5z z_hSDbWPbxJ$;aD2MNL1^gx$Oq8Z9E~&Z}Qf6K{rG^{^I0#~tj3zGi3Gbq%nP?T0RD z{YqKe13o2d06~WD7VM7AtR=+rZY7qNJ%~y;$S3g*3;Buc zJB+DVI<|AmWi>>(EX^nam_ou(X-FII_(NQDOMi0|F2)J(2wf7JL5`R|l?vOztNt=l3wN|o6QU{hA8MjuaQDLn|c=5 z37uiPtKq4CcVnc($-Eq)=(Il5H;@UubARaxVo#JO6;RRo<=~g|3k>)crbw?JrL8%8 zk>?NB%uT0uNBjBW&L;2u{PswKBCkV;{~lTg7~F*FdAas`9&GIj%mL`Tos*b@A! z@yfm&f)<{pDHrnzlXdq%V&a%37;4)VvVRbwv_&c7)}^9`lFY)l&_aGZ>+4Agk$*ic z4<~)EIR>t~L&J38kyhgtAs{{{GqdcsK#)_b5tbP)JgHZJp5J!?TKf`zwQ7zyK{?VQ zP`#;Fa(HXDvCaziZ$S<7(&ts*$RZ&h&td zYZY6Zy510e&2K&$W2jw0%Hw4^H4LrlqBJJ$qF0~GwAKym{d*Q`+p5VvX+x#V=2!Lg zGlvUSjU5oK8cHtZMNeH!6bJjnsJ<^!Fx0oAt;B2m*2K)|;bh^^!GG1^9=kwh>p$}* z9@{N#u&0@qsJ9H!Gg6^)&Fh6TIS1ViD#L26R0;vccQ}Q+dr5zCUW5p3{4ksw_(3mI4)T-Xw&=-ZF0W zdATD>zJ!6&Z(T4lxAZK7PZQl81JP%>8OV!bvSAEde-cv^EPoj*@yGd#S+cOG&@2JR z5;lv3DAb>@?0{vSB!Cu#CtOtekf=6643!4ymCi&?1(F6Kfp5SGk>Of*Hdg=#dW(N- zx3D>C%ViRzkMa|#DY425MIdHUT+n_p-G7-jT(c4yc6@52=(<$?ziq#K|pLA&we#?E}Z-_uQ6uYWfkLB3FlL-GLEtyVX?r z1--_sbbqXLjo?F9m&5&F$<9TY@ev0N4>;{vGH4)j;vVynB8hBAk{42J9PQv7sD(x) zl`;Vq5KO7~-o1`rh0jVC-&#nSzC z_?1-Vj=4R0n=ot0OXf1r9h87t*J@S5NvIQgw@4JD`3uRnn7(eYeL|&5Akh0GBYMLW zg*cyOK;kx!0UhnQL&B;mv@- z7k?0ZVgE@VJzo<=31C$ezhXm*wiuOE>-Tx@^>RZIayfGNtgNhAKgtPZVN~PZ7BEVn z5uTO$|KDonQ}xT)uNe;Uy?WGVN77IPZ*vhy-y7N?RQ)0<@i>zPY7c|h*X?s>)s5&L zB^BGt58R@4r9F@t;%B~%4O87Nb;^A@_THSfrc5Hdd^G&cK&o8FJ6Aog z>=*f9E9XQc7zs09Ut=|BtZJ|8K;C{9nE}Q!ha~eD)55Z({h~|0(n#HCK>VCaPG>1p zW%kQDG9DAHB-2Og+caqJXreWN0jShv$%+#;gD~O9=FziSFEAEdc`kd=%$hkeY=0&m zvJEY_dN+f|GI#ogNCZ*5xQkZ*lCx!-=rbH0*Lm|9I2+1f`493!(xzYn!lO38H}nx$ zPT4*w#G1hL(F~&*xzn(Ghf?#9 zG$5KBUkeL7LgsAK`iRsnP#Q}F;II-E{1I@plK7X0tmO5a6 z2F`b(c|rRo1tIje686*eZ}=S)p+(hrgp7F`e1n#0b9%oaKpdw`Vg8%jU0hjDpIy>Z z85LGF^WR(!RbznJ+q?eaBgAfFTNRfvTBc`L>Turhb@9PP!M#KU37*zk0zTIV*u5uG z#GYB89xRHEONC}QdU18CV}D}LTFRQI`wzG2{pj$b06Lb<6XjAM}_{eZO%MK%(k zfgX9f9{J73d?#XdGS2cCTi`&v#`UgjirtP6-2Z8&J|E`3Ic-cxoK`54U?DWKz!~8P z;NGiJTwy&==xvlzluWC*;L1_SUVaHLn*+Uw0P(RF)PK?;2M()?V}BaeSRO$%5LAR2 z&B*4A+eq;XQ$tpT7o4~|wV6Xqld3fdiyQ%Nv4qxG61-0#0H05}vys2MiIIAs2LP-2 zA(M(q+0H0W#!QI%3{KAtN-c2aNF70Ek4Qb6CII75IcRK4Jw{|rsaO8cvfNjBqQ=SEY=7eIz?fsEkO?BVbBN3w;x`l$AJjsYh~tG)=-ZBTDYiwuE!}KM zwf^~Gu|?PgG`W|@H?+sJ|L`Fp*=!GBZ!HQ7&S#1}fcMBYlD!VjufYM0b{o>mCLZqv zl?uKs45Pjn2d0Y;_J{+r`(o(QZby4TW*;&*m-0iqHgIa^(0`neYd90l776s&|C(i{ zP}iJAU}2n1`dlNgDx5%aD~oC`COo)3=mjGm(mW>LB`gq|p@Z!nDYAeRwT zs%;>ZHGd_s0)NR?6+yk@o7n=%D+=?vdu5xGA9f@yQRyq)iGE`&Xkm2C>?&1d_m!Bq4&xCq^ROx_<#N(nJ7f76(8pkum;mD-Cb%* zfRIypF`J`#6=&6~>Pj%2xne8$^Z&|x1?V?=)l4}*J?-2=Ps^n^J`B++lnJ}XPjlrH z9ei|m_iC;qA+6-TSePj=oEcb6Bb6w!t{!ZbjD;>!5E%kE&xTjMVbpfN4$3@Ovtcg{*EN}UU^@LvC1KxA zm@u^q`k4O?XzZpT%+g0rgiB>yp|L!Epjafh`p^93Zbx$B`28RCs=-hKk%; zF&C@fj@*i0Eg9{iCWk+RR%kw&;k6WwH;gZU6`s{74hoEGbbIxb%GZpt)zfI2MeBA| zisk_Pwra4p_z%}~2Ge0z3<2&V0=NlHMSp5D(9T@tCO4;eu|jun9zs79^Oaekx}RyT zz<%mumI)GI>(ylf(K$tXE=VpI@B?{LcgiV_dtA-#0VAg)Yhe4btD+>I>5Gs#iCH$9 zj$*bGr*z2Kfp9SJe?HhE5*qRu=CS^noA}X@w5S3vSMy%?l*MB^G!A?Hb=Tb|6Msq% ztXwI0`{)6ht~4_pa@S1!ZIE^H(rlU17ZFN5OcZw3jmH%~3NOlSSJxy}&Nt9^#p}&y z5JMFV@4o?|=&6(t@@Dw3&X6F$Tj#Y^bVIEuB~h=-qttD$UnZ9 z9YIJ4t4XPt#E*tqG+aBEA^c(xc>j8^IW~!jK-I+-8clJk>i9N!APR3c5ih295ijLl z&)Ha@XVi5NJB3FGzI=JCh7SL|junUF>gXIvB#b4hDDA!3sq?(kaDux1UPU%wK%OUtUSvMI!_fKvw`iL%qgr+klURYyWy`adI-U? zl8yEP9wJ>>$5{|m%0-p8zkj@yAEF+0;G+NP*!n;jibFA(i$%ZKU^g6UC7y z!S;SsQY1L(xcph-BJ{q2TZM>k$jsQ61^t!|@ozoW4=wJBQQGwhMSn?QmTGW&y4zZ0 zO7e7km;!Z!oSY(10>apRf?R>M@A{hwbq4a)$63{|V$b>$Wa*LGPA^GrF7d>_X>6Tt z2}sD}+%SJnc1V%s<816{v?rF1Wh<|{jRMGhS!Th0P6@mm{$PVD18ulJ2L6ZbqYqw} zyMgitEgjp>-JFA^t$z&26i{#kgF~fo8RFF<*ccna;C)z}ZMQdQQGfp$N=##XZQeyb zQ(w==J8G`ifiy8}w6XO)coRMfg!;H(rrtErkqX$CNnP|nEwXC{17}Vr15E}>C!1f0 zCKG1ID%wbl{od9qTaWUCzBB&`>p}r-h$FeM0pMes9_dWbA@;D6<6DfZ?P*QVMCx>1(j{! zHh_03ntvNxKu?|faa)otPAyU{-H>lyh&E%CBLs{6AA;)^WUzar!V!D-fKzbT0ycJ_8rtL zW&pHN;C%|N5(LJUFRz`kOpp|1Z1OS>m~)vjW`FEEZt7Hae-3kx561#nCzIosRj1ap zv6v*>FSZe(c7BKFd0$DZMk}0Qu`A?A&va($OVpUPxOP$j>f!;$DVn{mO(kD;Fn))6 zqVC%Bo@7iKsViaxFCv*!N`l6B^i}k5=apJACz*X!8_@qPDEtE*jZIvmAaL=fky@>p z3V&cmAQgQ_eV`|U7>>LMT}$cF8INu)0dSn08n1t3oAwZnJmB#E%zOPv`v8T|i0@s^ z&Cd9@qgajpQSt*+i_4m{Q(I(Yn|nzx!r~wrRQc0OE+uRGCJBqcdD1?xahR~Ou@&BvTbDb4i>FN} zLI+s{tL{&rJS=eG;U>v6AdN5*((q?sd?cL$&PGmzPVu3^nu_kKsaC2Iq<8<0PJg%A ziBDM-qSe91-R=BdA=U;q>Ydy!a5EEyE(?v#yKBv`aG)mL~{3j0OT7fhVfL?36a0FIkSc@u<;iSALNo}RoPJ6{jE`cON(q!j}!@ezHy{zs%W59 z2V>kwMf?RIBMydwPCll{+73Y65r1CiIY83Tf|0V}rK1C>wAs0}9`a1XhR^ICOCDq7 z;tJghh_qjT%V85bTF;-J7sRy8XwU!yiS9FV^ruOBPe02|OA&54GqZw!Q(Uy9)vh#Y zMRc*Ah$vuT2O;IjPLg3AQKRgm$2c?g^c;ZBRD&9(TaI+}%qJh+H{N9tU4J_R#b3fd z7HGRVQli`6&%#PECNd%?qL{%-0EMz$bP{je7&UFdu59R%Mn>Ynxrd`rqLI&?%&RJy zQ0#G1A0po;5lp391LX-6LPmGR&N&_3yW1dE(>>+ra;3`Wh|f7odsO5!2z<(O)^OMvO1?BC*UJ!Y}iqF*`o21|vc zZk5fb1w9m{-6)Ejb(3vBSdIIn&$FYGt&}T%K%ES3VYkV&ZJw7nWqA7m(4`4ujT7>U z&YB*e9RAGf(>A`=IDgP(B?pcOiK@v7#$=a_!IKsZgTd)vrT_6b`?%J zEny(ei5A=q2;*8Qd(d1(qAApyz~WO?dthP8P@KxO?^c`DNxNY54~tCCk%(IBhdjS3 z!bA3}hMzryS&yhkL;9;yAhd-TE$n+QPE59BIubhNhN-xgNPqtJ5Yz5*nUDo!TXQ$Q z#mxvZ1&RTUuR-4%Zy8{m7;t;+yA&d|F?&di7izKm^Vy+o)&~Z~wAT5=$9k32W*~lt zhbnm;8K9zCAc)!iEEgKuI>sEf3R}V+SS%jtOo%9~qhlgjYnOg70M~A-OZRmx92d6j zQV6R-7E`fP4SzIO_xGcSNKZz;FC{Z$xWFUQT)qhl4xerYb}p#S_|pz<9HAl*t+QZfE9UmX~jmAg4MOmw&TAti?A{JPnQ&<<^KJy=&@R zM?jh&V?P)@%sSEo?YhGiqGr_V^__7a7kj6k^Pc;Iiy-#^Q*V0SF)TT>;*|_scdiHw z`caaPJzY8+@iKt#y}qqAFvN)NtJAudf%;y6ju96ehQTWyJ+XvFuO#?2Pga21zI#5S zf*;<4GJi73h`q3amED{d_5Uz&kR~AwjlT4}aulcH;?m$~#JV@dDc%6`FQxNkNU%dP zEvqPvH&R2Y#7FvDl2f#+)^sT@dvspGlP*AgUO7yA`LC>tsF)x<)jE$Lz-k0&y?*EThg$zlXDYQh&Ehz zoEp#DgZG;s3WS%pzXmV3(>j#1EAowyt$%`NU82>>{0~EDh&*1C;i5QIx;Y~!PS1%N zd@1iwVC%+GGeL9+5}x_`*n3`t>8e-xYkxz=welWZ50^4groZQRbsB;(O$(8KoTC+{ z%Th7$aP-acYIALxAxa`uS}Q*$7YZgy*>K{6@Oepa;0N*^W5!#PUrV^M@)-H?zlTd> zeeq{QqtI^6oEAG=)wcbroJ8cuRqX2j%Exg$#eL5ZYl^H_!P=9U=u52&{Etw(pMSs> zsWq03CD{>=&}anhdT@zad2;l48CNZUu1%z#aH$1DSx8)=5%>~>*g=*$P2X*)Q<28v zNX;c7H3a!~c^F92b&jFmTOi>ip%>QgayHZaZW`3$pvGBc5kaBJ0`SpWEUaM-*rw6c z)qNFZeL5IBHHD+vZI>BiyO@`MeUFr5K&TlNVlpU6w9X+vx=?x^At*r^ zSofDpK%ZcmZ)r-raP6oSTLtGHdn8Gtm|ckS@)10UjFUbzR8lBwR>*{17k|Dx66-J} zWS(4=^a*bI7%tQb7|eMmqx&|6Rwvzm7`?bA1|=eGC;qOeec5q62ICCV6Q}^AXCa*7uOnr-K32UL($i@GCckwE^uWJ5A zQhsr9YHVOl7_rw9#`1oe%K>D3wXIoYNa2bnQ|+Ghh^cJuBtJzV9uv8*5{%$ohK>t@ z!Y425$}yNUeo%pxU86->Z`y~op+;E$q2n%x4LO%50%jkSeUch zeNKfR2#bm!7pk!!ihp237h?F;c+K#i_(UwNr}aB9z4QnR4lDn3xv*-i`^`!c5T*n$ zrU;6zCJAAShYX9kVJUBpQDK6a?gQ`4>S*NeAs|O5KuO;vHwDt$Bmu&)fqETEK-M}U zeSOUcz1tgGo<$u0xN95?;iUI}*`KLNkyA+0w}65;QVz&`D1S*&IA(wwW`3*YbmHPH zSmRl^heAKV=Bs=G1`L=VImd#phd^tH#^ZzHg6c8;?-AOgzc(p%@(91##8QdXmnbvF z!wUr=BoX}!h|BpEdo`0O)A&50MsN3BcBMc9sxsswSV~!Yf7W@vzBNTK6x@4i&q7!- zc%;eq=B@ABynj%};nS^5ia@#59po{CA?{o}fp|-@y50c0ITpR`Skk6x+?+|dz}I-i zrD>FazHcU)Aj5#rdxt!blu@BuvggD*r!0RTDh?R;-4ak}&9Y&tB>+zS)A{{w8b|S$ zk70RaY=DLkLSfd+q^5`cVa2{z#=GtrPH=F)|D|e7g?}VIiO83P9UfL>f)WCk?MwVA z^3?!}qie(fU_iwPOXTE4JB1syhxS8O58c~2l?KBPD~r}WY4U&898!!Q&E4^0ah*45 zVv!L+Vb3JU;05h-ha_)%qbRp+(L-VXmP3jv_Du7CMg?|kyU$QkK=Z2RCCrX83QF#POH zOPkAfv4Ys$^UwnD8#b|N>}7Vd zK7S@=fL;`83(TJIsJ=aG$)d~)Pm2TaohDR#az3~?R=!f|_fs@x>Rm%DTYpfY z%gW+huG->{=NrG9N?6$cR_eI>xk6Jv(qKC04*%&3FjKaOKs{q-_df*39_7~P zLNucwx)!?Ft4Lv@xFyBOS2)uXGYu3tu^3V_G!Yak1bi;~=!#{WSA;-S8*D`4(tp_o z-0omhRQSjDxHdq z?B-r4+T8Cb%*o~sTEJNwg7)!$m35DYU)2q%MTi1hOky_d7G~Sy=H5GBT%5EA6Rlnf z`v~;VCH3=Xp%#uvJMnscU*YK7PJV^G<2)qOkcNm_gB_$W| zIOm|;-G?t^P}?~1pqRm80Ju#Rp!4|qjXVp=_*Piv(SjmszZ|A7%xL&;^N(j1M|Fq! zfTZbL_If$dmXH!(WrZ2~;OPm_UAA<|ib!%p(^sl?Dd}q(*J~yk4y3_6%t*E>-x^s{mG>D30z*pXOuUHs2HO89jNq&AM0| zq__AF25AZ9g@N6cuDcH2IN0hUWSAtcc^5sd0Y59`3{TI<@3?#2(R==PzEQx*FBfeJ;iisr5*wo1uh)Rnv zVdblkA3p~N#9ryaNUr`xi@5?Wl7|L~*b0g}Dx7;2mLl22Mt1lb8nF{bIrgGXtWEsBKBm|KA>%qs6~1 zKTxb=6{5Dlz@k=63Ur4vWdfzZAwQ5cc&vL@p0w7Pet%h)IM`}$!2uytFZ$s7xsaT_ zOj1NT8tj%P0WOzcw~mO|G1n~M-JWLoe~N`&(zsqk=hFX-q~d}n+FouQv{+hsEoI{7 z|HRoz=Yhm}=Oy2W1r2!ufHV(c6x)6B@a}Ba^HU0h_Acs{_Z9fbNvTeG@WsYkHfSIF z2jr88Xn%H@iq*H+_R@+Ft7=rh4>@1L_rS$n4WGFGk8=<-Z!>w9Sjp;viVi}V7eh9a5V=q ze`2e9u4#jvx&=ZMOFRwvfFDaI)t>1Kbe)aj0Sr{X zvwx)6?L4<59LYlNt1mmKw^z=PH57Q7M`9=hYyjzKn_X*c&60L7IEDTAC1aC?t?u{~ z>$2R%{~T{VSnya1SxL*lx3*@?<~?|vYmHrwTYY?*&@p$*J!do_k9-}U^l~;nJhO@< zCM7eF`5dC@ibECn1}8fI81y5Dh@rP>Mt|=76_5(%bEoxES0D-XLPQae#@}E0QR?pG zioTl%c^+RJjBarx?^w7!qM{aL}gAeM3X`Ky$JDd2;TM}VOk0Iq&R$qG5N0h#a(L$il-hYoO znj6X1hO1FSQn?ck7YLt163l~Sn&wM_&*}Auu_V#7J2LfMs?@%gN&L)*A$Evf)FzX0 z*4d7S39h4`rUL+;{0Y{z*M$0q8DPxt7K!n|d|eSfmDaVB2mQwEtlC}`V3sSh%reHp z#;V0#8!87K@2!8771T?%`nqfr<$q2CV8(oZw+?GlP#^S3hC4H&#-Lk?S`8n$uSzYe zTy-0NDXH@UZxV(#AxVF^d;KS$2^Y+(@Nn#;TBhT&r$!A)VL_2Ie-L~le$04okMW%9 zU<@F7g4!Cs^d7N%BZQ}TMC8iGEGg1bd*@HFZe~Grd@|F2K-OC8TD1;Qzkhhfrp{^u z#LM0Sm9^DtY@T=dR__;m0=wHzA}m2HV{&N7`b(j;uBVIA2R4K6g^BZYJnfG@5mT9} zGr9+nkUwV-X~>SBdVc=R;D|HVW59_?jEl+J;>F-)ueM_IYhkxg~kdE1rjj&WmZm?Y^5;1 z;c5%K);zS!gBT!ILnYlOk*5ykK)g4S!xGVZ(u$~sEIp#V`26t=!{iK1sHSqx1Df-l zyLv%ca+gpJB<7?!5zT=$SVh#f-PI+o-iVZCpjK7FC*(2KHn--UAb&FBwLHOo9$M2C zLLX3S)W0XTko0@H!>+b!d&cY?ver^-2&G&7JIa zB5%QpBDOV!s2z@GS+@focW1BMKu^60TW4YI7A~tG{sF^1n?ptYQO^T5Cc_o{ps`Lh z%RbM*pt{HY_OZVZL4V&C<|aGn;4Ik2%AsPKZP0kGkx}lb=% z1IRM3HLEwEIK+sRjuZ<6ENa&o&C}y=+%wbqE(CkiV4>9vNN7F5OGXDz;dpW+FVix-M}IO~=*#$pSElQ`!pZf( z`i*m4c&+IRR>i_45xu?e{c#gKK&EjxmPRxq0XNoQA&Uj)iB+rgLC^x@6JG>TEvzq% z))stS?ql(cfFfS+-&a(-1jPqQL#zYj`AOF@2eOY z_P=!Xtl6AT%{_bwZs6%r#KyPsQy!oBBib}=x-9brjR-;-6#(>1`DeQ?I0jKAzo<$p zaeJ4S%6~r8+y-OT!l}J+L-3tmZc0R(!wm94#hNWarpLGcGSxn$kp-6p+CLcx7lCqW zTdg7ELG7X}JKqk4-5tF_#dN)S&Yv#r{Iy$^M^$A=`9*k!$&X|J3z!pW*Pa$P-q!qb z+5V2f{HqguZOL#`$EPp>}|MFWQ4-=hWO^{H7Iac{lF)YrO zrPq0S`6B~%UHXNMsjrus$kUd-TTkrf>{skIDOD6hfOromgdiej&$TYqF+Lf^UxYXU zK?s&UIlc473h}(9qqyCeY3#{AqEvO^XjEM&GZ#E0#G!X^M&yZiF)(H~uVjDOpTs1kse4|1EKAOvhZ(O-lX!;2P`FTHMu zYhDKeIF?&f=MjZi=nA@V{{g^Iq$U7QK(N2JI8@qV_LqVzw;fsB{ zgbcWSVN}p+s4=5MW9SQ!q9AAYhe~s3*7AQ;-4W(APdlW>7yUxlvQ>PMv-N{lNcYad z(EiQfwd$i;xDq#p?vQN`d?^N??Cw|AQL=y{DdczIAB7{601c;1s2}*2?`z-c9q&bJ zFP;T#-$tXI7I;uDH&l&s241Q$aM-L;a?WG1M1SF`4~y=Lolk5)+tRGJsvC&3BxQ%9?(-y24-(Wrwm3mHx z9S#?F^1W>8&QFGEr2yUK9AWUPm&O+`#;opFEnXOsy+2*dtLx&}^k{T+5>Q>!wRWdW zTH6t6k~dPXesAB4*0435k~!bD)Bk@TW`uX3|zR?)~JM-i0sbLF9MQqpFatLAYzSqZ64#_4>1KdNi6+9;3%6EujQ(aq z!wls_va;5_HLrsrMY3-CLc%Yx;1P(J*9=e)pIQF^>eNk6wF_+^#_C$J!$oB#t4mEe z^LZX`iFQ|74ypxGuUd}yd!}g zbu=88nlrX3*eR_Bg7+tijgWt>i0r!NF-)zf>aB)pH%t?#v0Xz7|9aM~_8vUEN|;n% z9e3?H;^)fLMn$1jpTeLIMIZ%Hn+gixKQ)8U4{Ao=D;*F}#F?Y0cfol50`GrgnO1V; zo&b!U;BUv@uYidH711Ykis85%I*Qc{QzR;w_H=;z#8CZZG6ybG(<38Jq$os-$`VpaSJ@>M_E0-nqo!Q>E45#{TmW9`_r4f6cm`G8I; z5D7c*%f*e4H!d@o2A<&!Ar9jf#haz>M4KmW<4_=ElISH$f^_m(WRo8x2PVL&ipHHE zajLzM;NOpi7OW$*?hk@y2WgskrD({6f^#mvP6s?a2^QXQ!UKQ3-i7E@VgVsV?ClVL zQx#q&pb5-;wNSx(1g%!dxQU)5U55SZyGEpW#CxV^mbf>*L%a!vD&5MBo zp9}G$GMM#J3rBx1nLE4_LwAFwiTloC$h5tS-WgBURAQk znvAz_Bq2FRG?HwnoY6~Jzw%A3!Or_t)<8ot8Fp)47_dk3)zz*f`k-`gpk{jZIDm7?p{XoZ6&U z-n7y;!(y>u6*|j4hF{d|RY1;Mnq$phU#un0NF;wNZ)D7eaJNw$Rt$Aqt&nD0pJQt4uAN zWxIxB%szXkw-q>5(GqF@wJI5U&v+oBY|RU<7E73(ey;2{g%8N}#g>Xm&JB1uW4lZw z&e(rh>_tRp3ggvW0qW?*X*09M-z%a&$Z^04LCYTLEWRfsqkhg zn{J$YHo&GhdCJ3TC-Hyx#-u8)GqIe{!nA)y3E--7UPWx}YXd838MfLG_M3L>qZfcjK`TWFeLGQ|&u3V%23Uq7tE z&&rc6x@;}<(gP4PMIq$|o`1S00mXBT&jBq*PmSj(%Je-YX0*mCEDWP+Ug+TY9*cj8 z&rAVKs$K8X@d2);Xq%R_(u3hIY>PHcJ|4AP zmDGk9KF{A|=~qx1k@9{5iz|+|3-Nz!u#5JF)~@RXKk;f8J2HT^u~|X6PO%;AeW26L z$=TxLQ+jroa;`(#s&;yqx{ze6#?4*X?kr0u5iM4&0?Ft!nIfA1q#w4)f1tO6)cxBC zY&q6psvu#HP#j@48}^=0Vp<&zhq?pl$JtMF;Z=U!nr@>RYoI# zosgByFkqrcEs7`mA)Ly0iY(PW-IXcoG)AgMEIJt0sec=q$P)Zg8#IbdOEJ)a99+Zy# zP&Ik(MmVzg7KJxT#MVaQ8v!g|+WgZJ2Rk_P9=D-&18SM?DtyW$2dk;rPKxG&AUOqe z3tJl_Bl;j~N&hK_!TW=k7Ur@dx+fM8NW@&`IV4lT0*_I@cIv$P9IAh+ZfkIQ==U79 zZPxa$!~wAA15E^H%)n9eZK%$97P}&&YdCo2P@#(7i#E@8&{BHd-Z6Z29p4`%$ZE9L z+!Nd?`)=a{Mj-7cIW=#>rYOTzTMo`efZGO0@H9;66LMsjT_axTGA}U|jn$4dyvSz@ zfR^MxO(#p<3RiThuqc1jGMW4oY2G4S6E4+Kep>BihCdH~NhsM3Grsf3LThd%~u<=PN9 zUB&EO3A7RC9VmWQQ9k&)U>KMcR89FTlzVU}%8jG9e-#%D`X#~tyk*Reivu#>#QUpv zAj|{N$Pq>OK(uQpN@60uK8&lp5`tSf+4n_n0Om(u+KF^R-7z}`9|u--0W_D4l)(Lc z49I-?2oV!t|1f_J%23g_4zSEpXk%+51>Pf0lQ@Vejw63EHw)0ZTQDvpcCP+W$ z<*(@qx~2)~P-Fq>q=!^dQ0En!;HF6HR^+-HuH?~+lm|3VQ5eI^=sa7&tasFtC9~kn zntt*w?{3V_g!2L4PDL<)HOD@%QfDwfiJ)yDtoZQ@U!|oG?VU#!--3e*<=r-sHR#XA zrkQC+r|Ey*FePa)eps!M;LdzJ=7yaBSaRASZuI-0!jGAhI4A>WBmHr`h#~+xen4$< zfO!?oY#XwdaQ|_L|cXW`<;u|s0aNlXSy@3GlyqutTMsnHgG!ZT&KO14KrdE z^(}vpFzu{0Q`k(0>)85PPs{RIG0}8G{t3?rwQgYf?*QRR3MpVH!fZL0b~;ys2P-jDMXF-{Xbm4v2WRfXZ zdQ6AffqbJr;Hybov4b2^u~ql5sgibiiR&b_|6iFk^XOP|CQuhI3JX=7&&<{Jf$Ksz z_Be&Aii^d|a+;|J=S07)`C`YA`oA;apuNrx1nB7RzPJ0N(deri{){0Ibc%fo9^QWw z4VW;QtcaKpyO2Rk+YWOJa(n99`x3KfRV_RYF%3;s%>I`)w8I(@_Q<34Nc&isPzvtNtz(Y*c8b{xM5FVX#*n=jvU>t6su{5B$DwGZ~XRS>H)$1VlM_6!s` zTX>%dG^`Pm$-droJEGd>{ZLHZNK=0syO0hegq2WU`%J%fmKEA3o^;8|-wd6huqP#x z-eM#rmZP1w@kDql0=joI!*u%r=KQ}gqBgGS%!t2L?RP!2C0gA@hkTP#5dRFLzYW~l z3yN#^9wlO!B!`v9+Ho(lrgL9y?f|>{@`XX#W12@{t`%HS3Vo8hWm89ECRTq2b?{aF zM|i$R#-5i*pY^49AIFsG6{R{**AQf#?gu_M4xB4CUL~?!c*EVTwP5}srFgt)pVUb_ zeEwRD+$Q#iSN5V;s%1RsTd)^1WHruX_@exBaUiTx=6pLSDVhbMKp(;d5Mx@y3n*4} zN9*hYaaXD*0bB;P;MW9-%)5U8)b+a9Hhq0?{nCT6D-$@(O9|%8D%RAGF(29@_@V?1 z8_JPS89JojY93>F6o!ytrXdUk(Or`OxPwkonewR^h<(g3Hnm2*53c6Rb_eLY^tF@> zuy(HgwX8|^NM26q|V@`*QSjPIQ`Nkp#z)UMi(5O;wT7Q2?sAV=KL?jQ{ zZ9xDI{jVFUB{GLOU`!NJm0e$ za(OEA#ZDlh^Bl4xk!dDu1vY_3>+h9zkR2FDT%31%T%&$8AMXNb&7uJG*92uBZF>xu z$||r>Y6M$Tmc$KtgQpgIkwmiSYcmk(0|bs!%di_zM`?`@`+$G$lvoAHQ=)1_kgzno zKU|Xx9zViN&``qVh-rMm7gHZ~ORm91S_@{%#XJv;d|CH2CRVjwOZCfwzHVo4#mW5)UnNS zWuK?vhF3oJCn%Wt<=UGtJ0LHp&8CgMP}HLT*x&$4#Ew+z;W>tS>hl!qhit83!PNLn zm3H@nJ!lJAX`)sTC&&LHRVXOIQtT&G3&JL3hkB3Q_XK~y&ZA*|*5L3}cO4oAo#Xdy zXn%IILlZe86(K?W*PI@onK^0kn#`bM^p0vjy7GA|ev@02=Rlyc_QX&+tP*u_HPp9{ z7F?2|bUv9Sae0<9^+97h4 zQ~vlX=bC{OmG#NV$$+Brrc1EG_j>Q4nb^_*>wKi38-AcIFu%q9k$GZMPiNuHrEC@x zX^EQsKVl{P=JgGg;~h`&qqZ%p8*7(Vg{z4VM|6fFG(>2fke(PIM@5l%STl z)UTzj35hGNJe-k8#%{uM+WWEZ>(`}Y+7cKRqsKBqDo1lauSA;hI1c4H^yu4ggGw3X zF@ctx%@0xi1wXbLXpU*UrUPn|VmKzQIZRD5u`mY5uA+_47*u<>dsQB!yDgw12M@lc ztb%_K6P3@GVrPjAmV-pc4b!`8t_aI1P8-^UToiQN7uY1@my%iT{Orz0eG8L=^n-#?TQAR>O{&S;dRsvGbm3o2KMFQ#x&rgq?gq(cl3O*1Tj~+vJUHQs?CwB8i@{~qj}Hpm0y`zwF;%POsjIl&|R`3T)_K3^;)fWD@MRT5bD z?(2p#s}V?92S_H1rp=@CJL@6dh0U9)@|U!G?ZoYJeh?}It;wwN&B>R`mAy{T`DjaU zkNMQ`9OOh=8x*^9)B9$&GWY`arE7;eW>fLkaB30)E9}D(f{96(%4`(k)PnllKi_}6 zrW5YT%6c@!^GC#h1Fzi`BNl+!Meijc+^F_BEj9->)oslmMQL-Jmq`-;}zkzmt@pC zOCBS7s!6(D0nrT5o}mnn&E|&75S1!PmvhHdit_xBBN!S|1M@<|w7u8?7}_dQVub%w zMY#L{sDjKN)$)Ns58$`G(%)a9gsk~>rBUsQB?kr z^Z_dGHa!{9tAbWdrJz;FH!Uq^w>6&9<%iV_j3quS9_g1UQ7MP2fdwQ){9TRqG$PoO z)wYOf5Jd{}NU12gGMWM&^QV6&@;M{xULLfl#wCIr3K3$(oXtUFu3{p;fR2ppnTmJd z!oiZ~p-}uzSxCvYF<&L_OGG%duE2sv32h{Dw8`_zUT>nBD91Az%d)fsB5ZPZywlny z`6rAWyLVwkz`~>%aL35hfr30mIMJ!tVRLkf{d$!hD;ru(eqQVx*NlGzEH{oH`$PAs z93LbLNaB^}+Mgnn*#TV80gD@K7uGOwOgjW}>MFC&r+i>!UZ;oV@QerAvdS3rqmpWQ zcQGlxkvK10H$j&QH)}(F@n7Nr2k%GD%6*Nwww{l}0$a@Yl?qjEnJ_Uth`P_G%Rwp^ z`P)`#9MViwbnFT6^iO|5Z0yO3kB@85A?h7pkoZs>`hMg1nf){`Wd!Ik%AcfCA*E7{Ks}PhZxpH&%cayv< zAaa*sA99`iR#T8yK2=$&1TVbXj>e$B9v|%rli@D2j&*+nFC}!F`vV~X08eTkhM^YR^m=50@vp#2NBJ#%l_!wB7F zOX4sA8|i+T5ztn}(q-913uvSkHR<%z&N@!*r#dV#9edsPa;QFv>8I9z*#SMS123s7 z3NZiz!jyk^PhiU@Fi}M`q<1ZU`SC(P&ib8$eBgRFe+3APOb4jhLhv%IRbd&bRG z_W#dPBby^YxK7XOQ`1GyK=q|0$_t}pH=>@KBBp;OLdrI?Y_Xh$2#4XgNa^!vJeQII zAjQ=2Ehi%MJ3aP&h}u-E*p5ml4)Ypi5<9OX9Sz_M!zGT0FRm@=npan_7-gA!G)9>a z@Ao)_7sw%f8f2l@V7#DTdlV@k-vL`!yI_$DR|ub;jjoBvXWGzRX&sVKpLe@agtInR zzQ}(qIn-OYkd+O9ALRF(mYBCxw@|E?(RLwMm4Y51CeuqBh-+EG;m=6(BeP)!teAQR znHl9Tp}(Z*&nJv0#dZux8k5TX0#);(#IL6o&r(wVfBN^FZb%)Rv$jNg|x{nB6encN{}a)e3O z!P%kE+;%EqQ=;0k6|pL-J1^c~6DZQ9Zdl$X7Lt2@SLM0}2@dd?FwOqimF1k3RVsGg8f6%XI5vPAS&5wIUXaO#|P(Vg6&!>9N;B~V%_hASIsVRpK zDTP-nfZZYhu>PU-{+j*2S5(g>aGo5~Pdd~HP5JUOkT<<)o*c;oHmmCTRazP-C)+77 zK|BO3${lG%$qixVGpCUDiT&n^io;%4pQt(rsiI`ku%p_lTxS)IY8qU6;puwmJptRmQG#&7`{^@Qfo$jAVTdTBFRXv0!797FN&IV`vnZ!~}mX8`if)DEcm%CINu3y1|9U%p82qVv8{c>y!*IdV|1>#; zHL^I3m3pCTvpTJC*3K;L0jCmoz@NF?mgFJTgm}V_nd7rZvx0vJ_=uFV4t+P`wPcUP zq;!vcT?XjwNs?I+74QwLkS9rls3-1&lQvS`us|Xz7%H%QU*g*4j$sPxTfG~4*61ao zjWi@%DtiJ@rCW-a=P@Kn3p4emD)J6yZKJM~pLD=V+LGa+1@p7PeiiY7K3_0cQ1Er_ ze|!7z>t%E`8JT}vxyXIn-*S#w49=`|67xEJP;YS!Mh;h$6Nx>Yrl!6!X~)II^hY+J zC#Yo|gH&bgt{#qo0^zi*k24|q_rN!=8s9shKjVTU7>5-g>4DT*rD(p5Q8-<>VA>0h zz+&-rIMa;>Oo@$;9EO=4dPG_#2CZ0cXTqU@_emzQd)a@(GKn#+IqxhrbTrSg@R(sl z(`bdAYR~54{_GXg7>ueaojLhahhinoLRZ1&Lm@^iW9v56fSyQVRD?96f~KRkS`=V* zWKA3d;Uy8e@z0(8cL$upgQlmmV_~8=9UovpR%L^!G=e>xr_HPQfy8i?9Qu!jqfWal zen+L+Vzz%WoJRV7$Ds@htGms6F#q%P$k^ITGD$C7pz$6%wh1Whfl1LJ`}9(`$n0u6 zwOXd`Ax%NP3ZCsd8awb<`Z6p!TcN-!ejV{JhHci@u+Ki3yk^+vUA!O&G1=!699tn> z%A1q8-&in=y$UZil=8h59oRr3mQ6_c)FB7*Dyx6#t(nUZUfjTUn&~bu>dj$;_j#w9 z5@^>F^*v-KcxZqLP zt=5i|Mn9Xg7yN~VJ~7azHL&@9vwkuV195bzXP%_zTvkv#l9`v{HNm)2=JmQ@dD>*QW-3j0Cm5f1ZQR~-;VB(&d6@7Z2W7!&}=JI_vG(Y{gwi=tHp(X=7DG**=Bd3|0ASvCL1 z;-jSWAm38VptZO3t^oVM+S|ATcv}H-yfj^%cK-%cmoX`s@6t7 z#8HKgWXTS+)*jCA=Q3r=WK0yD^{W?vPs>g$!j(;zvS!&n-!Hy073aieGj{Nnh&R`$uRy9lwq@DGj|Jux;vX<~Xg=@EptN*2UP0QZ;E9?0UuP=Y1cfz8$ zhU{b8#=lVJ<&>BSeMTG_oS6)Y($KZl5krLk`CJ~4KgYI7u~{AT(Xd@75OiALN#+r$ zFr0ltd{1L1zma~59B1RdAF+fX7b-RZL^0j1G3#qVHIiK>>gG2aKtD}2{jFUF>1D?& zb2sRsBn{D3>F! zz!QOSY*^*`C3ULxdwKjX^6L_^v@&Hd&1S3%65rP6-OOJZF3BtUwkFRL^yahrHl^A| zalm-5#U{UXf0_VNZz2|ajmZjg^E0$rTe^12=OY3-#HjT4%f02lo?3tPl-g}vo+RP-8@c7maE#fE zlk>%6h}#t-ihM;EAI*Oehoc=6VZ-x5P&gZ0$Jq=n4WgZ|8bswAU-*Uyp9(b80!5-h zR@^xixq1gjV{_NY5Jh0S{}Z zeiwsf$LAwA*e3QMs{Y+b(K3dOq3hejcgLxL47ZDXeDkvOE-`-rDi-`NM79WG-&X5! z7(lkeN`utv+=7}jU=6r%@9P+b2&~{Z1kDD=aCDftKJVKPqy4*lVwedP*jzjUNz4$3vB?cQC4?2l^{j zpJh6G6|i_V++u$=``Lp>m$=W_0PKHpwbZ>(ML(VCfLgsdFrZMoCG#8b!=eC#SDKkO zW7|tip*NBY?zdLX2mG8h(t<&se_JzqJc+Z5S!aNlv%#b~;mTO6KPus2XKUI+XZA%; zo<5mJp3hzJmcr_aIO9##0v3D;zJ+LJaKvS{75R=41QLI;E#7XN5lE5M2Dc1Pk!>Q4 zXmr3ROaI5R-!4LZ%iuofnxzRQBn>6LpX~8`jT^jnJGi`rw@K*wo%|kyDJ)erDAvWwSo{No!5FEE`~rEy^5sNiX0dS(ow zp?Z&cBy$nm+i`!S)EI_yhIa;QgDftqaH`QV`GXzk zyANx;s33Y)2w-Fp&sXpupw4C_E6EFq819Cyo42&JJH%!JH2=iz!miDW4~t-!ntT_N z?F-d*O`go&@hQqr3WZt&p|yGm+mWdwo^3y>c+|XGWrb|0+$G|58(|$F3ah2bH2P;W z$;*G^LikdP1hC+;%`m(=w^HF<=kRHbx#VmyiDec$2@v^;>n3qm@zq&A8Wg_g3vG7C z|JdIU?UAY2Sq*gc+pG~gIS#cJsS%x}Qp5>)6&nThiu*so)Gka%BZu%zEH6;WFC@wC!9g*of(IrV;cDkrcTw+lkkr64w zBUqpaWpiwbS=Y1;2Ra7_jR}>#&re;#rY85XE&J8=W^P#B|x&MHb z#1@!dE3DABgkKOR| z2sN&^4FPe$)EP9;_f|DJ&sBw%yUBr#G8Db9@(ujVsBH_G~s`;nT-RzWAr?_A&;Oy_M3na{muK((l>1 z1M5S`GZELL>-zslBx0jEgu50YB|<YF0)TLI@ryL)<}?rH6|4pl za-9jmn-j0N9fW@mA0?U8m$YXs#14>+mbURaES?8_4;{7X zPKn>|H42PL}}H@SPmVjGH%*aW+U>=&DtY{CE_;Kj&+cV~ zh*6mY&8&ZbHK)ZEY4LXyQBavkv31(Zdo{+0@Xc(qO%`v0EdEN{U=@NK^)tA9WX#We zg!9D+u;8GIY;V!N6iklbE)3lYnSVot36>F;c>ONY-Htek z)KM}zowx>EPWg-wn$Ef{X}$>7{8hAlhtxULbN7Es9YgU-`KK7Csi<4*yqpMf6lzK4 znn)g|>pMSin8@ajw=d&L)tB?Qnvir|E72(cF6$xvXif=#=0boXpD0=z^v=&S+o#Sp z5&XVPyFElgCuR*XRW;_(asP~~Z!4J3C{>~qty5em8IvmrfUvLE4= z_>@wbv5~ALDbZiKkSP43k=}fxVr3aK42EsNO`X1;LU=mI#^}Y5bxs*hGc{lgjX)is z>JY5e^*(Htmgrm{shgoC*vvi&ueNi(#xRnTh4pumxu1p?>Y%5=`x4!U-Y%t;@*H{?dDDN;GB2}qxMiObq z;xmc{UtoTNA@Uar#DK?Dm%n9vYSMqaRA22`jv_GWoM>R+piw2*6&~WCg{=QaKiKC0 zRyUj&>F|)Xo%n9{F>9VfH$ZzK{WM~f({fV8ZC6V;)k5MitUUwhralk9 zBH!gSr;pRTniDBn#Ei6vHDDipoju~>IC0Y|Aly@1pLe^^-=cumzhbOFmPNt+#z{~C6pCwAJRmeyb&AC+Qs zuhyj){od~`WP`1nfA+XxDUvzGnxsBCmE1c*3%M9`-$q2rFWi?@%Z|r^q=AVth0+K7 zP4Ja#so8i8z<80+WopG`VyGhh;0V35K zJ@M=W_dlvWp`PWaqvnuu%B%Pe9V*TS?P3#FH0AfXn&=cx(A=O+Zj67-F52|d%k{vHeXqW(Nm=x_RO)o6pe9e^V}R&3!gq(%Y2WXZ+8ORa05`i6S%*Q z7{gSrncSADie(}|&N78sPk?LFe^hTvpSMdXU{q`!zc@VzMytPd>K2g;@#wf7tZ?1A zynRUiM<7_A`4Zg~?52M>k%U-Z7$Mv;XJSilPIlLn(1x>v59l2|J7|1Bm%T(N3aMG$ z$p3zI3|TqGyeXb}Y&q2B`&4a=%+C)5a0TO3lq=bAZ7X&vp3xC9hS;tdV;b&+{=b@H zi8r|mJPhzlGK@=1@4kv1bWO`Z1d7#!UPeimQ|5cw1V z$2xkh=RRq_f{zH=a}6Pu1WGNu)^iItTrL_}yNz%N+~<5xk3}6j zXs2-QC8m*nLJefO^wuBjt6$oaNVcJkx}C_ufW-N{hLn4S+=tXEaP&eev$D-Zz)8Bv z)<^oY)ZB9}v|WF_eve*n*mnzQ2k;nVKw$Vp1h^wx!BZC^weu|%N>OOjphJ=UsLd(7 z(Ch^}43XQoV!^&7k$z{`M&hC3)wlTjh2_(@Mf4x)Uj*Cy7X+HQMM9E{G9ME>x3THE z0q+JlEb`C*eGkkaM0Xz983iF$0ma9A7K{VB8iuc;)S`bz|5|zD=|#)y+XaZO@vPg~ zjdsp4vr`+&DKNAIHl6XZe0Sf?V-w-sDiv1VM$j-^SLjRkew7J`0ClnS&c^QMLbK+d z)eY=_uMVsrqM2x7G@tG}y)#3Hjc*Lg0pze)@^^R204mpT-b@NfO%(B~ zL09>qOHzNrsT$Z2p-Z z)F^%~J-&|#yy&skhEw~I{3A7z*_Pp|f;SF=K#63|O{5?>D)YrdCPhuB6o-k|h1=^n z?E#Z5k{n{=z#@ao2NKN}t_~K@CM+dMtpDNLye@xk!{NrKaoT|0U=5I^l{6VyWW3g9 zPVgX6rw-{gaEEppq_t-o@tTl&h2HZQdP$)#y4s3cN~ZC*cjfRDK1(DFs?Pq3G4zj?)IP_Li*chCdWNRG!>@=3H2*h*$x!eDmh(^ zjuwABkU>j;&nKYA7%T&|(I1^Q@z4BvX`aCyS8JOLkK~P0X zMX@{>aaFMb(oCSaslk-qS&O0r1E0peFqg7(olSzX-?v$o#K8_T^l!8taq$xYFvE4S zy(7}R05>*cedn46Ltx7t@Y~i!UM>3jO89?h53^4gDDIKY(Ik;$NW&wudFK1~WRy}0 z+{F}WNXlfu@@_P7tzfvsxCgt}WU_ldl3 zzU72*MXS+2wC?V^A?7O#4?Wr=cn1;H+w?EH9}enWA*P-4H{YofEKvRFj z2AyTjEyqfxtvs1QO`Z#izr!&>yV)r&Ap8NsPrW6EmWF9nczBjJ6}2CQ z$^I})V{Fx!0I_2yFOg+yPtDV5{S1GMBAnBsQtxpcwht#$3K)9DOYz7%YNQ!OnZ;*~ z%qw6dpb(E%AD&=XYF1=*;?JhW)0^RT}4qA+lttb9?2St2vZ(Zo$ND%%PwPghXY(H>%sz&J5;_f5~JcjC}Z_&^-RVLv@D zuq?UU!!n>zQO_F~4EyAVw_!QC0TAJn3kheg0ALxf8>G@%dubeyWXctP*Qha_q_SJU z29&2l-pdPEU(Jr}ud%$xt2cjqfY#l*9jDxRHp9$UJ8tgDy7KR&%_JETtfHX8Gn4{? z?(-=IpP9;m<5_=?)A+IWYQ1FgY3-R%&rIbIFGP=6CRkj1coJCVbpnX~p)g&hL3l0Qxu3PwaS(lO%czrFxen&JBNFXN~{u>;3x5 zN*A)|+h}SorrP4pWOvDMv1_5?(eqk+D$L+6+B(K-^Zoql$KM5|0>ba7!n-Pk(tgL* z%Zajlm3)8Ol9PCl2)07fSDEE(sX=;&vW@s*r$VxC;BALd(x{JB|HwdVv;@Wt`9D$~ zDSKPH+2I-Z0YP81>qLKpV)3+CYMZIDkCKYe?fQRwjzn}suz@SKO+pwXp>0oHokUqe z#jqAPg^Ezk@0y}WCUr~$*s_n`!v!ZeY)HQg%G)5weo>b-Q99DGcL!lKemn86X%oUC zTWRBKkMj#-MuQNZ8yJ3ML04CeY~(EMY17b zxv+K7PMBw(3EZ-{Wi&bLOr*P@b=ntySMJK(A}5XUc&JOSNguotw?OaT^#LK~I;V`R z{2T_l<1)PyeR|Ce#as5~-(z6(krs@N=b>S?na#9aAKicZi#8{INR7k2e%$u#6$pZ! zS4S2H+jjJ4jJc?X@sO(Obhwb1%mo%~7qypz-Hj6eRxZ36MG=2wQb-Wr?3oFB(y~$t zWCYqbo2}su5H1#etjiD`Y|#4HyGS_McO`*1FbBpRzWt^1*Gk%%>X4{ffG{}y8c&Bc zN~})05$JzbzZ_kqA3(UM$IC`N84_4L!ndxL^yZhUB<>u%*|Y417<8J86<^;TL7}FD z6{GB&U@_KmzYje{nHv*k(NV$P-6OOIVPIS`U_r@h>9va6(wgs*LQx$SO#cfn7v=jH zru&zB4frku4XKdij%l;|^U(X4Q66pVd61RQ^34J@4|Y|m?B4O)p|U@|k7HbmeQ zZPA`1b7!vKK?o1UXlJrEom*Mie*|XnC0U7IdvEf|#(98{-cA4N5fZ%d5hA3XCi@s< z+5}cJ^39E6l3z&Jy2nK-g*db-M7y>M6plj?e~(dI9j9$f^I932L~~^IfQ~*1#f3xkxo83B zCfCZ3T{r$Rn`s`(hZ6^=Fl^3t)Wu{~I*lmKI?(|TN)9J|#Dyc9AH~!VOMRtcDv%l| zIzrJWb&leSUSzN+{H^tY3zAx5J%!{fm!?v^l#yJboZ54o2z`XRb9_efKII|Em6w0W zEG3!RN)?prvU(**R>!=SFMBwJe(Fp`#1@=Sw!4PdXn-lo%H`*U`I52%#b8By3(zj5 zAKpoX%VV|8?wBg(`V$OdN(cIhgFgm-A`m{PfOESWM6AxB&^waQcaj9@tGSVIAHUp5 zHjVfj997z>vIDCnp)#*Mk$Y1q0!e@UkxBQ(i(dvR;|0fXHOT^|rSxtqH(?ViTP18< z&Lh0){9Ng`nNA$kSTN+U<(d4040M6q`<%T6zo5uFuNt3EuhSF=tNA#7CsdH z&{lvA*)Fue3U1mLI8C9Lz7v1MK~ETJUkEGiX=EOf3^4ay(3Esdb2$a!PD50Lu$_1K znJfx5N3Jp+rm61CY*MA_kR8!U_WY5nT9|MD!d?~u?81RNThFy=79_kHQyaB2^xGj~ zr?Un4mCtuPZ>NI&Iw@(GmOFM^^MmAvuW4v2hFChL5eH7BKkOpsXfc0tUi0&%5ZeFe zgey*o4s3R>&@jTf5EmGW%O6J9odjHOuUEUOY-Fofm?bGvt@4xc)J}q$9Fa0|+U8f> zIjUs5D=WVO9aD2MkFsFs?QF6;<*(dkIx6ZK$C7*!`X<>r2=dM!maMujjtHI}u}RY7!4G%j<@3`j(3aQRLYU%|twj z+~pCP&}^DN2Ax|81^zP_ZMS?emQ}V$E-}!}wHkhLAJe(SG#@Nu@l-)=rdD}9L%TjR zLfT2dpmo525C4N7A8$U6C`cR-X?}KSKSl)@$e6kpxB-&ReByt^Zv+Qm#cgP&wmcjY zNQ84Y6%~Jfzq$0Ryy&7Cjn=GK)N1wZ>=PiT%ArGpWkI<*OU0B-nu_5PkBs?pJp?~F zhqDKGDy+z^JXyYv;_y|VDl8Cd@WEU?It^|$i#H6Cr04WEAi{Y2#oY|JD;14IA`?)S znSa2zUJn-d+$n#Y`CahI)6tsJO$1SxO|JBK0OE9QSImWYB|zGVzv}F4c3$;!1z!=3 z%s+kyYYOHAi}=lw>ALh9ovblnj>STf47j^MoTq^PD-}%vJYl(HOyMsjA%!t`c07Sg zh!5J_1Lpa><5P|Kxq4?jQDka4&+OkDsuTf%qZ64`yw88cmX3&U`0dEei4VD+Hx-4` zy-6z5=D$wg)2PDR<7t2M3TZ2LsGmjG+uE zm(yrwh?4<_EqKy@Y>@ojMO*B*r5wpMRaG9~N-TCR?eN?$@os`tPR(`Ggjcg2h9lgE z#t56at}re-IHqjz>%ZGA@;bSbaYzQa#gz$nTZAerdq&C1+wAnFM)@g17qpEl4_+69 zwa34Mp`=+^mV2_+e^C{JGg)=5>~0mImSt{&3Fy5`?+WpM1V~#AM-7bQ?9JtFZ$vg@ zAc+L1f*>#iMyoFSusno&;_}(_)N$Y-$vmYjp=p?&I}E`UikM_PUH}ESa}GrcjR#LW z!(KaLp_Rq<-k|#fsP*wva>L5b!8<2NNfVNMFq@3(0E%4soiUVjmpXPJ+_xo}}s=SF%&u z<)MaW6`zRIDhT#hfCYrO1lM+#TO2s){$HHQ)s@SC{Aj}>d{1CBmNWkjw5-)Z#^Y}> z5fP)6*F6YlLdVAvgmc4Uc~(bf#)84YEpJz({Ob1TO7dF@1P9@L`Hp(U<6cV-+%zaj zQR$|H6^Q$+ts`{<3ByVUyQQ}2;IA~Wff8-Dw320b2_~G(oBaAAVbkd=umq)8sgL&& ztSSkAPM}{2;Z%a8gmwMUNH%=`EK~s!8p|DiFWRTo`4fCY#dDa>T_PL~)~;ONoEwW5 z3y-My)T1`U)QvIIT5klb4t~x-1Dv)h_$h$$ieyt;b9ge(exe7_5uY=D)&+X!CMhnE z@GnQOS2h78W9z>g1KwNZ+B}l65tC53b*#mIMDpW*7H_VPE@A(_fg@^-E|tN2?*X6< z;N(;Cubh5n+3uLCZrcmn4P#m^o9Hxv{b@2hKo;DFFF@f(c8{AQrw`(nRH|3)>=w7G zvs?O5A#OkRku(Ah9U1sMOcg9ps-OX*m5;I zyY;rYy)ISszac;pzPTh?8%t<}t>K7&){Af84E~|SqK-l4gQ7S$L5u&ZODxkyple$i zhS2WWKr|?xmBjws2iZJaz zQ%!;nPtDtj9pky0>6bCV+D23;-1=E1bvodoNfrs{$8=wEgU`5<6n~0H7=J)w>RrphJ2ex zx@{T=;9Y!f9aP-0nC~v0y8F1DDxGCI74F0I9vQ0R+MWH~p%6R@ZW>{KBx>ra6{GdG zXtbyT2ljXw%o6(kj>1qcdxh0W+g^(k?X8E(w#B0s%TP+7%RJbJP0;0xsYlsyalP+;dITMD+RBspN!2{5xS+>WXB<;al9(BG(Uqc2pm4E)e;dd4Ch!{to z$4S&bgsHDh0iHt^)|YmFH~X|Ac&QYp`ZXL%W1M?k!DbeM-^%--6png|O|FOC5W-p57?r*hqhng+seMpvcR`R#aLTP%czOgw^y(g&S3XVXVLeZ* zSlAqVmmH(kQef;8Clg-eJ*4!)1T$z;vT(m4am5#6N4TJC@bb9MN1;=?AHE1bMrU>+>9L6OJiNWD*E)u!R(y%Q{sXc!e>RDvSFgo;Pk=sWp8!lV>~B@HHq5I z(v&7jd}EsM_@L5kHO!>;;=ZeJ|Ng_Xl44E&y!J$P$o)zU1dz)^G3hHadj*Sq7!xvm z^;ob3$XolaiSL|ITSS!Jf|Up0@V<+pnc#~uh(=I<`J>3~p9iD6J4{pB{!*C+zuyN; z4IqWzinHdoMoBOp2)I09oh*o~W60Aq4#nH5;8^QOxIS=w{5LEkT4`jdWWl(3p#&9h zV9MaW+v||H4YFP*JO+JF-EqB^{5GrlMNyil#ybAbzXlq+mD9{LJ@_)Od&eAjWp5uw zh8v-Oo@BSfgWjKi?S52j_mBZQY-S!ABLAHYrk=@U7#J4DF(j#%Ie_7ZA1PCWRPNTn_Y@4!-(17aq=cIR@?yv-*a|CmcI?oZ@!5uIm`lbS<}qn+GUm|0c))w0Frc1n ziDRMPkph3ZRwxn%mopKF;w3`q)#(~gb~PZQgZdXtMWOMOlYcP{dkc00m$IJexA8-n z5yUH4(5;~31vghF?_8$o@w04d+t;gq7;h9)e1ThBNBgk+^5LU<8>0ZFRFGcW?nQa} z-FT+rvJeUuujvkcDkc<+GpkVWk`UY zgqcjk@ADWizZ=H4%%RrO5l)Kkz~?Zf^ka|wyV&vlFtn--1+%|7cb{h91?5D4AV5f6 zXwSj|z<12hjxdpdARHVI^nAu9__ma}Jd7KLb||z$l7UcXT{s!A&_woU9oEuOMBK@q zU4LGy;&18ZbY86CV*)DveN2kEXbx4fua1HFDQ~s;Cum$shC| zg30k1E5L>T-`f!m&-hbRECHeONfg52b3)Kojl^aPzmG=Ve!px8`fS5MFIUC{GxU#k z#$hteW)oVA2-^>>433Jtn_SZ#qGaw!;y4B=3aVt%7goHi60V$gts7E%n;gJsq-z9e zFTVQf_E)l&au93QOuV^>zPQ{YJ}ScrtyqzLxp$GMtHHI?w6FVb(tD zU>#ot;oL5?`yuglqWBd>Q}FL$6o@sPTr{trgmF58)|@|K`7cU;QB6{xkMQQ%+OBGU zcoD4E{F`oRI6FFb9jLeOFgM*R;mDj&KgP$qf^yfjK*#~~I$s>?31y2XY;9_W!t`YU^L-?SDTBT z6pmm6R>T{)l^r&J4PZr7Ar?l$g-@2grSvO)sgktK#Atb!Z+XteoWx2cbwa)B54+WO zqs6G0kL_~j@75k98U{p4oTbWFDjH>S^X81FQ=N+U>VHOHWBcv@d^qoLtCJvG)O(0v z%H(np4Na$&xx)gBfVT9)jtn=G_1hKo^4Za(MW~W~2u$>U>s^jAx0YU@3(J6D^UPa7(Yx!{wy8mEVY55FQBe}XGU~7`LhoX5^H);ZoX)WGD>Mc#0JS5UA_53)^Qb0_Iv?1Tx_oWf=NkW z39>*oD|yrNDll%C9H2MKp}9Nl5Gue5O)h*KW=& z-XdRri1xYUhymHhqz&?zLUE(qg93~HsCWtqgov+k15S!Q(TRS5(E4g*r^CtK3}ei@ z;!hO1yUZ*XOoL{d{aPugOyOY=0w&@&q+P;28gT4GuIK|=3%M-O&QmLjEvZ*_kdT9u*tt4cwC z0$+Cuz@sW!0%7m+2<8`z;UWNSONe){HkaTz*6TZmKM6)9vfd@N0o_5SF7vVRY~P78 zZ~N3m3<$L90j=k2W)(W^5Il4pF<{r0L3$Fb>+5*RC$p_PEI6vd7mIZF%1W7&`3Km% z6$^By+Ml;MZ121-7R{j{ZZ(B9uUY7Sz3MkA`|6m;hNx&44Q2A(pkYEgz@J*0eajG= z=vF_B09U3tuT~3HSxT}#-w6_CyB#PaLnpjz7D`-MLM&2jcOyFDIy|fj=hVPUv0N@e z!wl`O;g1!#=H};A)JJ2p^7-B6S>~&Q)oQX#vYtV{H)+piSZ5Vd-@K4i0T%Oi}`XR#7tc_+g;JB@u=Tt>a*cb32Ey{bi|GO+fO2Hq9yZ01XuMyhgutHX!sZXTA)NPigt&%K^_WEud_Jm-jY%b_=%lWA%0 z?I%U~>6|pV!hlWn54+>+c;Zz;a=K*=!Y5pU)z4 zeW5zW)#wf+*K^p@f3zAXYQZ{nr&?3`>Gn{81q>uNIlAO(X^3w9)kCdHnO(U~%9xzo z<5f9FapL3{i0Y{pY2B!KS4Ntf=TtrN*FO}J7Rn#pCU}JphP16Om_BcK@FvqBmEgq? z?*z1rZy}hAGW);jm9hhWgOlferUHQcd=pAWgn`kC+!7T5xnqYyv}+= zlFQI71uRQMX6VR#E=$+$w&DCLHTani#qvVGbR%=HlSbew{zP(>Po?v6A1^H_l+rE> zYAbkstU)R$pCO{>U?n&|wme^ufuU;fQzMC})pqy-V<~fGQNSl>Ty)|PiW!PnGBQsO zXAHvSQ!y^$5=DJh7Z{@fvIhwOVN*Y{SFKw(=E4vWedIE( zOxZ8OO3Y+`yxK?4LsJ2PRr6lIkqTfX5@P$yxfKZdHgB&wvNY(ksrXTg`Gbn|hrC$V zuls-wV0~^7PN&u}`(-mbJdJ*c3IbeJ7d|j$)f5Z}F$+xSV-^Ho+iQS9Fq2>uHbqVk z{|}w z@_;Ikt+cRizW^t0fa&9J+-5q6X)D3MHJG=m%U3s&YS<#<+{T*SNf}&Cwk1uXD?2F+ zao68}1k8WKsA|#jlP-Tt%PSfLaAw;*WkwzJ;{ZvT4}3N0S2Ln6I>CH@D;eX0acD5q-<-%|69dmGq^)`G?W8|L4T(si$8BfUvx( z#Vz^)Y~9B3;v*e|2v(w#fNAd#{l|%s;Hu zLM3#{@=i3ub>Pc57OCI)J_AhOdnz$$90Y6tR=Ii@5`Tb0% zPQ=CXauLlp6hI987z1emK?%X?N{!Fa^z?E^}mfp)@g(N`+qJBDk{&S71T|P9tK>EIhMJGM${g_7C-4CUV+@SY6vK~Q*3~cCA;EeaH4f32r`7)Czj{33OISbg40JPFy-9_iwdr5AW z{LixxTitbB=Z0K&!5d4Z>9_s@XkZ>}da5|LeXd4x#4&F;{62h4><(=s$1{-PH%bk+ zDm^@0x)a)Pn~QsQBVAH$mp@y7gC5dSN*NuOX1+^#T;(G&C(kHm192L|sKD@%X?*An z@wL3C&n`uj@ragU=cvUMlHZ`rEa7xh!Ar06Wj4?`fLHtcGTXu|%Wn!Eeawe>h+S(F8T`^aaOJy&PRoYwLTNeWk3+KeA^TB2uX-3hLGi8{%D&Kf(HE7Q)zi^496 zTCT!+Xz7qOT7qEj-nxDB>Xs&GP|1n$U;&_T+J(t{h0a@WVID|itC+i|>DA#wfC1zP zWFB=GIwroG;$W01d%XgG1Ko{SmgMgK85s|oPRqHD^)DVLO`=_)%n);751k<~v;^Vx zCX?7rdc>Gx?XIbg0N85L-jt)}M}>tEx2{WEvIS(SOhyPEc|VvWB2AJU`&3|uK(&p} z;c6(~OF@E`ixfo7DQGj+L)M@u?0A%5DVW*sna}CHi<@R zB0xDf=dsz^$C?u}P#4sa87xT0t-6e{U8cn+Wt^^bgsLy`pS89C{tn-%^VATKJ!!@0 zRVBJZ*#$~bsqOlIwEAJ%9XtUGaUgtWc&}`uB*DFJ^&i@c;bcqaEsWrqXn3NB8V0Mg zDrqZ5I;WjMf+y9dr0f+Z@HLTKaM0HTTqYQ?;(40{5f0f#^mesBh%Zw^Putn^;{!HL zu)sR3{LW*1GY0I@k!xNi^75TAw#J9ff+wl27&|K!O?6p z+Ew9&&j3^jArN(F*^E9AYg!HqO_D)*J{z#SPdBA>Co>ze$|$cKPi|%pr(LwACimvU z+=tY<^8Gm`gI!y^seC0GVKx9$PRlIMaFnGrHjWRE#n|Z2;vo2E1(-ZE z>h0pbya(@puqEuYy-I=r)=3V@$(kR|;ov_x(J;U~l*JQIHgNCb2!y2+4}rn0Z1Ist z*$NvA{1la!D!fDLlzMHhaQKgm~~gUHz{t7Q$W&zI?l22KFii*c(putaplbOvYVzK znAvMK)m&4HmCFGNgbdRWJVmHGmgQW{YT|kF_<^l1TmsA6BGuL^|s-oEZ%EARsyARmj zP4?jXB#C)4y$~9Oj%=Xh1|e<3GCdp0UbtVt&Fe#B7S5F=c)e>uiv%-@rQW8vm zGZPxLA~a2rR1#tCP7B+p~Uac!3KD|`=Zv(0?%jDDq#K5-Svf8XfV5cCc10$ z?jxt~m0+e$nJZW4NhSs({qJ^kgavY*YmKY(^RQqp2k9glWWc}om{y5NJt{8MTjyL1Wwh(09kb!xZTw%mlI6F-Cooa#B#~ z87QB6B9WWZG|hcL4DowQ{V?r}gUw+**nEGFF7@|3&SsgM{CfG8D$!|O2`lbp9$=;v z#>8EAJOX@8UWL-V0-3?Fa7B)Pa$3=?8LtZwWJIf%5AyUR58CsmO;m?6rWdUaq?dx^ zO%}h%80-&g#KSjC>{I>Tmg)lMAKly)^SCZ_XcOEK z66wmyvH^eAHh8`KKcNrKx>Tqv(27r4pbVCGvmBT7RiUn)<}nLRLbMWpyVPR=NoRE7 zJl(+dNG>9k=_8#3pO<&8eA&c%Jps?4Pj>PY=Y4Hjql^;@g_%fVp$O;^%2O|RcKxRF z(XCECkNJTvWFr`5gKk)fuse75aX1}}rS0sA`cjj8F>Zh9Ls#j^Ld8O5S8E8-JwTt^ zZyF>us8DzIiBJmsrjBxdxlg1OOYNis6Ey5B_65+LARNh#dxLRIgh;_oX`B-TAxO~E ze@M6>VbtH?M-%=xr-lN?LpV0!O-EclMUHY-|M9biYa~~q5Laot-MgbW{_IU-ixLIP ztG9oW94r9VW)53L8V*?$b5~L*8@Eq|_LX+YP@IB+v;@u6g4T0?eqN>Km|e-fZ$&Em z)UjuQ*5@3bZuRfo{ju2(TcAVL|1*Vk5eo}7W75~khz3nMvOO@`hk4!rYW(LqaFdZZ z63Jzdd*H8I0mVwFUqPJpz-msUgbu+C*%m z*19!@F^arzZF&NKhKHSi$t!qT;&WSFTdnK?vsP)l2d_d(mmZF9 z$XiUFpmc9uU^@Rkszc{JnN|a6CMqNJtQa6{d;_J1 z>wo#O4v*+qeiv>E0oB|{lME-x^+eJ~GxgX|zARc+h}hPDqok8-uO?R>%kEqMl1E(w z-3ZLW1%F5|nlkNSN%;bWb&PlR>!m-VZlbxub#D(BJSrA5D&5esnEi42Dc3%f22I9- zJ73MXK_)U1B9ETT>Pe+|&=)1*){n!5Udip1U>ENk4$E1%$BW23b9A%zPGh;-7b-#K zHl671ZAUkMmC5m0m0t4{;)41Dp|dgHl!`pi@A*cCWY$blgTENc-wKNQaX&e;@^<2@ z2Vkr-(jkfaiHf~7e*ESW!!0bx^S}U%R~D-`K>k2uS%T#!Kr%y(*!T#|g3z|3)pKT# z&jn;?O4zaa;fJIcnKkN4qE*RZHyZ@t2E-6GnQ$_HYoG;pIQ+ePGW{NIP_RTvfPu+B z4f2Kyj4|*WYSP2oV^c6P^QXd90<)3VU(9|*ExtWq1hg~t=Ks?h1vqwp9q%#|Y#AIQ z{6pd~Dm28maZL(NF4!|`!0*5IY{o6(9X>GQxI)&9glj63Uk!KM9!G^d(kWJ~9B zrxdP#7VfnzTtFV|F>SD6dd)E{^-L~BwzqeiO92Zrn;=mMN)LN0V} zb80#vmO`EN<@*ob)y+LcN6a_=)ZmX}MWa`|7BwIA$SMrsl-8=Y!cX=_s*MrdY( zg_U^;g$`NMB6n)C#(;7|PS1-J7UT?@sM_;?x%h|}UmPf8pOQvecO&UtLrnd_07{NT z4%I7@CV;Uxr|t9d6r}qjJRdD)GEC1u^s0>`6*T#xgZ2cZ#1V_yL#*8lQ5M}oleMR( zTefGL^P-x-C>gKuLO~iwynDZI6Hjri?0H`ioFUi0bz4O!s(-gIOwR6D=w#G7^ftXYC5niprO5~r-_*gX3T(a@?4s*&F1pHzVO>Y* zJ?KHSVWzkvoVGmH?@DJttkM0V2lRl|dnzXd$3HC8LNoe18DE`DO~fi{!X@T^D}?Y4 z=-Bx4Nxc#nfWWg+qNGEibJ@cJf>nUu4?Y^7koOexDv*3N13QKvhk-8o)fJmE=nt3TedwpEj4<0{O{f0H^P5py z%thn(=ZzDI_?4ml=$dOEiJqu``0yJnr{+qIW*AQW>M9jOGO;S>NILj`>%f|LnsfrF zZG$&rCzbtvuB@aGR18^y#j2Wi6i{D5zJkdcG#jx2qZSjxnRZ~tbCP16lkr^#IMA1# z=Q$KnVDfuptaCTd3aPSl3>B9FIjL2It5N_g121A!>7kn^BVtD6#5wq@hs3+`pJ0Ec zl(yB<*!xlY%ZqG>cTxg>ixRG8yf_u!MCH7IAO*f!O~Gg0-Lu%Prad}crr|LterzQB zFlUGur27@IpW!pZWLG!saRkmti7b-aA0FmJ+ga5wnhLL0oN&}rGru*Oy+c5}t$o

#1H5^gn0~{G#@I((-Zvm^Pdo&MXZ;Nr<_>oY!HV}Slf_i4Z zQkWz( zVR{G*|HAQ(DrLYm3BJYS!hV`7pN}YlM={ij9UTVtI3$E5DO&Ts4V?ZWcX`?p1@a*6 zhB>vAmWI#yXGFZ{GOrTN&Ps=OW)dQcp%^p}{pUE@ zk#R1_T&&5GtqQ|qnQ6f2muk%?uIp#vxkQ}Y$4k$bW$*@7R|E#GMSkj2F1dfZ>(%gu z0N&Fvf>Pm6Cr1qQvcJRba@W-$Ak07TYBab_Xo;X?Q6>-X~y59a%2BC#5*Q zppohKXo}3VT8Aa}gmUb-pap5qZJvpvS_;a@_G#dO>#a(}{~HFoUR`QneMLq@Pw{Lg_u% ziV1u9*;h^;ok|G!$b0{R5Kw;zaEl6u+e zc~#pF>(TVfc+~>7*rZF1uieN996X+awk)i3Np76e+{Fi{4{VC2HW@Y1#{X(FqP||8 z@*iQfr0o#LGgA%d-}!-Vfom4j8YdLrAvR^81y0Gf`K?T{>aUXJk_p4<6`5!Q01knF zu}GTRkz^Jdp&Ws_z>6Se_xipF9O4{Nz1rm8!zo-ZTofI@uxKFZwo^wD5}Z(ZN6^C? zaGc6usijf*+#&w*&BZr+emmpVr+Qy$(??G^gV}uMaDOZj9}SX-!KZPlX1{Xs8MOSc zDyT1DVY@YKCtXLjAw?zLqDM4cBxBNlrbk&VHZTErVa zXu!-Lg-aw{`%SH>5H=Dwr|vjF+x*@eX|s3n$ofzsB2xrt6$rmbkREr*eBx3Ko ztWqr8E=FSJAo^4ep~VY+i=|Pkp<$BhUl!GAb{*Ax`ds2}bTFi;>%&7-t* z!t}iC#HL8CA<$8T=$#_7iXTR7p1tu_Dtej*=d@8Rj>b}Ro@6L zFj7%Li-uW<+m_*ys;P{ZMy&2%e7S>M;yuv`b`7n3VIKmH0I3!OP63S_?EA+xOXW|! z<9DK^XAelG1$kTed38oDIeM(n%qO1_F5m=CV(iy7W^{e(cC|d&jm#0&$KhNhnzs=m zG^Fy-gzXhhS~b{Nr~2N1vniZHz_$-!^uqz?b>n_Q&0x9aq0`}z1Dw5f&q+YM9ArSg z->d6SkgUlE$R<=i*zMiui&EcSZMLI&p0hj^&amR6$Np~zJt|`6(mUmR#Ns2=>TGee zSemDFRnRIPbC12}`Ylx_=ka2e$rlGiyL?hoiy>W|Yr?Vn-Bxsev`|YbQ6q-=?!L3u zVz`kB4ZCV2yUJovnBs44y3^&5fL#U=stqgHRxXC_6;+l)Cw| z!sHtD2tjJ?li+1D=(P3sKxnj(4!U_Nt%gW1+cV=Cl!saQO-29!05GtGK>z`!{{_{I VGa671Qa&&Zivj=!00001Sz6vR$f^JU diff --git a/data-raw/eucast_rules.tsv b/data-raw/eucast_rules.tsv index c541d740a..c529199b3 100644 --- a/data-raw/eucast_rules.tsv +++ b/data-raw/eucast_rules.tsv @@ -809,7 +809,7 @@ genus_species is Aeromonas veronii AMP, AMX, SAM, TIC R Table 1: Expected resi genus_species is Aeromonas dhakensis AMP, AMX, SAM, FOX R Table 1: Expected resistant phenotype in Enterobacterales and Aeromonas spp. Expected phenotypes 1.2 genus_species is Aeromonas caviae AMP, AMX, SAM R Table 1: Expected resistant phenotype in Enterobacterales and Aeromonas spp. Expected phenotypes 1.2 genus_species is Aeromonas jandaei AMP, AMX, SAM, TIC R Table 1: Expected resistant phenotype in Enterobacterales and Aeromonas spp. Expected phenotypes 1.2 -genus one_of Acinetobacter, Achromobacter, Burkholderia, Elizabethkingia, Elizabethkingia, Ochrobactrum, Pseudomonas, Stenotrophomonas, Chryseobacterium PEN, cephalosporins_1st, cephalosporins_2nd, glycopeptides, lipglycopeptides, FUS, macrolides, lincosamides, streptogramins, RIF, oxazolidinones R Table 2: Expected resistant phenotype in non-fermentative gram-negative bacteria Expected phenotypes 1.2 +genus one_of Acinetobacter, Achromobacter, Burkholderia, Elizabethkingia, Elizabethkingia, Ochrobactrum, Pseudomonas, Stenotrophomonas, Chryseobacterium PEN, cephalosporins_1st, cephalosporins_2nd, glycopeptides, lipoglycopeptides, FUS, macrolides, lincosamides, streptogramins, RIF, oxazolidinones R Table 2: Expected resistant phenotype in non-fermentative gram-negative bacteria Expected phenotypes 1.2 genus_species one_of Acinetobacter baumannii, Acinetobacter pittii, Acinetobacter nosocomialis AMP, AMX, AMC, CTX, CRO, ATM, ETP, TMP, FOS, TCY, DOX R Table 2: Expected resistant phenotype in non-fermentative gram-negative bacteria Expected phenotypes 1.2 genus_species is Achromobacter xylosoxidans AMP, AMX, CTX, CRO, ATM, ETP R Table 2: Expected resistant phenotype in non-fermentative gram-negative bacteria Expected phenotypes 1.2 genus_species one_of Burkholderia cepacia complex AMP, AMX, AMC, SAM, TIC, TCC, PIP, TZP, CTX, CRO, ATM, ETP, CIP, CHL, aminoglycosides, TMP, FOS, PLB, COL R Table 2: Expected resistant phenotype in non-fermentative gram-negative bacteria Expected phenotypes 1.2 diff --git a/data-raw/gpt_training_text_v2.1.1.9226.txt b/data-raw/gpt_training_text_v2.1.1.9227.txt similarity index 90% rename from data-raw/gpt_training_text_v2.1.1.9226.txt rename to data-raw/gpt_training_text_v2.1.1.9227.txt index c47a746e8..082fb42a8 100644 --- a/data-raw/gpt_training_text_v2.1.1.9226.txt +++ b/data-raw/gpt_training_text_v2.1.1.9227.txt @@ -1,6 +1,6 @@ This knowledge base contains all context you must know about the AMR package for R. You are a GPT trained to be an assistant for the AMR package in R. You are an incredible R specialist, especially trained in this package and in the tidyverse. -First and foremost, you are trained on version 2.1.1.9226. Remember this whenever someone asks which AMR package version you’re at. +First and foremost, you are trained on version 2.1.1.9227. Remember this whenever someone asks which AMR package version you’re at. Below are the contents of the NAMESPACE file, the index.md file, and all the man/*.Rd files (documentation) in the package. Every file content is split using 100 hypens. ---------------------------------------------------------------------------------------------------- @@ -4784,7 +4784,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -\verb{r create_eucast_ab_documentation()} +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), brodimoprim (\code{BDP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA02&showdescription=no}{J01EA02}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), chlortetracycline (\code{CTE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA03&showdescription=no}{J01AA03}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), clomocycline (\code{CLM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA11&showdescription=no}{J01AA11}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), demeclocycline (\code{DEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA01&showdescription=no}{J01AA01}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), eravacycline (\code{ERV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA13&showdescription=no}{J01AA13}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levofloxacin/ornidazole (\code{LEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA05&showdescription=no}{J01RA05}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), lymecycline (\code{LYM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA04&showdescription=no}{J01AA04}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metacycline (\code{MTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA05&showdescription=no}{J01AA05}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), norfloxacin/metronidazole (\code{NME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA14&showdescription=no}{J01RA14}), norfloxacin/tinidazole (\code{NTI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA13&showdescription=no}{J01RA13}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), ofloxacin/ornidazole (\code{OOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA09&showdescription=no}{J01RA09}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), omadacycline (\code{OMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA15&showdescription=no}{J01AA15}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), oxytetracycline (\code{OXY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA06&showdescription=no}{J01AA06}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), penimepicycline (\code{PNM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA10&showdescription=no}{J01AA10}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), rolitetracycline (\code{RLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA09&showdescription=no}{J01AA09}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sarecycline (\code{SRC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA14&showdescription=no}{J01AA14}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/tetroxoprim (\code{SLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE06&showdescription=no}{J01EE06}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Reference Data Publicly Available}{ @@ -6470,7 +6470,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -\verb{r create_eucast_ab_documentation()} +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), brodimoprim (\code{BDP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA02&showdescription=no}{J01EA02}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), chlortetracycline (\code{CTE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA03&showdescription=no}{J01AA03}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), clomocycline (\code{CLM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA11&showdescription=no}{J01AA11}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), demeclocycline (\code{DEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA01&showdescription=no}{J01AA01}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), eravacycline (\code{ERV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA13&showdescription=no}{J01AA13}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levofloxacin/ornidazole (\code{LEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA05&showdescription=no}{J01RA05}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), lymecycline (\code{LYM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA04&showdescription=no}{J01AA04}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metacycline (\code{MTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA05&showdescription=no}{J01AA05}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), norfloxacin/metronidazole (\code{NME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA14&showdescription=no}{J01RA14}), norfloxacin/tinidazole (\code{NTI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA13&showdescription=no}{J01RA13}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), ofloxacin/ornidazole (\code{OOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA09&showdescription=no}{J01RA09}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), omadacycline (\code{OMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA15&showdescription=no}{J01AA15}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), oxytetracycline (\code{OXY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA06&showdescription=no}{J01AA06}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), penimepicycline (\code{PNM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA10&showdescription=no}{J01AA10}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), rolitetracycline (\code{RLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA09&showdescription=no}{J01AA09}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sarecycline (\code{SRC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA14&showdescription=no}{J01AA14}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/tetroxoprim (\code{SLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE06&showdescription=no}{J01EE06}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Interpretation of SIR}{ diff --git a/man/eucast_rules.Rd b/man/eucast_rules.Rd index b5552be53..2fbf8d543 100644 --- a/man/eucast_rules.Rd +++ b/man/eucast_rules.Rd @@ -102,7 +102,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -\verb{r create_eucast_ab_documentation()} +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), brodimoprim (\code{BDP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA02&showdescription=no}{J01EA02}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), chlortetracycline (\code{CTE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA03&showdescription=no}{J01AA03}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), clomocycline (\code{CLM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA11&showdescription=no}{J01AA11}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), demeclocycline (\code{DEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA01&showdescription=no}{J01AA01}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), eravacycline (\code{ERV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA13&showdescription=no}{J01AA13}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levofloxacin/ornidazole (\code{LEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA05&showdescription=no}{J01RA05}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), lymecycline (\code{LYM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA04&showdescription=no}{J01AA04}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metacycline (\code{MTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA05&showdescription=no}{J01AA05}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), norfloxacin/metronidazole (\code{NME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA14&showdescription=no}{J01RA14}), norfloxacin/tinidazole (\code{NTI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA13&showdescription=no}{J01RA13}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), ofloxacin/ornidazole (\code{OOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA09&showdescription=no}{J01RA09}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), omadacycline (\code{OMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA15&showdescription=no}{J01AA15}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), oxytetracycline (\code{OXY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA06&showdescription=no}{J01AA06}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), penimepicycline (\code{PNM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA10&showdescription=no}{J01AA10}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), rolitetracycline (\code{RLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA09&showdescription=no}{J01AA09}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sarecycline (\code{SRC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA14&showdescription=no}{J01AA14}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/tetroxoprim (\code{SLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE06&showdescription=no}{J01EE06}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Reference Data Publicly Available}{ diff --git a/man/mdro.Rd b/man/mdro.Rd index 75a4a6e6e..20e053dbd 100644 --- a/man/mdro.Rd +++ b/man/mdro.Rd @@ -182,7 +182,7 @@ To define antimicrobials column names, leave as it is to determine it automatica The following antimicrobials are eligible for the functions \code{\link[=eucast_rules]{eucast_rules()}} and \code{\link[=mdro]{mdro()}}. These are shown below in the format 'name (\verb{antimicrobial ID}, \href{https://atcddd.fhi.no/atc/structure_and_principles/}{ATC code})', sorted alphabetically: -\verb{r create_eucast_ab_documentation()} +Amikacin (\code{AMK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB06&showdescription=no}{J01GB06}), amoxicillin (\code{AMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA04&showdescription=no}{J01CA04}), amoxicillin/clavulanic acid (\code{AMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR02&showdescription=no}{J01CR02}), ampicillin (\code{AMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA01&showdescription=no}{J01CA01}), ampicillin/sulbactam (\code{SAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR01&showdescription=no}{J01CR01}), apramycin (\code{APR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QA07AA92&showdescription=no}{QA07AA92}), arbekacin (\code{ARB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB12&showdescription=no}{J01GB12}), aspoxicillin (\code{APX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA19&showdescription=no}{J01CA19}), azidocillin (\code{AZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE04&showdescription=no}{J01CE04}), azithromycin (\code{AZM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA10&showdescription=no}{J01FA10}), azlocillin (\code{AZL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA09&showdescription=no}{J01CA09}), aztreonam (\code{ATM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF01&showdescription=no}{J01DF01}), bacampicillin (\code{BAM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA06&showdescription=no}{J01CA06}), bekanamycin (\code{BEK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB13&showdescription=no}{J01GB13}), benzathine benzylpenicillin (\code{BNB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE08&showdescription=no}{J01CE08}), benzathine phenoxymethylpenicillin (\code{BNP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE10&showdescription=no}{J01CE10}), benzylpenicillin (\code{PEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE01&showdescription=no}{J01CE01}), besifloxacin (\code{BES}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AE08&showdescription=no}{S01AE08}), biapenem (\code{BIA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH05&showdescription=no}{J01DH05}), bleomycin (\code{BLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=L01DC01&showdescription=no}{L01DC01}), brodimoprim (\code{BDP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA02&showdescription=no}{J01EA02}), carbenicillin (\code{CRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA03&showdescription=no}{J01CA03}), carindacillin (\code{CRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA05&showdescription=no}{J01CA05}), carumonam (\code{CAR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DF02&showdescription=no}{J01DF02}), cefacetrile (\code{CAC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB10&showdescription=no}{J01DB10}), cefaclor (\code{CEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC04&showdescription=no}{J01DC04}), cefadroxil (\code{CFR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB05&showdescription=no}{J01DB05}), cefalexin (\code{LEX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB01&showdescription=no}{J01DB01}), cefaloridine (\code{RID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB02&showdescription=no}{J01DB02}), cefalotin (\code{CEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB03&showdescription=no}{J01DB03}), cefamandole (\code{MAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC03&showdescription=no}{J01DC03}), cefapirin (\code{HAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB08&showdescription=no}{J01DB08}), cefatrizine (\code{CTZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB07&showdescription=no}{J01DB07}), cefazedone (\code{CZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB06&showdescription=no}{J01DB06}), cefazolin (\code{CZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB04&showdescription=no}{J01DB04}), cefcapene (\code{CCP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD17&showdescription=no}{J01DD17}), cefdinir (\code{CDR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD15&showdescription=no}{J01DD15}), cefditoren (\code{DIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD16&showdescription=no}{J01DD16}), cefepime (\code{FEP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE01&showdescription=no}{J01DE01}), cefepime/amikacin (\code{CFA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA06&showdescription=no}{J01RA06}), cefetamet (\code{CAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD10&showdescription=no}{J01DD10}), cefiderocol (\code{FDC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI04&showdescription=no}{J01DI04}), cefixime (\code{CFM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD08&showdescription=no}{J01DD08}), cefmenoxime (\code{CMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD05&showdescription=no}{J01DD05}), cefmetazole (\code{CMZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC09&showdescription=no}{J01DC09}), cefodizime (\code{DIZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD09&showdescription=no}{J01DD09}), cefonicid (\code{CID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC06&showdescription=no}{J01DC06}), cefoperazone (\code{CFP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD12&showdescription=no}{J01DD12}), cefoperazone/sulbactam (\code{CSL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD62&showdescription=no}{J01DD62}), ceforanide (\code{CND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC11&showdescription=no}{J01DC11}), cefotaxime (\code{CTX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD01&showdescription=no}{J01DD01}), cefotaxime/clavulanic acid (\code{CTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD51&showdescription=no}{J01DD51}), cefotetan (\code{CTT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC05&showdescription=no}{J01DC05}), cefotiam (\code{CTF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC07&showdescription=no}{J01DC07}), cefovecin (\code{FOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD91&showdescription=no}{QJ01DD91}), cefoxitin (\code{FOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC01&showdescription=no}{J01DC01}), cefozopran (\code{ZOP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE03&showdescription=no}{J01DE03}), cefpiramide (\code{CPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD11&showdescription=no}{J01DD11}), cefpirome (\code{CPO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DE02&showdescription=no}{J01DE02}), cefpodoxime (\code{CPD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD13&showdescription=no}{J01DD13}), cefprozil (\code{CPR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC10&showdescription=no}{J01DC10}), cefquinome (\code{CEQ}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QG51AA07&showdescription=no}{QG51AA07}), cefroxadine (\code{CRD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB11&showdescription=no}{J01DB11}), cefsulodin (\code{CFS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD03&showdescription=no}{J01DD03}), ceftaroline (\code{CPT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI02&showdescription=no}{J01DI02}), ceftazidime (\code{CAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD02&showdescription=no}{J01DD02}), ceftazidime/clavulanic acid (\code{CCV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD52&showdescription=no}{J01DD52}), cefteram (\code{CEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD18&showdescription=no}{J01DD18}), ceftezole (\code{CTL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB12&showdescription=no}{J01DB12}), ceftibuten (\code{CTB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD14&showdescription=no}{J01DD14}), ceftiofur (\code{TIO}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01DD90&showdescription=no}{QJ01DD90}), ceftizoxime (\code{CZX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD07&showdescription=no}{J01DD07}), ceftobiprole medocaril (\code{CFM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI01&showdescription=no}{J01DI01}), ceftolozane/tazobactam (\code{CZT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DI54&showdescription=no}{J01DI54}), ceftriaxone (\code{CRO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD04&showdescription=no}{J01DD04}), ceftriaxone/beta-lactamase inhibitor (\code{CEB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD63&showdescription=no}{J01DD63}), cefuroxime (\code{CXM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC02&showdescription=no}{J01DC02}), cephradine (\code{CED}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DB09&showdescription=no}{J01DB09}), chloramphenicol (\code{CHL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01BA01&showdescription=no}{J01BA01}), chlortetracycline (\code{CTE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA03&showdescription=no}{J01AA03}), ciprofloxacin (\code{CIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA02&showdescription=no}{J01MA02}), ciprofloxacin/metronidazole (\code{CIM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA10&showdescription=no}{J01RA10}), ciprofloxacin/ornidazole (\code{CIO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA12&showdescription=no}{J01RA12}), ciprofloxacin/tinidazole (\code{CIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA11&showdescription=no}{J01RA11}), clarithromycin (\code{CLR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA09&showdescription=no}{J01FA09}), clindamycin (\code{CLI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF01&showdescription=no}{J01FF01}), clometocillin (\code{CLM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE07&showdescription=no}{J01CE07}), clomocycline (\code{CLM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA11&showdescription=no}{J01AA11}), cloxacillin (\code{CLO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF02&showdescription=no}{J01CF02}), colistin (\code{COL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB01&showdescription=no}{J01XB01}), cycloserine (\code{CYC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB01&showdescription=no}{J04AB01}), dalbavancin (\code{DAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA04&showdescription=no}{J01XA04}), danofloxacin (\code{DAN}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA92&showdescription=no}{QJ01MA92}), daptomycin (\code{DAP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX09&showdescription=no}{J01XX09}), delafloxacin (\code{DFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA23&showdescription=no}{J01MA23}), demeclocycline (\code{DEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA01&showdescription=no}{J01AA01}), dibekacin (\code{DKB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB09&showdescription=no}{J01GB09}), dicloxacillin (\code{DIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF01&showdescription=no}{J01CF01}), difloxacin (\code{DIF}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA94&showdescription=no}{QJ01MA94}), dirithromycin (\code{DIR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA13&showdescription=no}{J01FA13}), doripenem (\code{DOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH04&showdescription=no}{J01DH04}), doxycycline (\code{DOX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA02&showdescription=no}{J01AA02}), enoxacin (\code{ENX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA04&showdescription=no}{J01MA04}), enrofloxacin (\code{ENR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA90&showdescription=no}{QJ01MA90}), epicillin (\code{EPC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA07&showdescription=no}{J01CA07}), eravacycline (\code{ERV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA13&showdescription=no}{J01AA13}), ertapenem (\code{ETP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH03&showdescription=no}{J01DH03}), erythromycin (\code{ERY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA01&showdescription=no}{J01FA01}), fleroxacin (\code{FLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA08&showdescription=no}{J01MA08}), flucloxacillin (\code{FLC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF05&showdescription=no}{J01CF05}), flurithromycin (\code{FLR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA14&showdescription=no}{J01FA14}), fosfomycin (\code{FOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX01&showdescription=no}{J01XX01}), framycetin (\code{FRM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D09AA01&showdescription=no}{D09AA01}), fusidic acid (\code{FUS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XC01&showdescription=no}{J01XC01}), gamithromycin (\code{GAM}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA95&showdescription=no}{QJ01FA95}), garenoxacin (\code{GRN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA19&showdescription=no}{J01MA19}), gatifloxacin (\code{GAT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA16&showdescription=no}{J01MA16}), gemifloxacin (\code{GEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA15&showdescription=no}{J01MA15}), gentamicin (\code{GEN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB03&showdescription=no}{J01GB03}), grepafloxacin (\code{GRX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA11&showdescription=no}{J01MA11}), hetacillin (\code{HET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA18&showdescription=no}{J01CA18}), imipenem (\code{IPM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH51&showdescription=no}{J01DH51}), imipenem/relebactam (\code{IMR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH56&showdescription=no}{J01DH56}), isepamicin (\code{ISE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB11&showdescription=no}{J01GB11}), josamycin (\code{JOS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA07&showdescription=no}{J01FA07}), kanamycin (\code{KAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB04&showdescription=no}{J01GB04}), kitasamycin (\code{KIT}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA93&showdescription=no}{QJ01FA93}), lascufloxacin (\code{LSC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA25&showdescription=no}{J01MA25}), latamoxef (\code{LTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DD06&showdescription=no}{J01DD06}), levofloxacin (\code{LVX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA12&showdescription=no}{J01MA12}), levofloxacin/ornidazole (\code{LEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA05&showdescription=no}{J01RA05}), levonadifloxacin (\code{LND}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA24&showdescription=no}{J01MA24}), lincomycin (\code{LIN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FF02&showdescription=no}{J01FF02}), linezolid (\code{LNZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX08&showdescription=no}{J01XX08}), lomefloxacin (\code{LOM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA07&showdescription=no}{J01MA07}), loracarbef (\code{LOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DC08&showdescription=no}{J01DC08}), lymecycline (\code{LYM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA04&showdescription=no}{J01AA04}), marbofloxacin (\code{MAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA93&showdescription=no}{QJ01MA93}), mecillinam (\code{MEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA11&showdescription=no}{J01CA11}), meropenem (\code{MEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH02&showdescription=no}{J01DH02}), meropenem/vaborbactam (\code{MEV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH52&showdescription=no}{J01DH52}), metacycline (\code{MTC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA05&showdescription=no}{J01AA05}), metampicillin (\code{MTM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA14&showdescription=no}{J01CA14}), meticillin (\code{MET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF03&showdescription=no}{J01CF03}), mezlocillin (\code{MEZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA10&showdescription=no}{J01CA10}), micronomicin (\code{MCR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=S01AA22&showdescription=no}{S01AA22}), midecamycin (\code{MID}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA03&showdescription=no}{J01FA03}), minocycline (\code{MNO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA08&showdescription=no}{J01AA08}), miocamycin (\code{MCM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA11&showdescription=no}{J01FA11}), moxifloxacin (\code{MFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA14&showdescription=no}{J01MA14}), nadifloxacin (\code{NAD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=D10AF05&showdescription=no}{D10AF05}), nafcillin (\code{NAF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF06&showdescription=no}{J01CF06}), nalidixic acid (\code{NAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB02&showdescription=no}{J01MB02}), nemonoxacin (\code{NEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MB08&showdescription=no}{J01MB08}), neomycin (\code{NEO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB05&showdescription=no}{J01GB05}), netilmicin (\code{NET}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB07&showdescription=no}{J01GB07}), nitrofurantoin (\code{NIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XE01&showdescription=no}{J01XE01}), nitroxoline (\code{NTR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX07&showdescription=no}{J01XX07}), norfloxacin (\code{NOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA06&showdescription=no}{J01MA06}), norfloxacin/metronidazole (\code{NME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA14&showdescription=no}{J01RA14}), norfloxacin/tinidazole (\code{NTI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA13&showdescription=no}{J01RA13}), novobiocin (\code{NOV}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01XX95&showdescription=no}{QJ01XX95}), ofloxacin (\code{OFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA01&showdescription=no}{J01MA01}), ofloxacin/ornidazole (\code{OOR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01RA09&showdescription=no}{J01RA09}), oleandomycin (\code{OLE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA05&showdescription=no}{J01FA05}), omadacycline (\code{OMC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA15&showdescription=no}{J01AA15}), orbifloxacin (\code{ORB}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA95&showdescription=no}{QJ01MA95}), oritavancin (\code{ORI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA05&showdescription=no}{J01XA05}), oxacillin (\code{OXA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CF04&showdescription=no}{J01CF04}), oxytetracycline (\code{OXY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA06&showdescription=no}{J01AA06}), panipenem (\code{PAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH55&showdescription=no}{J01DH55}), pazufloxacin (\code{PAZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA18&showdescription=no}{J01MA18}), pefloxacin (\code{PEF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA03&showdescription=no}{J01MA03}), penamecillin (\code{PNM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE06&showdescription=no}{J01CE06}), penimepicycline (\code{PNM1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA10&showdescription=no}{J01AA10}), pheneticillin (\code{PHE}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE05&showdescription=no}{J01CE05}), phenoxymethylpenicillin (\code{PHN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE02&showdescription=no}{J01CE02}), piperacillin (\code{PIP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA12&showdescription=no}{J01CA12}), piperacillin/tazobactam (\code{TZP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR05&showdescription=no}{J01CR05}), pirlimycin (\code{PRL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ51FF90&showdescription=no}{QJ51FF90}), pivampicillin (\code{PVM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA02&showdescription=no}{J01CA02}), pivmecillinam (\code{PME}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA08&showdescription=no}{J01CA08}), plazomicin (\code{PLZ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB14&showdescription=no}{J01GB14}), polymyxin B (\code{PLB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XB02&showdescription=no}{J01XB02}), pradofloxacin (\code{PRA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA97&showdescription=no}{QJ01MA97}), pristinamycin (\code{PRI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FG01&showdescription=no}{J01FG01}), procaine benzylpenicillin (\code{PRB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE09&showdescription=no}{J01CE09}), propicillin (\code{PRP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CE03&showdescription=no}{J01CE03}), prulifloxacin (\code{PRU}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA17&showdescription=no}{J01MA17}), quinupristin/dalfopristin (\code{QDA}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FG02&showdescription=no}{QJ01FG02}), ribostamycin (\code{RST}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB10&showdescription=no}{J01GB10}), rifampicin (\code{RIF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J04AB02&showdescription=no}{J04AB02}), rokitamycin (\code{ROK}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA12&showdescription=no}{J01FA12}), rolitetracycline (\code{RLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA09&showdescription=no}{J01AA09}), roxithromycin (\code{RXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA06&showdescription=no}{J01FA06}), rufloxacin (\code{RFL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA10&showdescription=no}{J01MA10}), sarafloxacin (\code{SAR}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01MA98&showdescription=no}{QJ01MA98}), sarecycline (\code{SRC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA14&showdescription=no}{J01AA14}), sisomicin (\code{SIS}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB08&showdescription=no}{J01GB08}), sitafloxacin (\code{SIT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA21&showdescription=no}{J01MA21}), solithromycin (\code{SOL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA16&showdescription=no}{J01FA16}), sparfloxacin (\code{SPX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA09&showdescription=no}{J01MA09}), spiramycin (\code{SPI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA02&showdescription=no}{J01FA02}), streptoduocin (\code{STR}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA02&showdescription=no}{J01GA02}), streptomycin (\code{STR1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GA01&showdescription=no}{J01GA01}), sulbenicillin (\code{SBC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA16&showdescription=no}{J01CA16}), sulfadiazine (\code{SDI}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC02&showdescription=no}{J01EC02}), sulfadiazine/tetroxoprim (\code{SLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE06&showdescription=no}{J01EE06}), sulfadiazine/trimethoprim (\code{SLT1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE02&showdescription=no}{J01EE02}), sulfadimethoxine (\code{SUD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED01&showdescription=no}{J01ED01}), sulfadimidine (\code{SDM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB03&showdescription=no}{J01EB03}), sulfadimidine/trimethoprim (\code{SLT2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE05&showdescription=no}{J01EE05}), sulfafurazole (\code{SLF}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB05&showdescription=no}{J01EB05}), sulfaisodimidine (\code{SLF1}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB01&showdescription=no}{J01EB01}), sulfalene (\code{SLF2}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED02&showdescription=no}{J01ED02}), sulfamazone (\code{SZO}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED09&showdescription=no}{J01ED09}), sulfamerazine (\code{SLF3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED07&showdescription=no}{J01ED07}), sulfamerazine/trimethoprim (\code{SLT3}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE07&showdescription=no}{J01EE07}), sulfamethizole (\code{SLF4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB02&showdescription=no}{J01EB02}), sulfamethoxazole (\code{SMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC01&showdescription=no}{J01EC01}), sulfamethoxypyridazine (\code{SLF5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED05&showdescription=no}{J01ED05}), sulfametomidine (\code{SLF6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED03&showdescription=no}{J01ED03}), sulfametoxydiazine (\code{SLF7}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED04&showdescription=no}{J01ED04}), sulfametrole/trimethoprim (\code{SLT4}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE03&showdescription=no}{J01EE03}), sulfamoxole (\code{SLF8}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EC03&showdescription=no}{J01EC03}), sulfamoxole/trimethoprim (\code{SLT5}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE04&showdescription=no}{J01EE04}), sulfanilamide (\code{SLF9}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB06&showdescription=no}{J01EB06}), sulfaperin (\code{SLF10}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED06&showdescription=no}{J01ED06}), sulfaphenazole (\code{SLF11}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01ED08&showdescription=no}{J01ED08}), sulfapyridine (\code{SLF12}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB04&showdescription=no}{J01EB04}), sulfathiazole (\code{SUT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB07&showdescription=no}{J01EB07}), sulfathiourea (\code{SLF13}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EB08&showdescription=no}{J01EB08}), sultamicillin (\code{SLT6}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR04&showdescription=no}{J01CR04}), talampicillin (\code{TAL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA15&showdescription=no}{J01CA15}), tebipenem (\code{TBP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01DH06&showdescription=no}{J01DH06}), tedizolid (\code{TZD}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XX11&showdescription=no}{J01XX11}), teicoplanin (\code{TEC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA02&showdescription=no}{J01XA02}), telavancin (\code{TLV}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA03&showdescription=no}{J01XA03}), telithromycin (\code{TLT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA15&showdescription=no}{J01FA15}), temafloxacin (\code{TMX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA05&showdescription=no}{J01MA05}), temocillin (\code{TEM}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA17&showdescription=no}{J01CA17}), tetracycline (\code{TCY}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA07&showdescription=no}{J01AA07}), ticarcillin (\code{TIC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CA13&showdescription=no}{J01CA13}), ticarcillin/clavulanic acid (\code{TCC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01CR03&showdescription=no}{J01CR03}), tigecycline (\code{TGC}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01AA12&showdescription=no}{J01AA12}), tilbroquinol (\code{TBQ}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=P01AA05&showdescription=no}{P01AA05}), tildipirosin (\code{TIP}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA96&showdescription=no}{QJ01FA96}), tilmicosin (\code{TIL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA91&showdescription=no}{QJ01FA91}), tobramycin (\code{TOB}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01GB01&showdescription=no}{J01GB01}), tosufloxacin (\code{TFX}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA22&showdescription=no}{J01MA22}), trimethoprim (\code{TMP}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EA01&showdescription=no}{J01EA01}), trimethoprim/sulfamethoxazole (\code{SXT}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01EE01&showdescription=no}{J01EE01}), troleandomycin (\code{TRL}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01FA08&showdescription=no}{J01FA08}), trovafloxacin (\code{TVA}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01MA13&showdescription=no}{J01MA13}), tulathromycin (\code{TUL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA94&showdescription=no}{QJ01FA94}), tylosin (\code{TYL}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA90&showdescription=no}{QJ01FA90}), tylvalosin (\code{TYL1}, \href{https://atcddd.fhi.no/atcvet/atcvet_index/?code=QJ01FA92&showdescription=no}{QJ01FA92}), vancomycin (\code{VAN}, \href{https://atcddd.fhi.no/atc_ddd_index//?code=J01XA01&showdescription=no}{J01XA01}) } \section{Interpretation of SIR}{